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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for iron
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
derived Dietary Reference Values (DRVs) for iron. These include Average Requirement (AR) and Population 
Reference Intake (PRI). For adults, whole-body iron losses were modelled using data from US adults. Predicted 
absorption values, at a serum ferritin concentration of 30 µg/L, of 16 % for men and 18 % for women were used 
to convert physiological requirements to dietary iron intakes. In men, median whole-body iron losses are 
0.95 mg/day, and the AR is 6 mg/day. The PRI, calculated as the dietary requirement at the 97.5
th
 percentile, is 
11 mg/day. For postmenopausal women, the same DRVs as for men are proposed. In premenopausal women, 
additional iron is lost through menstruation but, because losses are highly skewed, the Panel set a PRI of 
16 mg/day to cover requirements of 95 % of the population. In infants and children, requirements were 
calculated factorially, taking into consideration the needs for growth, replacement of losses and percentage iron 
absorption from the diet (10 % up to 11 years and 16 % thereafter). PRIs were estimated using a coefficient of 
variation of 20 %. They are 11 mg/day in infants (7–11 months), 7 mg/day in children aged 1–6 years and 
11 mg/day in children aged 7–11 years and boys aged 12–17 years. For girls aged 12–17 years, the PRI of 
13 mg/day is the midpoint of the calculated dietary requirement of 97.5 % of girls and the PRI for 
premenopausal women; this approach allows for the large uncertainties in the rate and timing of pubertal growth 
and menarche. For pregnant and lactating women, for whom it was assumed that iron stores and enhanced 
absorption provide sufficient additional iron, DRVs are the same as for premenopausal women. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a Scientific Opinion on Dietary Reference Values (DRVs) 
for the European population, including iron. These include Average Requirement (AR) and Population 
Reference Intake (PRI). 
Iron is required for oxygen transport, electron transfer, oxidase activities and energy metabolism. The 
main components of the body that contain iron are erythrocyte haemoglobin and muscle myoglobin, 
liver ferritin, and haem and non-haem enzymes. 
Dietary iron consists of haem (from animal tissues) and non-haem (including ferritin) iron. Foods that 
contain relatively high concentrations of iron include meat, fish, cereals, beans, nuts, egg yolks, dark 
green vegetables, potatoes and fortified foods. 
Iron is inefficiently and variably absorbed, depending on dietary and host-related factors. Iron 
absorption occurs primarily in the duodenum. A proportion of non-haem iron in foods is solubilised in 
the gastrointestinal lumen, reduced by duodenal cytochrome b reductase to Fe
2+
 and transported into 
the enterocyte by the transmembrane divalent metal transporter 1. There, iron is either stored as 
ferritin, some of which is subsequently lost when the cells are sloughed, is taken up by mitochondria 
for the synthesis of haem, or is transported across the basolateral membrane by ferroportin where it is 
carried in the circulation as diferric-transferrin after oxidation to Fe
3+
 by hephaestin. The mechanisms 
of absorption of haem iron and ferritin iron are uncertain, but once taken up iron is released from haem 
iron by haem oxygenase and then follows the same pathways as non-haem iron. 
Homeostasis is mediated via the regulation of iron absorption, as there are no active pathways for 
excreting iron. In healthy individuals, the mucosal uptake and transfer of iron is inversely related to 
systemic serum ferritin concentrations, and control is exerted via the expression of the hepatic 
hormone hepcidin. 
If the supply of iron is insufficient to meet physiological requirements, iron stores will be mobilised 
and iron deficiency will develop once the stores are exhausted. Iron deficiency anaemia (a microcytic 
anaemia with haemoglobin concentrations below normal) is the most common nutritional deficiency 
disorder, being found in all countries of the world. Subjects at greatest risk are those with high iron 
requirements owing to growth (infants, children, pregnant women) or high losses (women with high 
menstrual losses), or those with impaired absorption, e.g. in the presence of infection/inflammation. 
The risk of systemic iron overload from dietary sources is negligible with normal intestinal function. 
Chronic iron overload may occur as a result of specific clinical conditions and genetic mutations, but 
there is no evidence that heterozygotes for haemochromatosis are at an increased risk of iron overload. 
The Panel considers that health outcomes cannot be used to derive DRVs for iron because of the 
uncertainties in intake measurements, the poor correlation between intake and iron status, and the 
presence of confounders that prevent the determination of dose–response relationships and the 
assessment of risks associated with deficiency or excess. 
A factorial approach was used to derive dietary iron requirements. Data on iron turnover and total 
obligatory iron losses from the body (including skin, sweat, urine and faeces) obtained from 
radioisotope dilution measurements were used to determine iron requirements in men and 
premenopausal women. Although these data were collected from a North American population group, 
the Panel agreed to use them as a basis for the estimation and probability modelling of the mean and 
approximate variability of distribution percentiles for the iron losses of adult men and premenopausal 
women in the European Union (EU) population. Summary statistics were estimated for the main 
variables related to iron losses for men and premenopausal women and for associations among the 
variables which were considered to be explanatory for iron losses. From these, a regression model 
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equation for iron losses (as mg/day) was fitted to the data using a set of potentially relevant variables. 
This stage included an assessment of outliers and goodness of fit. The regression model was then used 
to derive a distribution for iron losses, combining the model equation with parametric distributions 
fitted to the sampling observations of each of the explanatory variables. 
Dietary (haem and non-haem) iron absorption was estimated from a probability model, based on 
measures of iron intake and status in a representative group of men and women from the UK National 
Diet and Nutrition Survey. This provides estimates of total iron absorption from a mixed Western-
style diet at any level of iron status. The Panel selected a target value of 30 µg/L for serum ferritin 
concentration. At this level, the predicted iron absorption is 16 % in men and 18 % in premenopausal 
women. The Panel decided to use 16 % for adults (except premenopausal women) and children aged 
12–17 years when converting physiological requirements into dietary intakes, based on the assumption 
that the relationship between serum ferritin concentration and efficiency of absorption holds for all age 
groups, as there are no indications that age will affect the relationship. 
In men, the 50
th
 percentile of the model-based distribution of obligatory iron losses is 0.95 mg/day. 
The 90
th
, 95
th
 and 97.5
th
 percentiles are, respectively, equal to iron losses of 1.48, 1.61 and 
1.72 mg/day. Using 16 % iron absorption to convert the physiological requirement into the dietary 
requirement results in a calculated dietary requirement at the 50
th
 percentile of 5.9 mg/day and of 
10.8 mg/day at the 97.5
th
 percentile. After rounding, an AR of 6 mg/day and a PRI of 11 mg/day were 
set. In the absence of information on the iron requirement for postmenopausal women and despite 
their lower body weight, the Panel decided to set the same DRVs for postmenopausal women as those 
set for adult men. 
In premenopausal women, the 50
th
 percentile of the model-based distribution of obligatory iron losses 
is 1.34 mg/day. The 90
th
, 95
th
 and 97.5
th
 percentiles are, respectively, equal to iron losses of 2.44, 2.80 
and 3.13 mg/day. Using 18 % absorption to convert the physiological iron requirement into the dietary 
requirement results in a calculated dietary requirement at the 50
th
 percentile of 7.4 mg/day. Intakes 
meeting the dietary iron requirement of approximately 90, 95 and 97.5 % of the premenopausal 
women are calculated as 13.6, 15.6 and 17.4 mg/day, respectively. After rounding, the Panel derived 
an AR of 7 mg/day and a PRI of 16 mg/day for premenopausal women. The Panel considers that the 
PRI meets the dietary requirement of 95 % of women in their reproductive years and is derived from a 
group of premenopausal women, some of whom used oral contraceptives, as is the case in the EU. The 
Panel decided that women with very high iron losses should not be included in the premenopausal 
group, as this would result in unrealistically high DRVs for the majority of this population group. 
In infants aged 7–11 months, the requirement for absorbed iron is 0.79 mg/day to replace obligatory 
losses (0.19 mg/day) and increase haemoglobin mass, tissue iron and storage iron (0.6 mg/day). 
Assuming 10 % absorption, this gives an AR of 8 mg/day and, based on a coefficient of variation 
(CV) of 20 %, which allows for high individual variation relating to growth rate, iron losses, 
absorption and dietary patterns, the PRI is 11 mg/day. In children aged 1–6 years, the AR is 5 mg/day, 
calculated from the sum of the requirements for growth (0.25 mg/day for ages 1–3 years and 
0.27 mg/day for ages 4–6 years) and obligatory losses of 0.022 (1–3 years) and 0.012 (4–6 
years) mg/kg body weight per day, and absorption of 10 %. Based on a CV of 20 %, the PRI is 
7 mg/day. In children aged 7–11 years, requirements for growth increase to 0.39 mg/day, but losses 
per kilogram of body weight do not change. Assuming 10 % absorption, the AR (after rounding) is 
8 mg/day and, based on a CV of 20 %, the PRI is 11 mg/day. 
In boys and girls aged 12–17 years, the requirements for absorbed iron are 1.27 and 1.13 mg/day, 
respectively, calculated from losses of 0.012 mg/kg body weight per day and menstrual blood losses of 
0.25 mg/day in girls, and growth needs of 0.61 mg/day for boys and 0.26 mg/day for girls. Assuming 
16 % absorption, the AR (after rounding) is 8 mg/day for boys and 7 mg/day for girls. The PRI for 
boys is 11 mg/day based on a CV of 20 %. In girls, because of the uncertainties related to the rate and 
timing of physiological development and the onset of menarche, and because of the skewed 
distribution of menstrual losses, the Panel decided to set the PRI as the mean of the calculated dietary 
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requirement of 97.5 % of girls aged 12–17 years (9.9 mg/day) and the PRI for premenopausal women 
(16 mg/day). After rounding, the PRI is 13 mg/day for girls. 
In pregnancy, iron intake should cover basal losses during the first trimester, taking into account the 
cessation of menstruation. The requirements then increase exponentially, and this is associated with a 
dramatic increase in the efficiency of iron absorption. The total quantity of iron required for a 
singleton pregnancy is 835 mg. If the serum ferritin concentration is 30 µg/L at conception, around 
120 mg of stored iron can be mobilised to support the pregnancy, which means that the total dietary 
requirement of iron is 715 mg. If the relevant percentage absorption figures determined from a study 
in pregnant women are applied to the entire pregnancy (7.2 % during weeks 0–23, 36.3 % during 
weeks 24–35 and 66.1 % during weeks 36–40 for non-haem iron, plus 25 % absorption for haem iron 
throughout the whole pregnancy), the total quantity of iron absorbed from a diet providing 13 mg 
iron/day is 866 mg. The Panel notes that using the absorption figures from single-meal studies in 
fasting mothers may be an overestimate, but, nevertheless, the quantity of iron absorbed is well in 
excess of the estimated 715 mg calculated by a factorial approach, and the progressive fall in serum 
ferritin concentration will be accompanied by an increased efficiency of absorption, irrespective of 
other homeostatic mechanisms. The Panel therefore considers that no additional iron is required in 
pregnancy. 
During lactation, the quantity of iron secreted in breast milk is approximately 0.24 mg/day. When this 
is added to basal losses of 1.08 mg/day (obtained from data in postmenopausal women), the 
requirement for absorbed iron during the first months of lactation is calculated to be 1.3 mg/day, 
assuming that menstruation has not yet resumed. This requirement is slightly less than in non-
pregnant, non-lactating women, but, for depleted iron stores to be replenished and to cover losses of 
iron when menstruation is re-established, the Panel considers that the AR and PRI for lactating women 
are the same as for non-pregnant women of childbearing age. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and, if necessary, to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice. 
In 1993, the SCF adopted an opinion on nutrient and energy intakes for the European Community.
4
 
The report provided Reference Intakes for energy, certain macronutrients and micronutrients, but it did 
not include certain substances of physiological importance, for example dietary fibre. 
Since then new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context, EFSA is requested to consider the existing Population Reference Intakes for energy, 
micro- and macronutrients and certain other dietary components, to review and complete the SCF 
recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre. 
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context, EFSA is asked to provide assistance on the translation of nutrient based 
recommendations for a healthy diet into food based recommendations intended for the population as a 
whole. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No. 178/2002,
5
 the 
Commission requests EFSA to review the existing advice of the Scientific Committee for Food on 
population reference intakes for energy, nutrients and other substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition. 
In the first instance EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically advice is requested on the following dietary components: 
 Carbohydrates, including sugars; 
 Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
 Protein; 
                                                     
4 Scientific Committee for Food, 1993. Nutrient and energy intakes for the European Community. Reports of the Scientific 
Committee for Food, 31st series. Food – Science and Technique, European Commission, Luxembourg, 248 pp. 
5 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1–24. 
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 Dietary fibre. 
Following on from the first part of the task, EFSA is asked to advise on population reference intakes 
of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal nutrition 
(food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
In 1993, the Scientific Committee for Food (SCF) adopted an opinion on nutrient and energy intakes 
for the European Community (SCF, 1993). For iron, the SCF set Population Reference Intakes (PRIs) 
for infants, boys and non-menstruating girls, adult men, and lactating and postmenopausal women. For 
menstruating girls and women, intakes at the proposed values were considered to cover the needs of 
90 or 95 % of the population. No PRI specific for pregnant women was proposed. For non-pregnant, 
non-lactating adults, an Average Requirement (AR) and a Lowest Threshold Intake were also 
proposed. 
2. Definition/category 
2.1. Chemistry 
Iron (atomic mass 55.85 Da, atomic number 26) is the fourth most common element in the Earth’s 
crust. It has oxidation states from –2 to +6, of which the most biologically relevant are the ferrous 
(Fe
2+
) and ferric (Fe
3+
) states. Biologically, iron complexes with nitrogen, like in the porphyrin ring of 
haem, and with sulphur forming iron–sulphur clusters, which are thought to have underpinned the 
evolution of life forms and the release of oxygen into the atmosphere. In higher life forms, iron–
sulphur clusters are involved in mitochondrial energy metabolism, the synthesis of the oxygen-binding 
molecule (haem) and in the regulation of cellular acquisition, homeostasis and the use of iron. 
2.2. Function of iron 
2.2.1. Biochemical functions 
Iron plays a major role in (1) oxygen transport (haemoglobin) and short-term oxygen storage 
(myoglobin), (2) haem enzymes involved in electron transfer (e.g. cytochromes a, b and c, and 
cytochrome c oxidase) and oxidase activities (e.g. cytochrome P-450 mixed function oxidases, 
oxidases and peroxidases) and (3) iron–sulphur clusters in energy transduction and oxido-reductase 
activities (e.g. succinate, isocitrate and NADPH dehydrogenase, xanthine oxidases). It is also a 
cofactor in various non-haem-containing enzymes (e.g. phenylalanine, tryptophan and tyrosine 
hydroxylases, and proline and lysine hydroxylases). 
Iron is necessary for most, if not all, pathways for energy and substrate metabolism. Globin-haems are 
transporters of oxygen, carbon dioxide, carbon monoxide and nitric oxide (e.g. haemoglobin and 
neuroglobin), stores of oxygen (e.g. myoglobin and neuroglobin) and scavengers of free radicals 
(Brunori and Vallone, 2006). The cytochrome P-450 oxidase system embraces over 11 000 diverse 
activities including the metabolism of endogenous substrates such as organic acids, fatty acids, 
prostaglandins, steroids and sterols including cholesterol and vitamins A, D and K. The citric acid 
cycle and respiratory chain involves six different haem proteins and six iron–sulphur clusters. 
2.2.2. Health consequences of deficiency and excess 
2.2.2.1. Deficiency 
The features of iron deficiency are continuously changing. Many have been traditionally attributed to 
iron deficiency, such as koilonychia (spoon-shaped nails), soft nails, glossitis, cheilitis (dermatitis at 
the corner of the mouth), mood changes, muscle weakness and impaired immunity, but they can also 
be secondary features of other nutritional deficiencies. Many studies examining relationships between 
iron deficiency and adverse sequelae use anaemia as a surrogate indicator of iron deficiency. Iron 
deficiency anaemia, defined as the combination of iron deficiency and anaemia (low haemoglobin), 
can be distinguished from that caused by other nutritional deficiencies, such as folate or cobalamin 
deficiency, by characteristic changes in the shape, density of haem content and size of red blood cells. 
However, the pathogenesis of iron deficiency may not be dietary. Non-dietary causes of iron 
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deficiency and anaemia include conditions that cause gastrointestinal blood loss or malabsorption, e.g. 
cancer and inflammatory bowel disease, intestinal infections and parasitism. Blood loss from the 
genito-urinary and respiratory tracts may also contribute to iron deficiency (Steketee, 2003). 
There is evidence that adolescent girls who were anaemic as toddlers have altered memory and spatial 
awareness. Iron-deficient and anaemic infants and children have delayed attention, poor recognition 
memory, reduced reward-seeking behaviours and impoverished social interactions. Some studies have 
shown an association between iron deficiency anaemia in early childhood and long-lasting poor 
cognitive and behavioural performance. However, much of this research is confounded by socio-
economic factors and by the difficulties in standardising the outcome measurements (McCann and 
Ames, 2007). Existing studies imply that iron-responsive defects occur at haemoglobin concentrations 
below 80, 95 and 110 g/L. However, in these studies, the degree of anaemia has not been considered 
as a continuous variable and it is difficult to characterise a specific threshold of anaemia (or even the 
degree of iron deficiency) for these phenomena. Thus, although the effects of early life deficiencies 
may persist and be irredeemable by subsequent iron supplementation, the vulnerable periods have not 
been well characterised. 
In women in whom anaemia has been induced by phlebotomy, impaired muscle endurance capacity 
and energetic efficiency are apparent as haemoglobin concentrations drop below 130 g/L, and the 
effect becomes greater with every 10 g/L fall in haemoglobin (Gardner et al., 1977). In related studies, 
iron-responsive impaired muscle endurance capacity has been demonstrated in groups without 
anaemia but with serum ferritin concentrations < 16 µg/L (Brownlie et al., 2004). 
Iron deficiency is a risk factor for increased blood concentrations of cadmium (Olsson et al., 2002; 
Gallagher et al., 2011) and lead (Zimmermann, 2008; Shah et al., 2011). For cadmium, this is probably 
due to enhanced intestinal absorption in the presence of raised levels of divalent metal transporter 1 
(DMT1) in iron deficiency. For lead, the mechanism is less clear (Bannon et al., 2003), but genotype 
appears to be a contributory factor; HFE variants have been reported to be associated with increased 
blood lead concentrations (Hopkins et al., 2008). 
In animal models, iron deficiency, with or without anaemia, is associated with inefficient energy 
metabolism, with altered glucose and lactate utilisation. It is also associated with reduced muscle 
myoglobin content, reducing muscle strength and endurance. Cytochrome c oxidase activity in muscle 
and the intestinal mucosa may be reduced. Impaired collagen synthesis and osteoporosis may occur, 
and the latter may be due, in part, to impaired hydroxylation of vitamin D (DeLuca, 1976; Tuderman 
et al., 1977). Similarly, altered vitamin A and prostaglandin metabolism has been noted (Oliveira et 
al., 2008). In the brain, dopaminergic and serotonin neurotransmission may be reduced in areas such 
as the substantia nigra, cerebellar nuclei, globus pallidus and hippocampus, and neuromyelination and 
synapse and dendrite development may be defective. Membrane fatty acid profiles (e.g. reduced 
docosahexaenoic acid content) can be altered, thereby affecting neuronal function. Functional 
impairments include delayed responses to auditory and visual stimuli and impaired memory and 
spatial navigation. These manifestations provide plausible mechanistic bases for inferring that iron 
deficiency, with or without anaemia, has similar effects in humans. The risk would be greater during 
periods of rapid growth (i.e. in infancy, childhood and adolescence and during gestation) and the 
tissues involved would be those with a rapid turnover, specialised function and high energy 
dependence, such as immunocytes, enterocytes, brain and muscle. It is important to note that these 
defects have been associated with severe iron deprivation or deficiency that are not representative of 
deficiencies customarily encountered in human nutrition, and that there are few data to enable the 
construction of dose–response curves, relating these outcomes to lesser degrees of iron deficiency. 
2.2.2.2. Excess 
The risk of systemic iron overload from dietary sources is negligible with normal intestinal function. 
Acute large intakes of iron (e.g. 20 mg or more elemental iron/kg body weight), particularly without 
food, cause corrosive haemorrhagic necrosis of the intestinal mucosa, leading to loose stools and blood 
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loss, hypovolaemic shock, damaging failure of systemic organs and death. Early clinical phenomena 
of this damage (gastritis, nausea, abdominal pain and vomiting) have been used to set exposure levels 
for health guidance. 
Chronic iron overload may occur in individuals affected by haemolytic anaemias, 
haemoglobinopathies or one of the haemochromatoses and results in increasing sequestration of iron 
in ferritin and haemosiderin in all tissues throughout the body. Eventually, the haemosiderin degrades 
releasing iron, which in turn causes oxidative architectural and functional tissue damage resulting in 
cardiomyopathy, arthropathies, diabetes mellitus and neurological disease. There is no evidence that 
heterozygotes for haemochromatoses are at an increased risk of iron overload compared with the rest 
of the population. 
African iron overload, previously called Bantu cirrhosis, is an ecogenetic disorder arising from an, as 
yet, uncharacterised genetic defect combined with increased exposure to iron from food and beer that 
had been prepared in iron utensils. The increased iron deposition affects the Kupffer 
reticuloendothelial cells of the liver rather than the hepatocytes, which is the case in the other iron 
overload syndromes. 
No Tolerable Upper Intake Level (UL) has been set for iron by the SCF or EFSA. Adverse 
gastrointestinal effects have been reported after short-term ingestion of non-haem iron preparations at 
doses of 50–60 mg/day, particularly if taken without food. EFSA (2004) considered that these adverse 
gastrointestinal effects are not a suitable basis to establish a UL for iron from all sources. EFSA (2004) 
also considered that a UL cannot be established for iron based on iron overload, because there were 
inadequate data to enable the construction of reliable response curves between intake, body burden, 
homeostatic adaptations and adverse health effects, including increased risk of chronic diseases such 
as cardiovascular disease, diabetes and cancer. The absence of convincing evidence of a causal 
relationship between iron intake or stores and chronic diseases was noted (EFSA, 2004). 
The Institute of Medicine (IOM, 2001) set a UL based on a Lowest Observed Adverse Effect Level 
(LOAEL) for gastrointestinal side effects observed in Swedish adults following supplementation with 
ferrous fumarate (60 mg/day) in addition to an estimated dietary iron intake of 11 mg/day. Using an 
uncertainty factor of 1.5, the UL was set at 45 mg/day for males and females aged 14 years and older, 
including pregnant and lactating women. For infants and children, the UL was set at 40 mg/day based 
on a No Observed Adverse Effect Level (NOAEL) for adverse gastrointestinal effects of 30 mg/day 
observed in toddlers, taking into account a dietary intake of about 10 mg/day and using an uncertainty 
factor of 1. 
2.3. Physiology and metabolism 
The systemic burden and homeostasis of iron is mediated via regulation of iron absorption and the 
deposition or sequestration of the element into intracellular pools, mainly in the reticuloendothelial 
system (RES) and liver. A major driver of systemic iron homeostasis is the cellular and mitochondrial 
need for iron and oxygen (hypoxia). 
2.3.1. Intestinal absorption 
2.3.1.1. Mechanisms of intestinal uptake and transfer of iron 
Iron absorption occurs mainly in the duodenum and proximal small intestine. The contribution by the 
distal small intestine and the colon is uncertain and is probably very small. Absorption involves the 
uptake of iron from the intestinal lumen into enterocytes, its transfer within enterocytes and its 
subsequent translocation across the basolateral membrane to carriers in the plasma of the portal 
circulation. 
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The enterocytic carrier mechanisms involved in iron uptake and transfer are responsive to the systemic 
need for the element. The body has no specific mechanism of excreting iron, and the rigorous control 
of the uptake and transfer of iron into the body is essential for preventing iron overload. 
Iron released by the digestion of food includes non-haem iron, haem iron and ferritin. Solubilisation of 
non-haem iron occurs in the acidic environment of the stomach and proximal duodenum, and uptake 
of inorganic iron occurs mainly in the duodenum and proximal jejunum, whereas the alkaline 
environment of the jejunum reduces the solubility of free, unbound iron. Uptake into enterocytes is 
initiated by the conversion of ferric (Fe
3+
) to ferrous (Fe
2+
) iron by duodenal cytochrome b reductase 
(DcytB/ferric reductase), which is located on the luminal surface of the enterocytes. The iron is then 
co-transported with protons (possibly provided by gastric hydrochloric acid or by a co-located Na
+
/H
+
 
exchanger) by transmembrane DMT1 across the apical membrane into the cytoplasm (Montalbetti et 
al., 2013). 
The mechanism for haem iron uptake remains unclear. Two main pathways have been proposed: 
receptor-mediated endocytosis of haem and direct transport into the intestinal enterocyte by haem (and 
possibly non-haem) iron transporters (West and Oates, 2008). A putative mucosal haem carrier 
protein 1 (Shayeghi et al., 2005) is now recognised to be principally a folate transporter. A specific 
haem transporter has been found in macrophages but not as yet in enterocyte apical membranes. 
There is controversy over the mechanism of absorption of ferritin. It has been reported to involve a 
carrier-mediated endocytic pathway into the enterocyte followed by lysosomal dissolution of the 
ferritin core to release the iron (Kalgaonkar and Lonnerdal, 2008a, 2008b; San Martin et al., 2008), but 
some (or all) of the iron may be released from the core of the ferritin molecule during gastric digestion 
and subsequently taken up by DMT1 (Hoppler et al., 2008). 
In the enterocyte, iron is released from haem by haem oxygenase, and forms a common exchangeable 
pool with non-haem iron and, presumably, with any iron that has been released by lysosomal 
degradation of ferritin. Iron from the enterocyte pool can enter three different pathways: (1) it can be 
transferred (in the ferrous state) to a transmembrane basal transporter (ferroportin 1) for translocation 
out of the enterocyte to carrier molecules in the portal plasma; (2) some may be sequestered in ferritin 
iron depots (and shed into the gut lumen at the end of the enterocyte’s lifespan); or (3) a small quantity 
may be taken into the mitochondria for haem synthesis. 
The export of iron across the basolateral membrane by ferroportin requires its oxidation to the ferric 
state. This is done by hephaestin, which is a copper-dependent ferroxidase bound to the basolateral 
membrane. The ferric iron is then transferred to apotransferrin for transport to the liver and systemic 
circulation. 
2.3.1.2. Regulation of absorption 
The regulation of the intestinal absorption of iron is integrated with that of systemic iron kinetics and 
distribution. Other tissues, particularly the central nervous system, and macrophages have uptake 
(DMTs) and export (ferroportins) systems for iron that are analogous to those in the enterocyte, and 
which respond similarly to iron deficiency, and also to stressors, inflammation and hypoxia (see 
below). In healthy subjects, the intestinal mucosal uptake and transfer of dietary iron is inversely 
related to serum ferritin concentrations, particularly at concentrations below 60 µg/L (Ganz, 2013). 
These reductions in the absorption of iron are mediated by a hepatic hormone, hepcidin, and by control 
of expression of the iron transport systems in the enterocytes. 
Hepcidin is also produced to a lesser extent by monocytes, macrophages and adipocytes (Ganz, 2013). 
Hepcidin induces the degradation of ferroportin, thereby reducing the enterocytic export of iron that 
has been taken up from the gut lumen. The iron trapped in the enterocytes is sequestered in ferritin and 
is subsequently lost into the gut lumen when the cells are shed. It has also been shown in a mouse 
model that hepcidin reduces DMT1 activity (Chung et al., 2009). 
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Hepcidin production is decreased when iron depots are low, when iron utilisation, such as 
erythropoiesis, is increased and when plasma transferrin concentration is reduced. It is increased when 
tissue, particularly hepatic iron depots and circulating transferrin concentrations, are high. Correlations 
have been noted between hepcidin mRNA levels and iron content in human liver tissue, and between 
serum concentrations of ferritin and hepcidin (Ganz, 2013). 
The expression of enterocytic carriers involved in the uptake (DMTs) and transfer (ferroportins) of 
iron is mediated by an interaction between transferrin and transferrin receptor 1 on the basolateral 
surfaces of the enteroblasts in the mucosal crypts. This crypt programming becomes effective when 
the enterocytes have matured and migrated to the villi (Montalbetti et al., 2013). Thus, this mechanism 
takes 1–2 days to modify iron uptake and transfer, whereas responses to increased hepcidin takes 
about 8 hours (Ganz, 2013). Hepcidin production is also stimulated by cytokines associated with 
inflammation, such as interleukins 1 and 6. As well as reducing intestinal absorption of iron, it also 
induces a “shut down” of systemic iron turnover mediated both through the degradation of cellular 
ferroportins, hence blocking the export of iron, and by reducing the cellular uptake of iron. This 
response to inflammation overrides adaptation to an inadequate iron supply and sustained 
inflammation or stress, e.g. frequent infections and chronic inflammatory diseases can induce a 
functional iron deficiency including anaemia in people with an adequate body iron content. This 
situation is known as the anaemia of chronic disease (Section 2.4). 
Hepcidin production is also down-regulated by hypoxia. Hypoxic conditions, including iron deficiency 
and anaemia, induce the production of hypoxia-inducible factors and, possibly, a bone marrow factor, 
both of which depress hepcidin expression and stimulate erythropoiesis, thereby ensuring an iron 
supply for red blood cell production (Ganz, 2013). 
2.3.2. Dietary iron forms and bioavailability 
Dietary iron consists of haem iron and non-haem iron; the latter includes ferritin, which is present in 
some animal and plant foods, particularly liver and legume seeds, but this form of iron makes only a 
small contribution to total iron intake in European diets. Small amounts of haem iron are present in 
some plants and fungi. Mixed diets provide about 90 % of the dietary iron as non-haem iron (Milman, 
2011; Jakszyn et al., 2013), the remainder being haem iron from animal foods (in non-vegetarian 
diets). The haem iron content of meat (from haemoglobin and myoglobin) varies considerably (Cross 
et al., 2012). Balder et al. (2006) undertook a literature search to obtain data for deriving the mean 
proportion of haem iron relative to total iron for beef, pork, chicken and fish. They selected only those 
studies that measured total iron directly and, after lipid extraction, haem iron in the same meat sample. 
The proportion of haem iron from total iron was 69 % for beef; 39 % for pork, ham, bacon, pork-based 
luncheon meats and veal; 26 % for chicken and fish; and 21 % for liver. Haem iron may be denatured 
during cooking (Martinez-Torres et al., 1986), and some iron is lost, according to the type of cooking. 
For example, losses of haem and non-haem iron are greater when lamb meat is boiled than when it is 
grilled (Pourkhalili et al., 2013). 
Fortification iron, commonly added to cereals and infant foods, is usually an iron salt or elemental 
iron, and percentage absorption varies greatly depending on chemical form and solubility in the 
gastrointestinal tract and the composition of foods consumed at the same time. 
Bioavailability is a measure of the absorption and utilisation (haemoglobin incorporation) of dietary 
iron, and is expressed as either a percentage or a fraction of the total iron intake. The availability of 
iron for absorption is dependent on the chemical form of iron in the duodenum and small intestine, and 
the physiological requirement that determines the quantity of available iron that is taken up into the 
enterocytes and transported into the blood. It can generally be predicted from measures of body iron 
stores (serum ferritin concentration). Dietary factors that facilitate or hinder intestinal uptake of iron 
become increasingly important when systemic needs are increased. 
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Early studies with radioisotope-labelled foods found that iron from animal foods was better absorbed 
than that from plant foods (Layrisse et al., 1969). Mean haem iron absorption in eight non-anaemic 
men given three radioisotopically labelled meals over one day (non-haem iron intake 16.4 mg, haem 
iron intake 1.0 mg) was 37.3 (standard error (SE) 2.8) % compared with 5.3 (SE 1.8) % for non-haem 
iron (Bjorn-Rasmussen et al., 1974). When radiolabelled haem iron absorption was measured from six 
meals given over two days (20–21 mg iron/day) in iron-replete men (geometric mean serum ferritin 
concentrations ranged from 86 to 110 μg/L) who had been consuming a diet of low or high iron 
bioavailability for a period of 10 weeks (Hunt and Roughead, 2000), absorption was 22 % from high-
bioavailability meals and 21 % from low-bioavailability meals. Absorption values at baseline were not 
significantly different, and this contrasts with non-haem iron absorption, where adaptation to diets of 
differing bioavailability results in alterations in the efficiency of iron absorption. Although there is a 
less marked effect of body iron status on haem than on non-haem iron absorption, the relationship 
needs to be taken into account when interpreting absorption values. In a study using radioisotopically 
labelled rabbit haemoglobin to label four meals per day (total iron intake 13 mg/day) for five days, the 
mean percentage absorption of haem iron was 35 % in 12 male blood donors (serum ferritin 
concentration 37 ± 16 μg/L), and 23 % in 19 non-blood donors (serum ferritin concentration 
91 ± 37 μg/L). From the regression equation describing the relationship between percentage iron 
absorption and serum ferritin, haem iron absorption was estimated to be 42.3 % when iron stores are 
close to zero (serum ferritin 15 μg/L) (Hallberg et al., 1997). The Panel considers that absorption of 
haem iron is approximately 25 %. 
In addition to systemic factors that control and/or modulate the efficiency of iron absorption, there are 
a number of components in food that affect non-haem iron absorption. A number of studies have been 
undertaken giving single meals labelled with radioisotopes or stable isotopes to subjects after an 
overnight fast, and have consistently shown an enhancing effect of ascorbic acid and muscle tissue 
(meat/poultry/fish), and an inhibitory effect of phytate, polyphenols and calcium (Hurrell and Egli, 
2010). 
Food components classed as inhibitors of non-haem iron absorption generally bind iron in the 
gastrointestinal tract and prevent its absorption, whereas enhancers of non-haem iron absorption either 
form complexes that can be taken up by the intestinal iron transport proteins, and thereby prevent the 
iron from binding to inhibitors, or reduce the more reactive Fe
3+
 iron to its less reactive and more 
soluble Fe
2+
 state. 
Phytate (myo-inositol hexaphosphate) is present at relatively high levels in whole-grain cereals and 
legume seeds and is the main inhibitor of non-haem iron absorption in vegetarian diets. This effect of 
phytate is dose-dependent and starts at very low concentrations (Hallberg et al., 1987). At phytate–iron 
molar ratios of > 6, iron absorption is greatly inhibited from meals containing small amounts of 
enhancing components, whereas, in cereal or soy meals with no enhancers, non-haem iron absorption 
is greatly inhibited by a molar ratio > 1 (Hurrell and Egli, 2010). Food processing methods such as 
milling, germination, fermentation and the addition of phytase enzymes can be used to degrade phytate 
and improve iron absorption from traditional or processed foods (Hurrell, 2004). 
Ethylenediaminetetraacetic acid (EDTA) will also overcome phytate inhibition in fortified foods such 
as wheat flour (Hurrell and Egli, 2010). 
Polyphenol compounds from beverages (tea, coffee, cocoa, red wine), vegetables (spinach, aubergine), 
legumes (coloured beans) and cereals such as sorghum inhibit non-haem iron absorption in a dose-
dependent way, depending on the structure of the phenolic compound and extent of polymerisation; 
the gallate-containing tea polyphenols appear to be most inhibitory (Hurrell et al., 1999). 
Calcium reduces both haem and non-haem iron absorption from single meals and, although the 
mechanism is not fully understood, the reduction in iron uptake and transport into the blood may be 
effected through temporary internalisation of the apical iron transporter DMT1 (Thompson et al., 
2010) and/or changes in expression of the iron transporters (Lonnerdal, 2010). In a small bread meal, 
the effect was dose-dependent up to 300 mg calcium, with 165 mg calcium causing about 50 % 
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inhibition whether added as calcium chloride or 150 mL milk (Hallberg et al., 1991). However, the 
same quantity of milk added to a meal of steak, carrots, French fries, Camembert cheese, apple, bread 
and water had no effect (Galan et al., 1991). 
Muscle tissue from beef, lamb, chicken, pork and fish, as well as liver tissue, enhance iron absorption 
from inhibitory meals (Lynch et al., 1989). The nature of the meat factor is uncertain, but partially 
digested cysteine-containing peptides could potentially reduce Fe
3+
 to Fe
2+
 iron and chelate iron in the 
same way as ascorbic acid (Taylor et al., 1986). Storksdieck genannt Bonsmann and Hurrell (2007) 
reported that, unlike other food proteins, muscle proteins are rapidly digested by pepsin and the arrival 
of many small peptides in the jejunum could be responsible for solubilising iron and improving 
absorption. Conversely, peptides from legume proteins and some milk proteins inhibit iron absorption 
(Hurrell and Egli, 2010). The inhibitory nature of soy protein is reported to be due to the peptides 
formed on digestion of the conglycinin fraction (Lynch et al., 1994), whereas the inhibitory nature of 
casein is thought to be due to non-absorbable complexes formed between iron and casein 
phosphopeptides (Hurrell et al., 1989). 
Ascorbic acid enhances non-haem iron absorption through its ability to reduce Fe
3+
 to Fe
2+
 iron at low 
pH and also its chelating properties (Conrad and Schade, 1968). The effect is dose-dependent over a 
wide range (Cook and Monsen, 1977) and is most pronounced with meals containing high levels of 
inhibitors such as phytate (Hallberg et al., 1989). Ascorbic acid can ameliorate most or all of the 
inhibitory effects of other food components, as well as enhance the absorption of all iron fortification 
compounds (Hurrell, 1992) except NaFeEDTA (Troesch et al., 2009). 
The relevance of results from single-meal absorption studies to whole diets has been questioned. They 
appear to exaggerate the effect of dietary enhancers and inhibitors, probably because of the test 
conditions used for single-meal absorption studies. Absorption efficiency is maximised after an 
overnight fast; in addition, the effects of enhancers and inhibitors are more pronounced when 
consumed in a single meal when there is no opportunity for adaptive responses to modulate 
absorption. The intestinal setting for uptake and transfer of iron, the primary homeostatic mechanism 
to maintain body iron balance, needs time to respond to changes in diet over longer time periods. 
Longer term interventions with single enhancers and inhibitors do not support results from single-meal 
studies, leading to the conclusion that dietary modulators of iron absorption are less important in the 
context of a Western diet than single-meal studies would suggest (Cook et al., 1991). Either there is a 
blunted effect, e.g. with ascorbic acid (Cook and Reddy, 2001) and meat (Reddy et al., 2006), or the 
effect is no longer observed, e.g. with calcium (Reddy and Cook, 1997), and it has been suggested that 
the association between meat consumption and higher iron status is mainly a result of the intake of 
haem iron rather than being an enhancing effect on non-haem iron absorption (Reddy et al., 2006). 
To compare and contrast results from different absorption studies, the individual data are usually 
“normalised” with regard to body iron status, as this is the key determinant of efficiency of absorption. 
One method involves the expression of the results as relative bioavailability by comparing the test 
substance/food/meal with a reference dose of iron, often 3 mg of well-absorbed iron such as ferrous 
sulphate or ascorbate (Layrisse et al., 1969). The observed absorption from the test food/meal is 
corrected to a mean reference value of 40 %, which corresponds to absorption by individuals with 
borderline low iron stores. This is achieved by multiplying test meal absorption values by 40 / R, 
where R is the reference dose absorption (Magnusson et al., 1981). Another widely used method is to 
correct the measured absorption to a serum ferritin concentration corresponding to low levels of iron 
stores (Cook et al., 1991) by using the following equation: 
Log Ac = Log Ao + Log Fo – Log Fr 
where Ac is corrected dietary absorption, Ao is observed absorption, Fo is the observed serum ferritin 
concentration and Fr is the reference serum ferritin value selected. Values of 30 and 40 µg/L have been 
used for Fr (Cook et al., 1991; Reddy et al., 2000). This method does not require administration of a 
reference dose of iron and is therefore simpler to use. 
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The World Health Organization (WHO) and the Food and Agriculture Organization (FAO) proposed 
dietary iron bioavailability values for setting Dietary Reference Values (DRVs) of 15, 10 or 5 % 
depending on the composition of the diet, but the evidence base from which these values were 
obtained was not provided. The highest bioavailability value is for diversified diets with generous 
amounts of meat and/or foods rich in ascorbic acid. The lowest bioavailability is for diets based on 
cereals, tubers and legumes with little or no meat or ascorbic acid-containing fruits and vegetables 
(Allen et al., 2006). 
Collings et al. (2013) undertook a systematic review of studies measuring non-haem iron absorption 
from whole diets, the aim of which was to derive absorption factors that could be used for setting 
DRVs. There was a wide range in mean percentage absorption values reported (0.7–22.9 %), with 
different conversions applied to allow for differences in iron status, so a meta-analysis was not 
possible. It was, however, clear that diet had a greater effect on absorption when iron status (serum 
ferritin concentration) was low, and absorption was higher in the presence of one or more enhancers, 
although single inhibitors did not appear to reduce absorption significantly. 
In pregnant women, there are studies demonstrating a higher efficiency of non-haem iron absorption. 
A longitudinal study reported the geometric mean percentage absorption from a breakfast meal to be 
7 % (95 % confidence interval (CI) 5–11 %) at 12 weeks of gestation, 36 % (95 % CI 28–47 %) at 24 
weeks of gestation and 66 % (95 % CI 57–76 %) at 36 weeks of gestation (Barrett et al., 1994). There 
does not appear to be an increase in haem iron absorption; in pregnant women (32–35 weeks of  
gestation), percentage utilisation (red blood cell incorporation) of haem iron (in pork meat labelled 
with 
58
Fe stable isotope) was significantly higher than that of ferrous sulphate (labelled with 
57
Fe 
stable isotope), 47.7 (standard deviation (SD) 14.4) % and 40.4 (SD 13.2) %, respectively, whereas, in 
non-pregnant women, the values were 50.1 (SD 14.8) % and 15.3 (SD 9.7) %, respectively (Young et 
al., 2010). There are limited data on iron absorption from whole diets in pregnant women. Svanberg et 
al. (1975) undertook a longitudinal study measuring non-haem iron absorption from a radiolabelled 
meal given on two consecutive days at 12, 24 and 36 weeks of gestation. Mean absorption was 1.5 (SE 
0.4) %, 5.8 (SE 0.8) % and 14.6 (SE 1.3) %, respectively, although there is no means of normalising 
the data to account for the effect of differences in iron status, as serum ferritin concentration was not 
measured and a reference dose of iron was not given. However, it is clear that physiological 
requirements for the products of conception, as with other physiological states associated with 
increased requirements, such as low body iron status, result in a marked increase in the efficiency of 
non-haem iron absorption. The Panel notes that percentage absorption values derived from studies in 
(non-pregnant) adults and algorithms may not be appropriate for pregnant women, particularly in the 
second and third trimester. 
The Panel notes the limited information on the effects of systemic and dietary factors on iron 
absorption from whole diets in adults and the very limited data in infants and children. One study 
(Lynch et al., 2007) measured absorption from two consecutive meals in 1- to 4-year-old children and 
the results appeared to support observations in adults that iron status is a key determinant of efficiency 
of non-haem iron absorption. 
Vegetarians have been reported to have lower iron stores than omnivores, which is attributed to the 
absence of meat (and fish) in their diet, but they are usually above the cut-off for serum ferritin 
concentration of 15 µg/L (SACN, 2010). Kristensen et al. (2005) measured the effect of consuming 
pork meat on radiolabelled non-haem iron absorption over a 5-day period and reported a significantly 
higher absorption from Danish (7.9, SE 1.1 %) and Polish (6.8, SE 1.0 %) pork meat diets than from a 
vegetarian diet (5.3, SE 0.6 %). The volunteers had a geometric mean serum ferritin concentration of 
19 (range 12–28) μg/L at screening, and when the absorption values were adjusted to a serum ferritin 
concentration of 30 μg/L (Cook et al., 1991), the corrected absorption fell to 4.2 (SE 0.6) %, 3.6 (SE 
0.7) % and 2.5 (SE 0.4) % for the Danish meat, Polish meat and vegetarian diets, respectively. Hunt 
and Roughead (1999) undertook an intervention study (randomised cross-over design) comparing the 
effect of a lacto-ovo-vegetarian and omnivorous diet for eight weeks on serum ferritin concentrations 
of 21 women aged 20–42 years, and reported that the type of diet had no effect on serum ferritin 
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concentrations. The Panel considers that DRVs do not need to be derived for vegetarians as a separate 
population group because the bioavailability of iron from European vegetarian diets is not 
substantially different from diets containing meat and other flesh foods. 
2.3.3. Metabolism 
The body has no mechanism for the excretion of iron, and it is argued that the acquisition and 
distribution of the element is tightly regulated, in order to avoid excessive accumulation of the 
element. This control of body iron depends on an effective co-ordination of intestinal uptake and 
transfer of iron, with the recycling of iron from the red blood cell mass and other tissues, the storage 
and release of iron from the liver, and integumental (i.e. loss from the epidermis and epithelia) and, in 
women, menstrual losses. At the functional level, the cells involved are the enterocytes, hepatocytes 
and macrophages of the RES (i.e. the monocyte–macrophage system). In macrophages, the uptake and 
export of iron is mediated by DMT1 and ferroportin, respectively, and as with enterocytes these 
processes are regulated by hepcidin (Ganz, 2013). A schematic diagram of whole-body iron 
metabolism is shown in Figure 1. 
 
Figure 1:  Whole-body iron metabolism. RE, reticuloendothelial 
2.3.3.1. Systemic distribution and turnover 
The systemic turnover of iron has the liver at its hub. The liver acts as the sensor of systemic 
requirements for iron and the regulator of intestinal absorption of iron and of its distribution (as di-
ferric transferrin) to peripheral organs and tissues, all of which are equipped with cell membrane 
transferrin receptors that enable the endocytosis of transferrin and the intracellular release of iron. 
There are two types of transferrin receptor (TfR): TfR1 is ubiquitous and is most abundant in 
erythroblasts, lymphoid tissues and the neuroepithelium, whereas TfR2 is principally sited on the 
basolateral membranes of hepatocytes, where it contributes to the sensory system controlling iron 
metabolism. 
The residual apotransferrin is released into the extracellular fluid, whereas the iron is either distributed 
to cytoplasmic functional sites and depots (ferritin) or transferred into the mitochondria where it is 
incorporated into the synthesis of iron–sulphur clusters and haem. Degradation of tissues results in the 
release of iron, which may be redistributed to other organs or recycled to the liver. The largest 
component to the pool of recycling iron is that produced by the breakdown of senescent red blood 
cells in the RES including the spleen. The size of the recycling pool is reduced by adventitious losses 
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of iron through blood loss, and epithelial, integumental and urinary losses, and by its use for new 
tissue synthesis (e.g. growth, pregnancy). The recycling and salvage of endogenous iron is at least 
90 % efficient. Any depletion is detected by hepatocytic TfR2, which, in turn via hepcidin, regulates 
the intestinal uptake and transfer of iron to replenish the recycling pool. 
2.3.3.2. Homeostasis of cellular iron 
Cellular iron homeostasis is mediated by two iron-responsive proteins (IRP1 and IRP2) which bind to 
iron-responsive elements (IREs) of mRNAs for proteins involved in iron kinetics. When iron supply is 
limited, the IRPs repress the production of the apoferritin chains, ferroportin, hypoxaemia-inducible 
factor 2α and δ-aminolevulinate synthase, the latter being the initial and rate-limiting enzyme in haem 
synthesis. This conserves cellular iron by reducing the ferroportin export of iron and inhibiting 
synthesis of erythropoietin and haem. Simultaneously, the IRPs increase induction of TfR1, DMT1 
and an organising molecule for the actin cytoskeleton necessary for endocytosis, thereby sustaining 
production of the cellular apparatus for the uptake of iron (Richardson et al., 2010; Ye and Rouault, 
2010). 
If cells have an adequate supply of iron, the synthesis of the IRPs is reduced, as is their stability, and 
the proteins are subjected to proteolysis. This iron-responsive intracellular regulatory complex 
involves some highly conserved iron–sulphur clusters and proteins, and is disrupted by, amongst other 
things, hypoxia and inflammation, oxygen and nitrogen radicals, and nitric oxide (Richardson et al., 
2010). 
2.3.4. Transport in blood 
The main carrier of iron in the extracellular space and systemic circulation is transferrin, which is 
synthesised, mainly in the liver, as a sialylated glycoprotein, apotransferrin. This protein binds one or 
two ferric iron molecules and delivers them to cell surface TfR1. Approximately 80 % of transferrin-
bound iron is used for haemoglobin synthesis, and the half-life of recently absorbed iron in plasma is 
about 75 minutes. 
The degree of sialylation of transferrin affects its function. For example, transferrin is more highly 
sialylated in pregnancy, which favours binding to placental transferrin receptors and the uptake of iron 
by the placenta, whereas, with infections and eclampsia, transferrin is less sialylated, which limits its 
binding to transferrin receptors. 
2.3.5. Distribution to tissues 
About 25 mg of systemic iron is recycled daily (Figure 1). Much of this turnover represents the 
salvage and recycling of iron from the 10
11
 senescent erythrocytes daily by the monocyte–macrophage 
system. Iron is released from the red blood cell haem by haemoxygenase, and it is either exported as 
ferric iron by the macrophages’ ferroportin to apotransferrin, which moves the iron elsewhere, or 
deposited in the macrophages’ intracellular ferritin pool. Iron from the turnover of other tissues is 
recycled similarly by the monocyte–macrophage system. 
Transferrin–TfR complexes on cell membranes are endocytosed. The pH of the endosome is reduced 
through the activity of a proton pump, which decreases the affinity of transferrin for iron, and iron is 
released, reduced to the ferrous form by a ferrireductase in the endosomal membrane, and transferred 
out of the endosome into the cytoplasm by DMT1. In the cytoplasm it forms a chelatable iron pool, 
which supplies iron for metabolic needs, including iron uptake by the mitochondria for haem and iron–
sulphur cluster synthesis (Richardson et al., 2010). The apotransferrin and TfR proteins return to the 
cell surface and the apotransferrin is recycled into plasma. 
The circulation contains a small amount of non-transferrin-bound iron. Some of this is circulating 
ferritin, which has a high L-chain content, suggesting it is from the RES rather than from the liver. 
Other circulating ligands include acetate, citrate and albumin. Furthermore, a siderophore-bound form 
of iron has been found in mammals. The significance of these forms is unknown. However, whereas 
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the transferrin cycle of iron is essential for red blood cell production, other tissues are able to acquire 
iron from non-transferrin-bound iron (cited in Chen and Paw (2012)). 
In pregnant women, similar transport mechanisms exist for the placental transfer of iron. In the 
developing fetus, iron is accumulated against a concentration gradient and, even with maternal iron 
deficiency, the placenta can protect the fetus through the increased expression of placental TfR 
together with a rise in DMT1. Iron released from endosomes is carried across the basolateral 
membrane by ferroportin and is oxidised from ferrous to ferric iron by zyklopen, prior to incorporation 
into fetal transferrin. An additional haem transport system has been hypothesised, which may explain 
why certain gene knockouts are not lethal for the developing fetus (McArdle et al., 2014). 
During lactation, the uptake of iron into the mammary gland follows the same process as in other cells, 
but there is no evidence that DMT1 facilitates iron export from endosomes. Iron in the intracellular 
chelatable iron pool can be secreted across the luminal membrane into milk. Export of iron from the 
mammary gland is most likely achieved by ferroportin, which is localised to the endoplasmic 
reticulum in reticuloendothelial cells, where it is believed to transport iron into intracellular vesicles 
prior to secretion (Lonnerdal, 2007). 
2.3.6. Storage 
Whole-body iron is approximately 3.8 g in men and 2.3 g in women, which is equivalent to 50 mg/kg 
body weight for a 75-kg man (Bothwell et al., 1979; Bothwell, 1995) and 42 mg/kg body weight for a 
55-kg woman (Bothwell and Charlton, 1981). More recently, Hunt et al. (2009) assessed obligatory 
loss of endogenous iron twice yearly for up to three years in 53 free-living subjects using values based 
on haemoglobin concentrations (3.39 mg iron/g haemoglobin), estimated total blood volumes 
calculated with formulae based on body weight and height, systemic iron stores calculated from serum 
concentrations of TfR and ferritin, and the loss of a previously administered radioiron tracer. Whole-
body iron was calculated to be 4.4 g in men and 2.8 g in women, and to be 48 mg/kg body weight in 
males and 38 mg/kg body weight in females (Hunt et al., 2009) (see Section 2.3.7.3). 
The main systemic depot for iron is the liver, where it is stored as the soluble protein complex ferritin 
and, to a lesser extent, ferritin-derived insoluble haemosiderin. Estimates of body iron distribution are 
as follows: haemoglobin 2.5–3.5 g, myoglobin 0.3–0.4 g, and the haem and non-haem enzymes 
100 mg. Ferritin and haemosiderin together comprise 1.0 g of iron (although this is very variable) and 
the transit pools of extracellular transferrin and intracellular carriers are considered to contain around 
3 mg and 7 mg of iron, respectively. 
Iron that is not functionally used and that cannot be excreted by cells is deposited in ferritin in the 
cytosol and mitochondria. Ferritin is a hollow sphere comprising 24 apoferritin subunits. It has 
channels through which iron can enter and leave the sphere. There are two subunits, heavy and light, 
and the ratio of these varies between organs (heavy chains predominate in the heart and brain, and 
light chains in the liver and spleen). Ferritin contains iron in the ferric state; this is enabled by the 
heavy chain, which has a ferroxidase activity, and the ratio of heavy to light chains influences the 
mobility of their associated iron. Expression and synthesis of the heavy and light apoferritin chains 
and that of other proteins mediating iron turnover are controlled by a common intracellular iron-
sensing system, and their synthesis is promoted by an adequate iron supply and by inflammation, ionic 
iron and oxidative stressors. The principal pools of ferritin are the liver and the RES. The former 
mobilises iron to maintain the systemic pool and is the main repository for excess iron, whereas the 
latter represents an endogenous recycling pool of iron supporting the erythron. 
2.3.7. Losses 
As the body has no specific pathway for the excretion of iron, it is only lost from the body 
adventitiously via turnover and shedding of skin and hair, via the mucosa of the gastrointestinal, 
respiratory and genito-urinary tracts, and via sweat, intestinal secretions (including bile), urine, semen 
and menstrual blood. 
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2.3.7.1. Losses via skin, hair, sweat, urine and faeces 
Estimations of dermal and sweat losses of iron are methodologically and analytically challenging. 
Although some differentiation between the amount of iron in sweat and that in exfoliated skin cells 
can be achieved when great care is taken (Jacob et al., 1981), these studies demonstrate that dermal 
iron losses are not directly related to estimated endogenous iron load or to dietary intake, but are 
closely related to body weight and size. This relates to the greater epithelial surface area of larger 
people; a similar but non-significant correlation can be detected in women if their data are corrected 
for menstrual losses (Hunt et al., 2009). The vast majority of iron excreted in the faeces is dietary in 
origin (unabsorbed iron), but a small quantity of systemic iron is excreted in the intestinal tract, 
primarily via biliary secretions. Iron losses in urine are very small, totalling approximately 
0.08 mg/day (IOM, 2001).  
2.3.7.2. Menstrual iron losses 
There is a very wide inter-individual variation in menstrual blood loss, but for individuals it is fairly 
constant between cycles (Hallberg and Nilsson, 1964). Excessive menstrual blood loss 
(hypermenorrhoea) is a well-established risk factor for iron deficiency anaemia. The classic definition 
of hypermenorrhoea is a blood loss of 80 mL or more per cycle (Warner et al., 2004), and it is 
influenced by contraceptive use; losses are reduced with oral contraceptives (Larsson et al., 1992) and 
increased with intrauterine devices (Milsom et al., 1995). In the 1960s, before widespread use of oral 
contraceptives, Hallberg et al. (1966a) measured menstrual losses in groups of Swedish females aged 
15, 23, 30, 40 and 50 years, and reported a mean value for all 476 females of 43.4 mL. The group of 
15-year-olds (n = 95) had the smallest mean value of menstrual blood loss (33.8 mL, 90
th
 percentile 
65.1 mL) and the group of 50-year-olds (n = 37) had the highest mean value of menstrual blood loss 
(62.4 mL, 90
th
 percentile 133.1 mL); the 90
th
 percentile for all ages combined was 83.9 mL. No 
information on contraceptive use was given. The authors concluded that the upper normal limit of 
menstrual blood loss is between 60 and 80 mL and that a loss above 80 mL should be considered as 
pathological. Menstrual iron losses have been estimated to account for 90 % of the variance in the loss 
of endogenous iron for women (Hunt et al., 2009). 
In a small study of 13 premenopausal women, iron losses in menstrual periods ranged from 0.5 to 
56 mg per period or, adjusted for the reported number of menstrual periods per year, 0.015 to 
1.86 mg/day (Hunt et al., 2009). The geometric mean iron loss from menstruation was 0.28 (0.08 –SD, 
1.05 +SD) mg/day when calculated on a daily basis. These values were similar to those derived earlier 
by Harvey et al. (2005), who undertook measurements in 90 women aged 18–45 years, 35.5 % of 
whom used oral contraceptives and 5.5 % used an intrauterine device, and reported a mean (SD) iron 
loss of 0.43 (0.45) mg/day with a median menstrual iron loss of 0.26 mg/day. The data were highly 
skewed, with 70 % of women losing less than 0.5 mg/day through menses. Hypermenorrhoea was 
observed in 7 % of the women. There was a significantly lower median blood loss (mL/cycle) in oral 
contraceptive users than in those using other forms of contraception (excluding intrauterine devices). 
Percentiles of iron losses in this group of 90 women are shown in Appendix A. 
In a cohort of more than 12 000 randomly selected women aged 15–49 years from five European 
countries (Skouby, 2010), oral contraceptives were reported to be used by 45, 34, 27, 19 and 19 % of 
women in France, Germany, the UK, Italy and Spain, respectively; the overall mean was 30 %. 
Information on the use of intrauterine devices (which increase menstrual blood loss) is not provided, 
but this method of contraception is much less common than oral contraceptives because reversible 
long-term methods, which include intrauterine devices/systems, implants and injection, were used by 
only 11 % of the European study population. 
According to data collected from Finland in 2007, the median age at natural menopause was 51 years 
(Pakarinen et al., 2010) and, based on data collected in the period 1979–1986 from 11 different 
countries for WHO, the median age at natural menopause ranged between 49 and 52 years (Morabia 
and Costanza, 1998). 
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2.3.7.3. Whole-body iron losses 
In the context of setting DRVs, the most pragmatic approach is to avoid estimating total adventitious 
iron loss based on data for the individual routes of loss, as this increases variability; it is preferable to 
use composite data acquired from long-term studies of body iron loss. Iron radioisotopes have been 
used to label the systemic pool and enable measurement of losses of endogenous iron. Total obligatory 
losses from the body were measured in white men in the USA (0.95 ± 0.30 mg/day), Mestizo men in 
Venezuela (0.90 ± 0.31 mg/day) and Indian men in South Africa (1.02 ± 0.22 mg/day) (Green et al., 
1968). The average loss was 0.9–1.0 mg/day, which equates to 14 µg/kg body weight per day for a 70-
kg man. More recently, Hunt et al. (2009) measured basal losses of iron using a similar method to 
Green et al. (1968) in 29 men, 19 menstruating women and 5 postmenopausal women. Mean iron loss 
by men was 1.07 ± 0.47 (range 0.11–2.07, median 1.18) mg/day, which equates to 12 ± 5 μg/kg body 
weight per day; losses were normally distributed. Losses in the postmenopausal women were similar 
to those in the men, 1.08 ± 0.28 (range 0.86–1.57, median 0.99) mg/day, which equates to 
16 ± 4 μg/kg body weight per day. In contrast, iron losses in the premenopausal women were highly 
skewed, with a geometric mean of 1.69 (0.98 –SD, 2.92 +SD; range 0.65–4.88) mg/day, which equates 
to a geometric mean of 23 (13 –SD, 40 +SD) μg/kg body weight per day. When the women using oral 
contraceptives (n = 4) were excluded from the analysis, the iron loss was higher, with a geometric 
mean of 1.89 mg/day. The Panel notes the relatively small number of individuals in this study and the 
wide variability, particularly in the premenopausal women, but considers the data to be the most 
accurate estimate of whole-body losses for deriving dietary requirements for iron. 
2.3.7.4. Breast milk 
Regulated transport of iron through the mammary gland epithelium is suggested by the lack of 
correlation between plasma mineral concentration and milk mineral concentration, and studies in 
animals have shown that iron is transported by DMT1 through the basolateral membrane into the 
alveolar cells and is then exported by ferroportin1 in the apical membrane. DMT1 and ferroportin1 
concentrations are higher during early lactation and are possibly involved in iron transfer into milk 
(Leong and Lonnerdal, 2005). Transferrin receptors are also likely to be involved in iron uptake 
(Sigman and Lonnerdal, 1990). The mammary gland has a capacity to control milk iron concentration 
by adapting to both maternal deficiency and excess of iron (Lonnerdal, 2007). Thus, the iron 
concentration of human milk does not correlate with maternal iron intake (Picciano and McDonald, 
2005) or status (Celada et al., 1982). No differences in iron concentration of milk from women 
receiving iron supplements were observed even in women with intakes of at least 30 mg iron/day 
(Picciano and Guthrie, 1976). This finding is in agreement with other investigators, who have been 
unsuccessful in attempts to raise the iron concentration in milk with dietary supplementation 
(Karmarkar and Ramakrishnan, 1960). 
A wide range of values has been reported in the literature for iron in human milk at all stages of 
lactation, partly owing to differences in sampling procedures and timing (e.g. milk iron concentration 
is lower in the morning than in the afternoon), as well as differences in the stage of lactation. Changes 
in iron concentration throughout the day were explained by both intra-individual (53 %) and inter-
individual (39 %) variation (Picciano and Guthrie, 1976). Milk iron concentration decreases with 
longer durations of lactation (Feeley et al., 1983); for example, Picciano (2001) reported that the iron 
concentration of milk in the early stages of lactation was 0.5–1.0 mg/L and that mature milk contained 
0.3–0.9 mg/L. IOM evaluated nine studies with small groups of lactating women at various stages of 
lactation and concluded that the mean iron concentration of human milk is about 0.35 mg/L (IOM, 
2001). SCF (2003) considered the iron concentration of mature breast milk to be about 0.3 mg/L on 
the basis of reported values in European women (Siimes et al., 1979), later confirmed by Domellof et 
al. (2004). In 30 women of Mexican-American heritage, Hannan et al. (2009) found a mean iron 
concentration in milk of 0.5 ± 1.0 mg/L on days 30–45 of lactation and 0.4 ± 0.3 mg/L on days 75–90. 
The Panel considers that the iron concentration of mature human milk in European women is around 
0.3 mg/L. 
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2.3.8. Interactions with other nutrients 
The availability of iron for absorption in the duodenum and small intestine is affected by a number of 
dietary constituents, which act as either inhibitors (e.g. phytate and polyphenols) or enhancers (e.g. 
ascorbic acid and animal tissue) (see Section 2.3.2). The mechanism of action is the formation of iron 
complexes in the digestive chyme in the gut lumen, and the strength of binding dictates whether or not 
the iron can be removed from the complex by DMT1. In addition, ascorbic acid reduces ferric (Fe
3+
) 
iron to ferrous (Fe
2+
), which is the chemical form that is taken up by DMT1 (see Section 2.3.1). 
Calcium and zinc have been reported to reduce iron absorption, but the mechanisms are unclear and 
the effect appears to be short-term. The proposed mechanism for the inhibitory effect of calcium on 
iron absorption is internalisation of DMT1 (Thompson et al., 2010) and, because this is an acute effect, 
adaptation will occur with time, which could explain why long-term calcium supplementation studies 
fail to show an effect on iron status (Lonnerdal, 2010). A recent review of published studies on the 
effects of zinc on iron absorption concluded that the inhibitory effect of zinc occurs at a Zn–Fe 
(weight/weight) ratio of 1:1 in aqueous solutions but, importantly, there is no inhibitory effect in food 
matrices (Olivares et al., 2012). When iron absorption from a hamburger meal, labelled with radioiron, 
was measured in the presence of additional zinc (15 mg) and manganese (3 mg), there was no effect 
with added zinc, but manganese had a strong inhibitory effect (Rossander-Hulten et al., 1991). The 
mechanism is probably via competition for DMT1. Effects of copper and zinc on the regulation of iron 
transporters have recently been proposed (Scheers, 2013). Although there is no direct competition for 
DMT1, copper is required for the efflux of ferrous iron through ferroportin. Zinc up-regulates DMT1 
expression in Caco-2 cells, thereby increasing iron uptake (Yamaji et al., 2001), and enhances 
ferroportin transcription by stimulating the binding of metal transcription factor 1 to the ferroportin 
promoter (Troadec et al., 2010). 
Copper–iron interactions are influenced by age and stage of development (Collins et al., 2010). They 
can affect prenatal development (Gambling et al., 2008). In addition to the well-understood effects of 
copper deficiency on iron metabolism (leading to anaemia), there is some evidence suggesting that 
copper deficiency results in lower liver iron concentration, and delivery of iron (as well as copper) to 
the fetus may be compromised (Andersen et al., 2007). 
Vitamin A can affect several stages of iron metabolism, including erythropoiesis and the release of 
iron from ferritin stores. A number of trials have been undertaken to examine the effect of vitamin A 
supplementation/fortification on indices of iron status (Michelazzo et al., 2013), and many report an 
impact of vitamin A on haemoglobin and other parameters. Studies examining the effect of vitamin A 
on iron absorption have produced conflicting findings and it is not clear whether vitamin A and/or iron 
status are key determinants of an effect (Hurrell and Egli, 2010). 
Riboflavin is involved in erythropoiesis, and deficiency results in disturbances in the production of red 
blood cells. The mechanism is thought to be impaired mobilisation of iron from ferritin (via reduced 
flavins). The very limited evidence available suggests that iron absorption is not affected (Fairweather-
Tait et al., 1992), and that the effects on iron are through changes in iron economy (Powers, 2003). 
The Panel considers that interactions between iron and other minerals, vitamins and certain dietary 
constituents (see Section 2.3.2), in the context of a mixed European diet, are not relevant for setting 
DRVs for iron. 
2.4. Biomarkers of intake and status 
There are no known biomarkers of iron intake, so the information has to be obtained by measuring 
dietary intake. Accurate measurement of dietary iron intake is hampered by several factors including 
the quality of food composition data (especially information on haem iron and foods fortified with 
iron), and use of iron supplements. The approaches that can be used include duplicate diet collection, 
weighed or estimated (from household measures/portion sizes) dietary records, 24-hour recalls, diet 
history and (validated) food frequency questionnaires (FFQs) (EFSA NDA Panel, 2010). 
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A review of methods to assess iron status was published by Zimmermann (2008). They can be 
categorised according to whether they represent the main functional use of iron (synthesis of 
haemoglobin), transport and supply of iron to tissues, or iron storage (SACN, 2010), and include: 
 Haemoglobin and haematocrit. These markers are widely used but have low specificity and 
sensitivity, and reference ranges and cut-off criteria differ with ethnicity, age, sex and the 
laboratory where it is measured. Intra-individual variability of haemoglobin is low (< 3 %). 
The measurements can be made in fasted or non-fasted blood samples and only small samples 
are required, so capillary blood can be used. However, this can lead to inaccurate or variable 
results if the capillary sample is not collected properly. 
 Reticulocyte haemoglobin content. Measurement of reticulocyte haemoglobin content in 
peripheral blood samples is useful for diagnosis of iron deficiency in adults (Mast et al., 2002) 
and children (Brugnara et al., 1999; Ullrich et al., 2005; Bakr and Sarette, 2006). Reticulocyte 
haemoglobin content can be used to differentiate iron deficiency from other causes of 
anaemia. 
 Mean cell volume (MCV), mean cell haemoglobin (MCH) and the red cell distribution width 
are part of the profile obtained from automated cell counter analysers, but are not commonly 
used in the diagnosis of iron deficiency. MCV is a relatively late indicator of iron deficiency 
and is affected by thalassaemia. 
 Erythrocyte zinc protoporphyrin (ZPP). A lack of iron in the bone marrow during the final 
stages of haemoglobin synthesis leads to the incorporation of zinc into protoporphyrin instead. 
This is a common screening tool for field work but is affected by lead poisoning, malaria, 
chronic infections, inflammation and haemoglobinopathies. 
 Serum iron, total iron-binding capacity (TIBC) and transferrin saturation. The serum iron pool 
comprises Fe
3+
, bound to transferrin. The percentage transferrin saturation is the ratio of serum 
iron to TIBC. Although this biomarker can be used to screen for iron deficiency, it is limited 
by circadian variation and confounding effects of infectious diseases and many other clinical 
disorders. For these measurements, fasting blood samples must be taken, as serum iron is 
affected by dietary iron intake. Serum iron is sometimes used to diagnose iron overload 
(haemochromatosis). 
 Bone marrow biopsy. The bone marrow is a major storage site for iron and the absence of 
stainable iron in the bone marrow is the gold standard for the diagnosis of iron deficiency 
anaemia, especially in the diagnosis of complicated anaemias in hospital patients. It is, 
however, an invasive procedure and there may be methodological problems with the aspiration 
of bone marrow. Therefore, it is not commonly used to measure iron status. 
 Serum ferritin. This is probably the most useful laboratory measure of iron status, because the 
concentration is directly proportional to stainable iron in the bone marrow and thus is 
indicative of the capacity of hepatic stores to sustain iron levels in the erythron. Estimates 
from phlebotomy studies indicate that 1 g/L of serum ferritin corresponds to 8 mg 
mobilisable iron from systemic stores (Walters et al., 1973). However, because serum ferritin 
is an acute phase protein, it may not provide an accurate estimate of iron stores in acute or 
chronic inflammation or infection. 
 Soluble serum transferrin receptor (sTfR). This is a useful diagnostic tool for iron deficiency, 
being less confounded by inflammation than serum ferritin, although its diagnostic value for 
children in regions where malaria and infection are endemic is less certain. 
 Ratio of sTfR (R) to ferritin (F). The ratio has been shown to be more reliable than either 
parameter alone for the identification of iron deficiency. It is the best predictor of absent bone 
marrow iron and is the most sensitive indicator of a change in iron status following iron 
supplementation. It was validated for men using quantitative phlebotomy plus correction for 
absorbed iron. Body iron can be calculated from the serum transferrin receptor/ferritin ratio 
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(body iron (mg/kg) = −[log(R/F ratio) − 2.8229] / 0.1207) and is particularly useful for 
assessing longitudinal changes in iron status, e.g. resulting from an intervention. 
The greatest challenge when assessing iron status is to distinguish between iron deficiency anaemia 
and anaemia of chronic disease, the latter resulting from the enhanced expression of hepcidin (Section 
2.3.1.2). Inflammatory biomarkers, such as C-reactive protein or α-1-acid glycoprotein, can be 
measured to identify the presence of infection or inflammation. Assessing iron status in populations in 
which infectious diseases are common, as in some developing countries, and in which inflammation is 
present, as in older adults (Fairweather-Tait et al., 2014), is most problematic. There is also limited 
information on reference values for infants and young children, and allowances have to be made for 
blood volume expansion in pregnancy. As most biomarkers of iron status have low sensitivity and 
specificity, they are sometimes combined in models to define iron deficiency, for example the ferritin 
model based on low serum ferritin and transferrin saturation and high ZPP. Although this increases 
specificity, these models tend to underestimate iron deficiency. 
A pragmatic approach to identifying iron deficiency or a significant risk thereof is to use, as a 
threshold, a serum ferritin concentration of 15 μg/L. Where several indices can be measured, the best 
combination is haemoglobin, serum ferritin, sTfR and/or ZPP (see also Appendix B). 
2.5. Effects of genotype 
Hereditary haemochromatosis is one of the most common single-gene disorders found in Northern 
European populations. This disease is due to mutations in the HFE gene, and two common variants of 
the gene, C282Y and H63D, have been identified. The clinical penetrance of homozygosity for C282Y 
is very variable (ranging from 1 to 25 % depending on the study design and endpoints used) and the 
majority of individuals with this genotype do not present with iron overload (Beutler et al., 2002). 
However, in those affected, up to 10–33 % eventually develop haemochromatosis-associated 
morbidity (Whitlock et al., 2006). The mechanism for the effect is increased iron absorption 
(Pietrangelo, 2010). Homozygosity for the C282Y mutation has been reported to occur in 
approximately 0.5 % of the Caucasian population (Allen et al., 2008). The frequency of heterozygotes 
in Caucasians is estimated to be 13 % (range 9.5–18 %) (Nelson et al., 2001). Iron absorption does not 
appear to be significantly increased in heterozygotes (Hunt and Zeng, 2004), although the distribution 
of serum ferritin concentration is shifted to the right, indicating higher body iron levels (Roe et al., 
2005). The HFE H63D variant is more widespread worldwide but has a less well-defined role in 
predisposing individuals to iron overload. Other types of genetic haemochromatosis are caused by 
defects in haemojuvelin, hepcidin, TfR2 and ferroportin, but these are very rare in European 
populations. 
The Panel concludes that carriers of HFE mutations have the same dietary requirements for iron as 
wild-type individuals and that rare polymorphisms should not be taken into consideration when 
deriving DRVs for iron. 
3. Dietary sources and intake data 
3.1. Dietary sources 
Foods that contain relatively high concentrations of iron include meat, fish, cereals, beans, nuts, egg 
yolks, dark green vegetables, potatoes and fortified food products; the iron content of dairy products 
and many fruits and vegetables is much lower. 
Currently, ferrous bisglycinate, ferrous carbonate, ferrous citrate, ferric ammonium citrate, ferrous 
gluconate, ferrous fumarate, ferric sodium diphosphate, ferrous lactate, ferrous sulphate, ferrous 
ammonium phosphate, ferric sodium EDTA, ferric diphosphate (ferric pyrophosphate), ferric 
saccharate and elemental iron (carbonyl + electrolytic + hydrogen reduced) may be added to both 
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foods
6
 and food supplements,
7
 whereas ferrous L-pidolate, ferrous phosphate and iron (II) taurate may 
be used in food supplements only.
7
 The iron content of infant and follow-on formulae
8
 and processed 
cereal-based foods and baby foods for infants and young children
9
 is regulated. 
3.2. Dietary intake 
EFSA estimated dietary intakes of iron from food consumption data from the EFSA Comprehensive 
European Food Consumption Database (EFSA, 2011a), classified according to the food classification 
and description system FoodEx2 (EFSA, 2011b). Data from 13 dietary surveys from nine EU 
countries were used. The countries were Finland, France, Germany, Ireland, Italy, Latvia, the 
Netherlands, Sweden and the UK. The data covered all age groups from infants to adults aged 75 years 
and older (Appendix C). 
Nutrient composition data for iron were derived from the EFSA Nutrient Composition Database (Roe 
et al., 2013). Food composition information of Finland, France, Germany, Italy, the Netherlands, 
Sweden and the UK were used to calculate iron intakes in these countries, assuming that the best 
intake estimate would be obtained when both the consumption data and the composition data are from 
the same country. For nutrient intake estimates of Ireland and Latvia, food composition data from the 
UK and Germany, respectively, were used, because no specific composition data from these countries 
were available. In the case of missing values in a food composition database, data providers had been 
allowed to make use of values from another country’s database. The amount of borrowed iron values 
in the seven composition databases used varied between 15 and 85 %. Estimates were based on food 
consumption only (i.e. without dietary supplements). Nutrient intake calculations were performed only 
on subjects with at least two reporting days.  
Data on infants were available from Finland, Germany, the UK and Italy. The contribution of human 
milk was taken into account if the amounts of human milk consumed (Italian INRAN-SCAI survey 
and the UK DNSIYC) or the number of breast milk consumption events (German VELS study) were 
reported. In the case of the Italian INRAN-SCAI survey, human milk consumption had been estimated 
based on the number of eating occasions using standard portions per eating occasion. In the Finnish 
DIPP study, only the information “breast-fed infants” was available, but without any indication about 
the number of breast milk consumption events during one day or the amount of breast milk consumed 
per event. For the German VELS study, the total amount of breast milk was calculated based on the 
observations by Paul et al. (1988) on breast milk consumption during one eating occasion at different 
ages, i.e. the amount of breast milk consumed on one eating occasion was set to 135 g/eating occasion 
for infants aged 6–7 months and to 100 g/eating occasion for infants aged 8–12 months. The Panel 
notes the limitations in the methods used for assessing breast milk consumption in infants and related 
uncertainties in the intake estimates for infants (Appendices D and E). 
Average iron intake ranged between 2.6 and 6.0 mg/day (0.9–1.9 mg/MJ) in infants (< 1 year, four 
surveys), between 5.0 and 7.0 mg/day (1.2–1.6 mg/MJ) in children aged 1 to < 3 years (five surveys), 
between 7.5 and 11.5 mg/day (1.1–1.7 mg/MJ) in children aged 3 to < 10 years (seven surveys), 
between 9.2 and 14.7 mg/day (1.1–1.7 mg/MJ) in children aged 10 to < 18 years (seven surveys) and 
between 9.4 and 17.9 mg/day (1.2–2.1 mg/MJ) in adults (≥ 18 years) (eight surveys). Average daily 
intakes were in most cases slightly higher in males (Appendix D) than in females (Appendix E), 
mainly owing to larger quantities of food consumed per day. 
                                                     
6 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26. 
7 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.7.2002, p. 51. 
8 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC. OJ L 401, 30.12.2006, p. 1. 
9 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
young children. OJ L 339, 06.12.2006, p. 16. 
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The main food group contributing to iron intake was grains and grain products representing more than 
20 % and up to 49 % of the iron intake in all population groups except infants. Other main 
contributing food groups were meat and meat products, vegetable and vegetable products and 
composite dishes. Differences in the main contributors to iron intakes between sexes were minor 
(Appendices F and G). 
EFSA’s iron intake estimates in mg/day were compared with published intake values from the same 
survey and dataset and the same age class using the German EsKiMo and VELS surveys in children 
(Kersting and Clausen, 2003; Mensink et al., 2007), the DIPP study in Finnish children (Kyttälä et al., 
2008; Kyttälä et al., 2010), the study in Finnish adolescents (Hoppu et al., 2010), the French national 
INCA2 survey (Afssa, 2009), the Irish National Adult Nutrition Survey (IUNA, 2011), the FINDIET 
2012 survey (Helldán et al., 2013), the Italian INRAN-SCAI survey (Sette et al., 2011), the Dutch 
National Food Consumption Survey (van Rossum et al., 2011), the Swedish national survey 
Riksmaten (Amcoff et al., 2012), the DNSIYC-2011 study in UK infants and young children (Lennox 
et al., 2013) and the UK National Diet and Nutrition Survey (Bates et al., 2012) (Table 1). 
Table 1:  EFSA’s average daily iron intake estimates, expressed as percentages of intakes reported 
in the literature 
Country Percentage of published intake (% range over different age classes in a specific survey) 
Finland  83 (DIPP young children, 1 to < 3 years), 104 (DIPP children, 3 to < 10 years), 111–116 
(NWSSP), 100–105 (FINDIET 2012) 
France 96–115 (INCA2) 
Germany 90–99 (VELS infants), 111–122 (VELS children), 101–108 (EsKiMo) 
Ireland  104–109 (NANS) 
Italy 94–102 (INRAN-SCAI infants and young children, 1 to < 3 years), 98–102 (INRAN-SCAI other 
age groups) 
Netherlands 108–113 (DNFCS) 
Sweden 116–121 (Riksmaten) 
UK 107–109 (DNSIYC infants and children up to 1.5 years), 95–112 (NDNS Rolling Programme, 
Years 1–3) 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; DNSIYC, Diet 
and Nutrition Survey of Infants and Young Children; EsKiMo, Ernährungsstudie als KIGGS-Modul; FINDIET, the national 
dietary survey of Finland; INCA, étude Individuelle Nationale des Consommations Alimentaires; INRAN-SCAI, Istituto 
Nazionale di Ricerca per gli Alimenti e la Nutrizione – Studio sui Consumi Alimentari in Italia; NANS, National Adult 
Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; 
VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung 
eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
 
When the EFSA intake estimates were compared with published intake estimates from the same 
survey and age range, the EFSA estimates differed up to around 15 % from the published values in 
Finland, France, Ireland, the Netherlands, the UK and Germany, except for German children in the 
VELS study, for which they were higher by up to 22 % than published values. In Sweden, the EFSA 
intake estimates were higher by 16–21 % than published values. Overall, several sources of 
uncertainties may contribute to these differences, including inaccuracies in mapping food consumption 
data according to food classifications and in nutrient content estimates available from the food 
composition tables, the use of borrowed iron values from other countries in the food composition 
database, and replacing missing iron values by values of similar foods or food groups in the iron intake 
estimation process. It is not possible to conclude which of these intake estimates (i.e. the EFSA intake 
estimate or the published one) would be closer to the actual iron intake. 
Iron intakes in 521 457 individuals aged 35–70 years from 10 European countries were recently 
calculated as part of the European Prospective Investigation into Cancer and Nutrition study (Jakszyn 
et al., 2013). Total iron intake was around 12 mg/2 000 kcal with mean (SD) intakes of haem and non-
haem iron, expressed as mg/2 000 kcal, of 0.49 (0.26) and 11.51 (2.67), respectively, in tertile 1 of 
haem iron intake; and 1.91 (0.59) and 11.96 (2.29), respectively, in tertile 3 of haem iron intake. 
Although haem iron represented only 4 % of the total iron intake in omnivores, it is more bioavailable 
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than non-haem iron; therefore, its potential contribution to total absorbed iron is greater than the intake 
values indicate. 
4. Overview of Dietary Reference Values and recommendations 
4.1. Adults 
The German-speaking countries (D-A-CH, 2015) considered that iron requirements depend on iron 
losses through the intestine, the kidneys, the skin (about 1 mg/day) and menses (for menstruating 
women, about 15 mg/month), although about 20 % of women have substantially higher monthly iron 
losses (Hallberg et al., 1966b). Dietary iron absorption in the majority of industrial countries was 
considered to be between 10 and 15 % (FAO/WHO, 1988), or higher by two- or three-fold in the case 
of iron deficiency. With an absorption of 10–15 %, an iron intake of 15 mg/day was estimated to 
provide the body with 1.5–2.2 mg of absorbed iron per day and to cover the needs of all women with 
normal menstrual blood losses. Based on German data (Arab-Kohlmeier et al., 1989), the German-
speaking countries considered that postmenopausal women would not have a higher iron requirement 
than men, for whom the Recommended Intake (RI) was set at 10 mg/day. 
The Nordic countries (Nordic Council of Ministers, 2014) considered (1) median basal iron losses of 
0.014 mg/kg body weight per day (Green et al., 1968), multiplied by mean body weight for the Nordic 
population, and (2) for women of childbearing age, menstrual iron losses (median, 90
th
 and 95
th
 
percentile) evaluated from the amount of menstrual blood losses (median 30 mL/28 days) (Hallberg et 
al., 1966b; Hallberg and Rossander-Hultén, 1991), a haemoglobin concentration of 135 g/L and an 
assumed iron content of 3.34 mg/g of haemoglobin. For women of childbearing age, iron absorption 
was assumed to be 15 %, although subjects in the top 5
th
 percentile of iron requirement probably have 
a higher absorption rate. Blood loss during menstruation was considered to be variable among adult 
women, but fairly constant for a given woman (Hallberg and Rossander-Hultén, 1991). Finally, for 
women of childbearing age, an AR was set at 10 mg/day and an RI was set at 15 mg/day, which 
corresponds to the amount of iron required to meet the needs of about 90 % of women. In addition, a 
lower level of intake of 5 mg/day was set for postmenopausal women, while a value of 7 mg/day was 
set for men, considering their greater body size. To cover basal iron losses, ARs of 6 mg/day for 
postmenopausal women and of 7 mg/day for men were derived and RIs were set at 9 mg/day for both 
population groups. 
WHO/FAO (2004) adapted the conclusions from their earlier report (FAO/WHO, 1988), considering 
more recent calculations on the distribution of iron requirements in menstruating women (Hallberg 
and Rossander-Hultén, 1991). They considered mean body weights, median basal iron losses and, for 
women of childbearing age, the median and 95
th
 percentile of menstrual iron losses (without taking 
into account the normal variation in haemoglobin concentration), in order to calculate the median and 
the 95
th
 percentile of total requirements for absorbed iron. Total basal iron loss from the skin, the 
intestine, the urinary tract and the airways was considered to be 0.014 mg/kg body weight per day 
(Green et al., 1968), and the range of individual variation was estimated to be ±15 % (FAO/WHO, 
1988). Median basal iron losses of 1.05 mg/day for adult men and 0.87 mg/day for adult women were 
estimated. Menstrual blood losses were considered to be constant for a given woman, but variable 
among women (Hallberg et al., 1966b), and greatly influenced by the choice of contraceptive method; 
moreover, their distribution was considered to be highly skewed. The median and 95
th
 percentile of 
menstrual iron losses were estimated to be 0.48 and 1.90 mg/day for women of childbearing age. The 
median and the 95
th
 percentile of total absorbed iron requirements were estimated to be 1.46 and 
2.94 mg/day for women of childbearing age, 1.05 and 1.37 mg/day for men, and 0.87 and 1.13 mg/day 
for postmenopausal women. WHO/FAO also considered that iron requirements per unit of body 
weight for postmenopausal women and physically active older adults are the same as for men, but that, 
when physical activity decreases with advanced age, blood volume and haemoglobin mass decrease, 
leading to a shift of iron usage from haemoglobin and muscle to iron stores, and therefore a reduction 
in iron requirements. The main source of variation in iron status in different populations was 
considered to be variation in iron absorption, and the amount of dietary iron absorbed was considered 
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to be mainly determined by body iron stores and by the properties of the diet, i.e. iron content and 
bioavailability. WHO/FAO finally based their Recommended Nutrient Intakes on the 95
th
 percentile of 
the total requirements for absorbed iron, and considered four different bioavailability figures: 15 and 
12 % (for Western-type diets, depending mainly on meat intake), and 10 and 5 % (for developing 
countries). The Recommended Nutrient Intakes for an iron bioavailability of 15 % were set at 
9.1 mg/day for adult men, 19.6 mg/day for women of childbearing age and 7.5 mg/day for 
postmenopausal women. 
The SCF (1993) followed a similar approach to that of WHO/FAO (2004), i.e. adapted the data from 
the earlier report (FAO/WHO, 1988) using more recent data on the distribution of iron requirements in 
menstruating women (Hallberg and Rossander-Hultén, 1991). It considered the same data for basal 
iron losses (Green et al., 1968) (2 SD being added to the median basal iron loss to estimate the 95
th
 
percentile) and menstrual blood losses (Hallberg et al., 1966b). Assuming a bioavailability of 15 %, 
the SCF based their PRI on the 95
th
 percentile of total iron requirements and set the same values as 
WHO/FAO (2004). However, it also proposed rounded figures and, for menstruating women, two PRI 
values based on the 90
th
 and 95
th
 percentiles of total iron requirements, as the SCF considered that a 
PRI based on the 95
th
 percentile would be unrealistically high for the great majority of women. The 
probability of adequacy among menstruating adult women for various amounts of absorbed iron was 
also provided, as well as the dietary intake necessary to provide these amounts, assuming a 
bioavailability of 15 %. 
The Agence française de sécurité sanitaire des aliments (Afssa, 2001) considered that daily basal iron 
losses in adults due to desquamation of cells from the surfaces of the body are 0.9–1 mg, i.e. about 
14 µg/kg body weight, comprising 0.6 mg for faecal, 0.2–0.3 mg for dermal and 0.1 mg for urinary 
losses. Iron bioavailability of the usual French diet was considered to be 10 % (Galan et al., 1985; 
Lynch and Baynes, 1996; Lynch, 1997). The PRI was set at 9 mg/day for adult men and 
postmenopausal women. For women of childbearing age, menstrual iron losses were considered in 
addition to basal iron losses (FAO/WHO, 1988; INACG, 1989). Afssa reported median menstrual 
blood losses between 25 and 30 mL/month, i.e. menstrual iron losses of 12.5–15 mg/month or 0.4–
0.5 mg/day, and indicated that 50 % of women would have total iron losses higher than 1.3 mg/day 
and 10 % would have losses higher than 2.1 mg/day. Factors such as heredity, weight, height, age, 
parity and particularly choice of contraception method were mentioned to have an impact on the 
volume of menstrual blood losses. The PRI was set at 16 mg/day for women of childbearing age. 
IOM (2001) considered the maximal bioavailability of iron to be 18 % in (non-pregnant, non-
lactating) adults, based on a conservative estimate of 10 % for the proportion of haem iron in the diet 
of adults (Raper et al., 1984) and children (based on data of the Continuing Survey of Food Intakes by 
Individuals, CSFII, 1994–1996), a conservative estimate of 25 % for overall haem absorption 
(Hallberg and Rossander-Hultén, 1991), and an estimated bioavailability of non-haem iron in self-
selected diets of 16.8 % for individuals with a serum ferritin concentration of 15 µg/L (Cook et al., 
1991). IOM only took into account basal losses when estimating the needs for absorbed iron in adult 
men and postmenopausal women, and did not consider the higher iron stores in men than in women. 
Basal iron losses in men were assumed to be 0.014 mg/kg body weight per day, based on the study by 
Green et al. (1968). Owing to the lack of data to estimate the variability of basal losses in adult men, 
the median and variability for basal losses were calculated using the median body weight recorded in 
the National Health and Nutrition Examination Survey (NHANES) III and its variability calculated 
using the square root of the median weight for men. For men, the calculated median and 97.5
th
 
percentile for daily iron loss were 1.08 and 1.53 mg/day, respectively. The Estimated Average 
Requirement (EAR) was calculated by dividing the median daily iron loss by the estimated iron 
bioavailability and was set at 6 mg/day, and the Recommended Dietary Allowance (RDA) was 
calculated by dividing the 97.5
th
 percentile of daily iron loss by the bioavailability and was rounded to 
8 mg/day. For menstruating women, menstrual iron losses were added to basal iron losses using data 
from Hallberg et al. (1966b, 1966a); Hallberg and Rossander-Hultén (1991). Percentiles of blood loss 
were predicted from a log-normal distribution, and the predicted median was 30.9 mL/cycle. Blood 
losses per menstrual cycle were converted into estimated daily iron losses averaged over the whole 
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menstrual cycle; haemoglobin concentration was taken as a constant (135 g/L) in adult women 
(Beaton et al., 1989); the iron content of haemoglobin was considered to be 3.39 mg/g (Smith and 
Rios, 1974); and the duration of the average menstrual cycle was considered to be 28 days (Beaton et 
al., 1970). Median menstrual iron loss was calculated as 0.51 mg/day and the 97.5
th
 percentile was 
calculated to be 2.32 mg/day. As there were no direct measurements of basal iron losses (separated 
from menstrual iron losses) in women, values for women were derived from those used for men 
(Green et al., 1968) by linear body weight adjustment. The median and variability for basal losses 
were calculated in the same way as for men. The median and the 97.5
th
 percentile of basal iron losses 
were therefore 0.896 and 1.42 mg/day, respectively. Distributions of requirement for absorbed iron 
and dietary iron were calculated by Monte Carlo simulation from the estimated distributions of 
menstrual and basal iron losses, considering a bioavailability of 18 %. For menstruating women not 
using oral contraceptives, the median absorbed iron requirement was calculated as 1.41 mg/day and 
was used to set the EAR at 8 mg/day (rounded value). Moreover, the calculated 97.5
th
 percentile of 
absorbed iron requirement of 3.15 mg/day was used to set the RDA at 18 mg/day (rounded value). For 
postmenopausal women, basal iron losses were also taken as 0.014 mg/kg body weight per day (Green 
et al., 1968) and the median and variability for basal losses were calculated in the same way as for 
adult men. The calculated median and 97.5
th
 percentile for daily iron loss were estimated at 0.896 and 
1.42 mg/day, respectively. The EAR was calculated by dividing the median iron loss by the estimated 
iron bioavailability of 18 % and was set at 5 mg/day; and the RDA was calculated by dividing the 
97.5
th
 percentile of daily iron loss by the bioavailability and was rounded to 8 mg/day. Special 
considerations were made regarding the use of oral contraceptives and hormone replacement therapy 
(HRT), vegetarianism, intestinal parasitic infection, blood donation, and increased iron losses in 
exercise and intense endurance training. Based on a re-analysis of data on decreased menstrual blood 
losses in women using oral contraceptives (Nilsson and Solvell, 1967), a reduction of about 60 % was 
estimated, and the requirements at the 50
th
 (EAR) and 97.5
th
 (RDA) percentiles for premenopausal 
women using oral contraceptives were set at 6.4 and 10.9 mg/day, respectively. Women on HRT and 
still menstruating were considered to possibly have higher iron requirements than postmenopausal 
women not on HRT. The iron bioavailability of a vegetarian diet was estimated to be about 10 % 
(instead of 18 % for a mixed Western diet), and the iron requirement was thus considered to be 1.8 
times higher for vegetarians. The EAR for iron was assumed to be 30 % greater in subjects engaged in 
regular intense exercise (Ehn et al., 1980) and 70 % greater in athletes (Weaver and Rajaram, 1992). 
The Netherlands Food and Nutrition Council (1992) estimated average basal iron losses (through 
faeces, urine and sweat) to be 0.9 mg/day in men and 0.8 mg/day in women, and the average menstrual 
iron loss to be 0.8 mg/day. The average quantities of absorbed iron to compensate for total losses were 
1.1 mg/day for men and 1.7 mg/day for women aged 19–22 years (adding an iron amount for growth 
to basal iron losses and, for women, menstrual losses); 0.9 mg/day for men and 1.6 mg/day for women 
aged 22 years and over; and 0.8 mg/day for postmenopausal women. Iron absorption from the Dutch 
diet was estimated to be 12 %, considering the estimated absorption of haem and non-haem iron 
(Hallberg, 1981), the average ratio of haem and non-haem iron, the vitamin C content and the quantity 
of meat in the Dutch diet, as well as studies on complete meals and breakfasts. The minimum 
requirements were estimated as 9 mg/day (19–22 years) and 8 mg/day (22 years and over) for men, 
and 14 mg/day (19–22 years), 13 mg/day (22 years and over) and 7 mg/day (postmenopause) for 
women. A coefficient of variation (CV) of 20 % was applied to cover variation in individual 
requirements (and a CV of 15 % was applied for growth). Adequate levels of daily intake were derived 
by adding 2 SD to the average minimum requirements for the different age and sex groups. 
The UK Committee on Medical Aspects of Food Policy (COMA) (DH, 1991) considered daily iron 
losses of 0.14 mg through desquamated gastrointestinal cells, 0.38 mg for haemoglobin, 0.24 mg for 
bile and 0.1 mg through urine (Green et al., 1968), i.e. a total of 0.86 mg/day with a CV of 15 %, and 
the amount lost through skin and sweat was considered negligible (Brune et al., 1986). A 
bioavailability of 15 % was considered typical in industrialised countries (FAO/WHO, 1988). For 
adults over 50 years of age, the Lower Reference Nutrient Intake (LRNI) was set at 4.7 mg/day, the 
EAR was set at 6.7 mg/day and the RNI was set at 8.7 mg/day. In women of childbearing age, 
menstrual iron losses were estimated from Swedish data on menstrual blood loss, showing a highly 
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skewed distribution (Hallberg et al., 1966b). For a 75
th
 percentile of blood loss of 52.4 mL, a 
haemoglobin concentration of 13 g/100 mL and an iron content of haemoglobin of 0.347 %, the 
calculated menstrual iron losses were added to basal iron losses, leading to an EAR of 11.4 mg/day, an 
LRNI of 8.0 mg/day and an RNI of 14.8 mg/day, but this intake was considered to be insufficient for 
the 10 % of women with the highest menstrual losses. Specific considerations regarding frequent 
blood donors were also provided. The UK Scientific Advisory Committee on Nutrition (SACN) 
(2010) considered that these DRVs were derived from limited data but that new data were insufficient 
to reassess them. 
An overview of DRVs for iron for adults is presented in Table 2. 
Table 2:  Overview of Dietary Reference Values for iron for adults 
 D-A-
CH 
(2015) 
NCM 
(2014) 
WHO/FAO 
(2004) (a) 
Afssa 
(2001) 
IOM 
(2001) 
SCF  
(1993) 
NL 
(1992) (b) 
DH 
(1991) 
Age 
(years) 
19–50 18–60 ≥ 18 ≥ 20 19–50 ≥ 18 19–22 19–50 
PRI 
men 
(mg/day) 
10 9 (c) 9.1 for a 
bioavailability of 
15 % (up to 27.4 
for a bioavail-
ability of 5 %) 
9 8 9 (c) 11 8.7 
PRI 
women 
(mg/day) 
15 15 (d) 
(postmenopause 
9 (c)) 
19.6 for a 
bioavailability of 
15 % (up to 58.8 
for a bioavail-
ability of 5 %) 
16 18 (10.9 for 
women using 
oral 
contraceptives) 
16 (d) 
20 (c) 
16 14.8 
Age 
(years) 
≥ 51 ≥ 61   ≥ 50  ≥ 22 ≥ 50 
PRI 
men 
(mg/day) 
10 9 (c) As for younger 
men 
 8 As for younger 
men 
9 8.7 
PRI 
women 
(mg/day) 
10 9 (c) Postmenopause: 
7.5 for a 
bioavailability of 
15 % (up to 22.6 
for a bioavail-
ability of 5 %) 
 8 Postmenopause 
8 (c) 
15 (22–50 
years)/ 
8 (≥ 50 
years) 
8.7 
NCM, Nordic Council of Ministers; NL, Netherlands Food and Nutrition Council. 
(a): Recommended Nutrient Intake, based on the 95th percentile of iron requirements. 
(b):  Adequate level of daily intake. 
(c): Based on the 95th percentile of iron requirements. 
(d): Based on the 90th percentile of iron requirements. 
4.2. Infants and children 
The German-speaking countries (D-A-CH, 2015) estimated daily iron losses of infants and children to 
be 0.2–0.4 mg. Requirements for growth were considered to amount to 0.7 mg/day between 6 and 12 
months, and 0.3–0.5 mg/day after the age of 1 year (Dallman, 1988; Fairbanks and Bleutler, 1988). 
The requirement for absorbed iron was estimated to be about 1 mg/day for infants aged 4 to < 12 
months; hence, an iron intake of 1 mg/kg body weight per day or 8 mg/day was recommended. For 
older children, the German-speaking countries took into account iron losses and iron requirements for 
growth and concluded that about 0.8 mg/day of absorbed iron was needed, also taking into account the 
increased iron requirement during puberty owing to an increased growth rate and, for girls, the start of 
menstruation. 
For children aged 6 months to 5 years, the Nordic countries (Nordic Council of Ministers, 2014) 
retained their previous recommendation of 8 mg/day, as no iron deficiency was observed in older 
infants consuming on average 9 mg/day of iron provided mostly by iron-fortified phytate-rich cereals 
(Lind et al., 2003), and as a higher recommendation would require a diet much denser in iron for that 
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age group than for older children and adults. For children aged 6–9 years, an intake of 9 mg/day was 
recommended. For children aged 10–17 years, it was assumed that iron absorption is 15 %, although 
subjects in the top 5
th
 percentile of iron requirement probably have a higher absorption efficiency. The 
Nordic countries considered (1) the iron requirements for growth, (2) median basal iron losses 
estimated to be 0.014 mg/kg body weight per day (Green et al., 1968) multiplied by mean body weight 
(Andersen et al., 1982), and (3) for menstruating girls, menstrual iron losses evaluated from the 
amount of menstrual blood losses (median: 28.4 mL/28 days) (Hallberg et al., 1966b; Hallberg et al., 
1991; Hallberg and Rossander-Hultén, 1991; Borch-Iohnsen, 1993), a haemoglobin concentration of 
135 g/L, an assumed iron content of 3.34 mg/g of haemoglobin and an equation (derived from a fitted 
log-normal distribution with a Monte Carlo simulation (IOM, 2001)) to calculate the 95
th
 percentile of 
blood loss. Blood loss during menstruation was mentioned to be less variable among adolescent girls 
than adult women. The RIs correspond to the amount of iron to meet the needs of about 95 % of 
children of all age groups, except for girls after menarche, for whom the RIs are assumed to cover the 
needs of 90 % of the group. 
For infants and children, WHO/FAO (2004) adapted the conclusions from their earlier report 
(FAO/WHO, 1988). They considered mean body weights, the iron requirement for growth, median 
basal iron losses and, for menstruating girls, the median and 95
th
 percentile of menstrual iron losses 
(0.48 and 1.90 mg/day), in order to calculate the median and the 95
th
 percentile of total requirements 
for absorbed iron for children between 0.5 and 17 years. The total basal iron loss was considered to be 
0.014 mg/kg body weight per day (Green et al., 1968), and the range of individual variation was 
estimated to be ±15 % (FAO/WHO, 1988). Iron requirements in term infants were considered to rise 
markedly in the second half of infancy, as body iron stores almost double between the age of 6 months 
and 1 year, and then double again between 1 and 6 years of age. WHO/FAO stressed the high iron 
requirements of adolescents that are the result of rapid growth (Rossander-Hulthén and Hallberg, 
1996), and the marked individual variation in growth rate and consequently in iron requirements 
(Hallberg et al., 1966b; Tanner et al., 1966a, 1966b; Karlberg and Taranger, 1976; Dallman and 
Siimes, 1979; FAO/WHO, 1988). The same considerations for women of childbearing age (see 
Section 4.1) are applied to menstruating girls regarding the intra-individual and inter-individual 
variability of menstrual blood losses (Hallberg et al., 1966b), their statistical distribution and the 
impact of contraceptive methods, as well as the impact of iron bioavailability. Finally, the 
Recommended Nutrient Intakes were based on the 95
th
 percentile of the requirements for absorbed 
iron and the four levels of iron bioavailability already considered for adults (15, 12, 10 and 5 %). 
Separate values for pre- and post-menarchal girls aged 11–14 years were also provided. 
The SCF (1993) followed an approach similar to that of WHO/FAO (2004), i.e. adapted the data from 
the earlier report (FAO/WHO, 1988) using more recent data on the distribution of iron requirements in 
menstruating women (Hallberg and Rossander-Hultén, 1991) and considering the same data for basal 
iron losses (Green et al., 1968) and iron requirements for growth (Karlberg and Taranger, 1976). For 
infants aged 0.5–1 year, bioavailability of iron from weaning foods was considered to be lower than 
that of iron from the adult diet because of an often high content of inhibitors of iron absorption such as 
milk and phytate in infant cereals, and a low content of enhancers of iron absorption such as meat and 
ascorbic acid. Moreover, the bioavailability of iron used to fortify infant foods was considered 
unknown. Therefore, bioavailability was assumed to be highly variable and on average lower than for 
other age groups, i.e. 10 %, and a PRI of 9.3 mg/day was set for older infants. For a bioavailability of 
15 %, the SCF based their PRI on the 95
th
 percentile of total iron requirements and set the same values 
as WHO/FAO (2004), but also proposed rounded figures and two PRI values based on the 90
th
 and 
95
th
 percentiles of total iron requirements for menstruating adolescent girls. 
Afssa (2001) considered daily basal iron losses of about 14 µg/kg body weight and a bioavailability of 
10 % (Galan et al., 1985; Lynch and Baynes, 1996; Lynch, 1997). Afssa reported that iron 
requirements of infants were very high to cover basal losses, erythrocyte mass expansion and growth 
of body tissues, and that iron body stores doubled during the first year of life. Total iron requirements 
at 1 year of age were mentioned to be 8–10 times higher than those of an adult man if expressed per 
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kilogram of body weight. Iron requirements for growth during adolescence and for menstrual losses in 
adolescent girls were also taken into account. 
For infants aged 7–12 months, IOM (2001) modelled the major factorial components of absorbed iron 
requirements, which were basal (i.e. faecal, urinary and dermal) losses, the increase in haemoglobin 
mass, the increase in tissue iron and the increase in storage iron. Considering median body weights at 
6 and 12 months (Dibley et al., 1987) and reference body weights from NHANES III (1988–1994), a 
CV for weight of 10 % and an estimated basal iron loss of 0.03 mg/kg body weight per day (Garby et 
al., 1964), and assuming its variability is proportional to the variability of weight, the mid-range 
estimate of basal losses for infants aged 6–12 months was calculated to be 0.26 ± 0.03 mg/day. The 
median weight increment was assessed to be 0.39 kg/month or 13 g/day (Dibley et al., 1987), 
considering a CV of 50 %. The increase in haemoglobin mass was calculated to be 
0.37 ± 0.195 mg/day. This calculation was done by multiplying the median monthly weight increment 
by a blood volume of 70 mL/kg (Hawkins, 1964), a median haemoglobin concentration of 
0.12 mg/mL and an iron content of haemoglobin of 3.39 mg/g (Smith and Rios, 1974), dividing by 
30 days and applying the CV accepted for weight gain (50 %). The increase in tissue iron content was 
calculated as 0.009 ± 0.0045 mg/day. This was done by multiplying the median daily weight 
increment by the estimated tissue iron content of 0.7 mg/kg body weight at 1 year (Smith and Rios, 
1974), assumed to be identical at 7 months of age, and applying the CV accepted for weight gain 
(50 %). The increase in storage iron was calculated as 0.051 mg/day. This was done by multiplying the 
sum of the increase in haemoglobin iron and the increase in non-storage iron by the percentage of total 
tissue iron stored (12 % (Dallman, 1986)), and dividing by the percentage of total iron not stored. The 
median total requirement for absorbed iron was therefore 0.69 ± 0.145 mg/day, and the 97.5
th
 
percentile was 1.07 mg/day. For a moderate bioavailability of 10 % (considering the low 
bioavailability of iron in fortified infant cereals (Davidsson et al., 2000) and the proportion of infants 
consuming meat at 1 year (Skinner et al., 1997)), the EAR was set at 6.9 mg/day using the median 
total requirement, and the RDA was set at 11 mg/day using the 97.5
th
 percentile of the total 
requirement.  
For children aged 1 to 8 years, IOM estimated the median rate of weight gain to be 2.29 kg/year or 
6.3 g/day, from the slope of a linear regression of reported median body weights on age (Frisancho, 
1990). The midpoints of 2.5 and 6.5 years were used to set the EAR and RDA for the age groups 1–3 
years and 4–8 years, respectively. As for infants, the major components of iron requirement modelled 
by IOM (2001) were basal iron losses and the increase in haemoglobin mass, tissue iron and storage 
iron. Basal iron losses were derived from total iron losses measured in adult men (Green et al., 1968) 
adjusted to the child’s estimated body surface area (Haycock et al., 1978) (which is directly related to 
dermal iron losses (Bothwell and Finch, 1962)). Haemoglobin mass was estimated by multiplying 
blood volume at specific ages (Hawkins, 1964) by the estimated age- and sex-specific haemoglobin 
concentration ((Beaton et al., 1989), using 119 ± 1.4 g/L per year in males and 121 ± 1.1 g/L per year 
in females). The estimated yearly change in haemoglobin mass was multiplied by its assumed iron 
content (3.39 mg/g). The increase in the tissue iron content was 0.004 mg/day whatever the age, 
calculated by multiplying the median yearly rate of weight gain by the estimated tissue iron content 
(0.7 mg/kg body weight (Smith and Rios, 1974)). Up to the age of 3 years, the increase in storage iron 
was calculated in the same way as for older infants, by multiplying the sum of the increase in 
haemoglobin mass and the increase in tissue iron by the portion of total tissue iron that is stored. The 
estimated values fell until 9 years of age (when the value was 0). The median total requirement for 
absorbed iron was based on the higher estimates for boys and was set at 0.54 mg/day between 1 and 3 
years and at 0.74 mg/day between 4 and 8 years. The variability of requirements was estimated, 
considering the variability of weight velocity (CV of 40 % between 1 and 8 years), which was also 
assigned to the variability of haemoglobin iron deposition and tissue iron deposition, and an overall 
CV of basal iron losses of 38 %. Considering the same bioavailability as for adults, i.e. 18 %, EARs 
and RDAs were calculated based on the median and 97.5
th
 percentile for each year increment between 
1.5 and 8.5 years.  
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For children aged 9–18 years, the major components of iron requirement modelled by IOM were basal 
iron losses, the increase in haemoglobin mass and the increase in storage iron, like for younger 
children (but not the increase in tissue non-storage iron), as well as menstrual iron losses for girls aged 
14–18 years. Median requirements for absorbed iron were estimated for each year of age, and the 
variability of these requirements and the 97.5
th
 percentile were assessed at the midpoint of the age 
ranges 9–13 years and 14–18 years. Median yearly weight gains in boys (aged 9–12, 13–14, 15–17 
and 18 years) and girls (aged 9–11, 12–13, 14–17 and 18 years) were estimated from the slopes of 
linear regressions of median body weights on age (Tanner et al., 1966b), and decreased to 0 at 18 
years of age. Basal iron losses for each sex and each year increment between 9 and 18 years were 
extrapolated from data on adult men (0.014 mg/kg body weight per day) (Green et al., 1968) and 
multiplied by median body weights recorded in NHANES III. The amount of iron needed for the 
increase in haemoglobin mass was calculated by adding the estimated yearly rate of change in 
haemoglobin concentration multiplied by median body weights and the estimated yearly weight gains 
multiplied by haemoglobin concentration. This sum was then multiplied by blood volume and the iron 
content of haemoglobin and divided by 365 days. Blood volume was considered to be about 75 mL/kg 
body weight in boys and 66 mL/kg body weight in girls (Hawkins, 1964), the iron content of 
haemoglobin was considered to be 3.39 mg/g (Smith and Rios, 1974), and the yearly rates of change in 
haemoglobin concentration were estimated as the coefficients of linear regressions of haemoglobin 
concentration on age for boys and girls aged 8–13 and 14–18 years (Beaton et al., 1989). Tissue iron 
was calculated by multiplying the median yearly weight gains by the iron content in muscle tissue 
(0.13 mg/kg of total weight gain (Smith and Rios, 1974)) and dividing by 365 days. For the estimation 
of menstrual losses in adolescent girls, the model assumed that all girls were menstruating at age 14 
years and over, and that girls younger than 14 years did not menstruate. As done for menstruating 
women, a log-normal distribution was fitted to reported menstrual blood losses in Swedish women 
(Hallberg et al., 1966b, 1966a; Hallberg and Rossander-Hultén, 1991), and the predicted median blood 
loss was 27.6 mL/cycle. Median menstrual iron loss was calculated as 0.45 mg/day, by multiplying the 
calculated median blood loss by the haemoglobin concentration estimated according to age (for 14–
20 years: 131 g/L + 0.28  age in years) and the iron content of haemoglobin of 3.39 mg/g (Smith and 
Rios, 1974). The distributions of the components of the total requirement for absorbed iron were 
reported to be skewed and the variability of each component was assessed to estimate the variability of 
the total requirement. The modelled distribution of total iron requirement, combining the several 
estimated components in a Monte Carlo simulation, was used to set the EAR (based on the median) 
and the RDA (based on the 97.5
th
 percentile), assuming the same absorption efficiency as for adults, 
i.e. 18 %. The physiological processes associated with puberty with a major impact on iron 
requirements were considered to be the growth spurt in both sexes, menarche in girls and the major 
increase in haemoglobin concentrations in boys. IOM also described how to adjust estimates for 
requirements for individuals underlying the growth spurt or onset of menstruation. An increased 
requirement for dietary iron was set at 2.9 mg/day for boys and at 1.1 mg/day for girls identified as 
currently in the growth spurt, and at 2.5 mg/day for girls under the age of 14 years and starting to 
menstruate. The estimated percentiles of the distribution of iron requirements in children aged 0.5–1 
year, 1–3 years, 4–8 years, 9–13 years and 14–18 years were also provided. 
The Netherlands Food and Nutrition Council (1992) calculated basal iron losses in childhood by 
extrapolation using body weight to the power of 0.75. Menstrual iron losses were estimated to be 
0.6 mg/day in girls aged 13–16 years (Schlaphoff and Johnston, 1949). Requirements for growth were 
calculated from variation in body iron stores (average: 40–50 mg/kg body weight (Fomon and 
Anderson, 1974)) and their SD was considered to be 15 %. Total average amounts of absorbed iron to 
compensate for losses (basal, menstrual for adolescent girls) and growth were 0.8 mg/day at 0.5–
1 year, and between 0.7 and 1.5 mg/day in boys and 0.7 and 1.8 mg/day in girls aged 1–19 years. 
Considering an absorption efficiency of 14 % for infants aged 0.5–1 year and girls aged 13–19 years 
(Hallberg, 1981), and the same absorption efficiency as in adults, i.e. 12 %, for the other age groups of 
children, the minimum requirements were estimated as 6.5 mg/day at 0.5–1 year and between 6 and 
13 mg/day in boys and girls aged 1–19 years. Considering an SD of 15 % for growth and no variation 
for menstrual losses, adequate levels of daily intakes were set at 7 mg/day for infants aged 0.5–1 year 
and between 7 mg/day and 15 mg/day (boys) or 14 mg/day (girls) between 1 and 19 years. 
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For infants and children, the UK COMA (DH, 1991) added to basal losses the amount of iron required 
for expanding red cell mass and growing body tissues, as well as menstrual iron losses for adolescent 
girls aged 11–18 years, and considered an iron absorption of 15 %. The LRNI was set at 4.2 mg/day 
and the EAR was set at 6.0 mg/day for infants aged 7–12 months. The LRNIs ranged between 3.3 and 
8.0 mg/day and the EARs ranged between 4.7 and 11.4 mg/day depending on sex and age group 
between 1 and 18 years. RNIs were 7.8 mg/day for infants aged 7–12 months and ranged between 6.1 
and 14.8 mg/day depending on sex and age group between 1 and 18 years. 
An overview of DRVs for iron for children is presented in Table 3. 
Table 3:  Overview of Dietary Reference Values for iron for children 
 D-A-CH 
(2015) 
NCM 
(2014) 
WHO/FAO (a) 
(2004)  
Afssa (b) 
(2001)  
IOM 
(2001) 
SCF 
(1993) 
NL 
(1992) 
DH 
(1991) 
Age 
(months) 
4–< 12 6–11 6–12 6–12 7–12 6–11 6–12 7–12 
PRI 
(mg/day) 
8 8 (c) 6.2 (bioavailability 
during this period 
varies greatly) 
7 11 6 (c) 
[9.3] (d) 
7 7.8 
Age 
(years) 
1–< 7 1–5 1–3 1–3 1–3 1–3 1–4 1–3 
PRI 
(mg/day) 
8 8 (c) 3.9 7 7 4 (c) 7 6.9 
Age 
(years) 
7–< 10 6–9 4–6 4–6 4–8 4–6 4–7 4–6 
PRI 
(mg/day) 
10 9 (c) 4.2 7 10 4 (c) 7 6.1 
Age 
(years) 
10–< 19 10–13 7–10 7–9 9–13 7–10 7–10 7–10 
PRI 
(mg/day) 
12 (M) 
15 (F) 
11 (c) 5.9 8 8 6 (c) 8 8.7 
Age 
(years) 
 14–17 11–14 10–12 14–18 11–14 10–13 11–18 
PRI 
(mg/day) 
  11 (M) (c) 
15 (F) (e) 
9.7 (M) 
9.3 (f)/21.8 (F) 
10 11 (M) 
15 (F) 
10 (M) (c) 
9 (F) (f) 
18 (F) (e) 
22 (F) (c) 
10 (M) 
11 (F) 
11.3 (M) 
14.8 (F) 
Age 
(years) 
  15–17 13–19  15–17 13–19  
PRI 
(mg/day) 
  12.5 (M) 
20.7 (F) 
13 (M) 
16 (F) 
 13 (M) (c) 
17 (F) (e) 
21 (F) (c) 
15 (M) 
12 (F) (g) 
14 (F) (g) 
 
F, females; M, males; NCM, Nordic Council of Ministers; NL, Netherlands Food and Nutrition Council. 
(a): Recommended Nutrient Intake, for a bioavailability of dietary iron of 15 %. 
(b): Values are from the table on page 507 of the Afssa (2001) report. 
(c): Calculations were based on the 95th percentile of iron requirements and absorption was assumed to be 15 %. 
(d): Bioavailability during this period varies greatly. The value in square brackets is for a bioavailability of 10 %. 
(e): Based on the 90th percentile of iron requirements. 
(f): Pre-menarche. 
(g): At an absorption efficiency of 14 %. 
4.3. Pregnancy 
For pregnancy, the German-speaking countries (D-A-CH, 2015) took into account iron requirements 
of about 300 mg for the fetus, about 50 mg for the placenta and about 450 mg for the increased blood 
volume of the mother (Hallberg, 1988). D-A-CH considered that the RI of 30 mg/day during 
pregnancy cannot usually be met with food alone. 
The Nordic countries (Nordic Council of Ministers, 2014) did not set RIs for dietary iron for pregnant 
women, in line with SCF (1993). Iron stores of about 500 mg were reported to be required at the 
beginning of pregnancy to achieve iron balance during pregnancy. Maternal iron requirements were 
shown to increase slowly during pregnancy, from the amount needed to cover basal losses in the first 
Dietary Reference Values for iron 
 
EFSA Journal 2015;13(10):4254 35 
trimester to an amount of 10 mg/day in the last six weeks (Barrett et al., 1994), in relation to 
requirements for growth and maintenance of the fetus and uterus, the increase in red cell mass and the 
expected iron losses during birth. Total iron requirement during pregnancy was estimated to be 
1 040 mg, including 840 mg for the fetus, the rest being lost when giving birth (Hallberg, 1988). Iron 
absorption was assumed to increase during the last two trimesters. It was noted that, for some pregnant 
women, the amount of iron in foods is not enough to satisfy the greatly increased iron demand, and 
iron supplementation starting in the second trimester was therefore recommended. 
WHO/FAO (2004) and SCF (1993) did not derive a Recommended Nutrient Intake or a PRI for 
pregnant women, because the iron balance of pregnant women depends on the properties of the diet 
and on iron stores. However, iron requirements were reported to be 300 mg for the fetus, 50 mg for the 
placenta, 450 mg for the expansion of maternal red cell mass and 240 mg for basal iron losses, and 
thus 1 040 mg in total. Net iron requirement in pregnancy was considered to be 840 mg, assuming 
sufficient iron stores (i.e. stores of 500 mg available during the last two trimesters). Total daily iron 
requirements were noted to increase during pregnancy from 0.8 mg to about 10 mg during the last six 
weeks, and iron absorption was reported to increase during pregnancy. SCF (1993) considered that 
iron requirements during the second half of pregnancy are huge and cannot be met by diet alone or the 
body iron stores of the mother. Thus, SCF recommended daily iron supplements during this period, in 
accordance with DeMaeyer et al. (1989). 
Afssa (2001) considered a bioavailability of 10 % like for other age groups (Galan et al., 1985; Lynch 
and Baynes, 1996; Lynch, 1997) and reported an increased iron requirement during pregnancy 
(FAO/WHO, 1988; Hercberg et al., 2000) in relation to the increase in red cell mass (about 500 mg of 
iron) and the synthesis of fetal tissues (about 290 mg of iron) and the placenta (25 mg of iron). Basal 
iron losses during pregnancy were considered to be 220 mg and total iron requirement was estimated 
to be over 1 000 mg, i.e. 2.5–5.2 mg/day depending on iron stores at the beginning of pregnancy. 
Afssa also noted that there was an increase in iron bioavailability during pregnancy (Whittaker et al., 
1991; Barrett et al., 1994) related to a gradual decrease in body iron stores. Afssa set a PRI of 
30 mg/day during the last trimester of pregnancy and considered that it cannot be met by usual diets. 
For pregnant women, IOM (2001) considered basal losses, iron deposited in fetal and related tissues, 
and iron utilised in the expansion of haemoglobin mass as components for factorial modelling. Basal 
iron losses of 0.896 mg/day, calculated for non-pregnant, non-lactating women with a body weight of 
64 kg and an average basal loss of 0.014 mg/kg body weight per day (Green et al., 1968) were taken 
into account, i.e. about 250 mg for the whole pregnancy. For iron deposition in the fetus, the umbilicus 
and the placenta, IOM selected the value of 315 mg (FAO/WHO, 1988), rounded to 320 mg, and 
provided estimates per trimester (Bothwell and Charlton, 1981). For the expansion of haemoglobin 
mass, the value of 500 mg (FAO/WHO, 1988) was selected. However, IOM noted that the estimate 
depends on the haemoglobin concentration and the extent of iron supplementation provided, and 
referred to the reference curve of the evolution of median haemoglobin concentration by week of 
gestation in healthy, iron-supplemented pregnant women in industrialised countries (IOM, 1993). In 
line with FAO/WHO (1988), the expansion of haemoglobin mass was assumed to be zero during the 
first trimester and equally distributed between the last trimesters (owing to a lack of data on the 
precise timing), i.e. 250 mg/trimester or 2.7 mg/day. The net cost of pregnancy was estimated to be 
about 700–800 mg of iron. Bioavailability in the first trimester was estimated to be the same as for 
non-pregnant women, i.e. 18 %, while the maximal value was estimated to be about 25 % in the last 
two trimesters (Barrett et al., 1994). The requirement for absorbed iron was finally set at 1.2, 4.7 and 
5.6 mg/day, and the dietary iron requirement was set at 6.4, 18.8 and 22.4 mg/day, for the first, second 
and third trimesters, respectively. For pregnant adolescents, a similar approach was followed, but 
estimated basal losses and iron deposition in tissue were those calculated for non-pregnant 
adolescents. The variability of the components of iron requirements was assessed to estimate the 
variability of the total requirement for absorbed iron. The EARs were established based on estimates 
for the third trimester to build iron stores during the first trimester of pregnancy and were 23 mg/day 
for adolescents aged 14–18 years and 22 mg/day for adult women. The RDA was set at 27 mg/day for 
pregnant women of all ages based on the 97.5
th
 percentile of the requirement for absorbed iron. 
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The Netherlands Food and Nutrition Council (1992) considered iron absorption to be 12 % during the 
first trimester of pregnancy and about 16 % in the last two trimesters and during lactation. Basal iron 
losses during pregnancy were considered the same as those of non-menstruating women (0.8 mg/day). 
No CV was applied for losses during birth, and a CV of 15 % was considered for the iron requirement 
for growth of the fetus and the placenta. The iron amount needed during pregnancy for the fetus and 
the placenta was considered to be about 300–350 mg (Widdowson and Spray, 1951; Bowering and 
Sanchez, 1976), the distribution being 10, 40 and 60 % in the first, second and third trimesters, 
respectively. Thus, during the first, second and third trimesters of pregnancy, respectively, the average 
total amounts of absorbed iron were estimated to be 1.1, 2.2 and 2.9 mg/day, the minimum 
requirements for dietary iron were estimated to be 9, 14 and 18 mg/day and the adequate levels of 
daily intake were set at 11, 15 and 19 mg/day. 
The UK COMA (DH, 1991) reported an estimated iron requirement for the products of conception of 
680 mg (Committee on Iron Deficiency, 1968), but did not set any RNI for iron for pregnant women 
because of cessation of menstrual losses, mobilisation of maternal iron stores and increased intestinal 
absorption (Svanberg et al., 1975). 
4.4. Lactation 
The German-speaking countries (D-A-CH, 2015) recommended an intake of 20 mg/day for both 
lactating and non-lactating women after birth to compensate for the losses during pregnancy. 
For lactating women, the Nordic countries (Nordic Council of Ministers, 2014) considered the 
frequent absence of menstruation during the first months of lactation (Habicht et al., 1985). However, 
it was also stated that women in Northern countries breastfeed their infants for prolonged times, so 
that menstrual losses would occur within the breastfeeding period. The RI set for lactating women was 
the same as that for non-pregnant, non-lactating women of childbearing age, i.e. 15 mg/day. 
For lactating women, WHO/FAO considered a mean body weight of 62 kg, a total basal iron loss of 
0.014 mg/kg body weight per day (Green et al., 1968) with an SD of 15 %, a daily iron secretion into 
milk of about 0.3 mg and, therefore, a median basal iron loss of 1.15 mg/day. Median and 95
th
 
percentile of total requirements for absorbed iron were estimated to be 1.15 and 1.50 mg/day, 
respectively. The Recommended Nutrient Intake was based on the 95
th
 percentile of total iron 
requirement and the various levels of iron bioavailability already considered for adults and children 
(15, 12, 10 and 5 %), and was set at 10 mg/day for a bioavailability of 15 % (up to 30 mg/day for a 
bioavailability of 5 %). 
For lactation, SCF (1993) considered an amount of iron secreted with human milk of 0.15–0.3 mg/day, 
and set a PRI of 10 mg/day assuming a bioavailability of 15 %. 
For lactating women, Afssa (2001) recommended an iron intake of 10 mg/day. The iron concentration 
of human milk was considered to be 0.55 mg/L 2 weeks after birth, 0.4 mg/L 6 to 8 weeks after birth 
and about 0.3 mg/L 3 to 5 months after birth (Siimes et al., 1979). The iron loss through human milk 
was thus estimated to be 0.2–0.4 mg/day in the case of exclusive breastfeeding, and the absorption of 
iron was reported to be increased during lactation. 
For lactation, IOM (2001) estimated median iron requirements as the sum of iron secretion in human 
milk and basal iron losses of non-pregnant, non-lactating women (0.896 mg/day), until the initiation of 
menstruation after around six months of exclusive breastfeeding. The average iron concentration of 
human milk was considered to be 0.35 mg/L and the CV was estimated to be 33 %. The average 
volume of milk secreted during the first six months was estimated to be 0.78 L/day. Iron losses with 
human milk were thus estimated to be 0.27 ± 0.089 mg/day and the median total requirement for 
absorbed iron was estimated to be 1.17 mg/day. The approach was similar for lactating adolescents 
(14–18 years), but provision was also made for the deposition of iron in tissues (0.001 mg/day) and 
haemoglobin mass (0.14 mg/day), and the median requirement for absorbed iron was estimated as 
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1.26 mg/day. Like for other age groups, a simulation model was used to derive the 97.5
th
 percentile of 
this requirement used to set the RDA, and a bioavailability of 18 % was assumed. 
For lactating women, the Netherlands Food and Nutrition Council (1992) considered that the amount 
of iron lost during birth (50–250 mg) represented an increased requirement of about 1.6 mg/day over a 
lactation period of three months. The average amount of iron secreted with human milk was assumed 
to be about 0.5 mg/day, and the basal losses were considered to be the same as for non-menstruating 
women, i.e. 0.8 mg/day. The average total amount of absorbed iron was thus estimated to be 
3.0 mg/day. The minimum requirement was set at 19 mg/day and the adequate level of daily intake 
was set at 20 mg/day. 
For lactating women, the UK COMA (DH, 1991) reported iron concentrations in human milk at 6–8 
weeks post-partum of 0.4 mg/L and at 17–22 weeks post-partum of 0.29 mg/L (Vuori, 1979), 
considered a daily volume of milk production of 850 mL, and thus calculated the iron secretion in milk 
to be 0.25–0.34 mg/day. No PRI was derived for lactating women, as lactational amenorrhoea was 
considered to compensate for the amount of iron secreted in milk. 
An overview of DRVs for iron for pregnant and lactating women is presented in Table 4. 
Table 4:  Overview of Dietary Reference Values for iron for pregnant and lactating women 
 D-A-CH 
(2015) 
NCM 
(2014) 
WHO/FAO 
(2004) 
Afssa 
(2001) 
IOM 
(2001) 
SCF 
(1993) 
NL 
(1992) 
DH 
(1991) 
Pregnancy    Third 
trimester 
    
PRI 
(mg/day) 
30 No DRV given No DRV given 30 27 No 
DRV 
given 
11 (first 
trimester) 
15 (second 
trimester) 
19 (third 
trimester) 
No 
DRV 
given 
Lactation       3 months  
PRI 
(mg/day) 
20 (also 
applicable to 
non-
breastfeeding 
women who 
gave birth) 
15 10 for a 
bioavailability of 
15 % (up to 30 
for a 
bioavailability of 
5 %) 
10 10 (14–
18 years)/ 
9 (adult) 
10 20 No 
DRV 
given  
NCM, Nordic Council of Ministers; NL, Netherlands Food and Nutrition Council. 
WHO/FAO (2004) and SCF (1993) consider that iron supplements should be given to all pregnant women. NCM (2014) 
states that the physiological iron requirement of some women cannot be satisfied during the last two-thirds of pregnancy with 
food only, and supplemental iron might be needed. 
5. Criteria (endpoints) on which to base Dietary Reference Values 
5.1. Indicators of iron requirement 
Assessments of iron status (see Section 2.4) of individuals show a wide range between the two 
extremes of iron deficiency and excess, with no good dose–response data to determine thresholds at 
which adverse or significant adaptive events associated with these two conditions are observed. 
Adequate iron status implies the presence of normal erythropoiesis and iron-dependent functions, 
together with a contingency supply of storage iron for physiological requirements. Reference ranges 
have been developed to indicate iron sufficiency, but values outside the range do not necessarily 
define deficiency or excess. The Panel notes that the most commonly used biomarkers of iron status 
are haemoglobin (functional iron) and serum ferritin concentration (storage iron), but these cannot be 
used to determine iron requirements. 
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5.1.1. Factorial approach for estimating physiological iron requirement 
Obligatory iron losses in all population groups include dermal losses (sweat and skin); epithelial loss 
from the intestinal, oropharyngeal and respiratory, and genito-urinary tracts; hepatic, pancreatic and 
intestinal secretions; urine; and menstrual blood loss in women of child-bearing age. To maintain iron 
balance, the sum of these losses plus the iron required for growth in infants, children and adolescents, 
and during pregnancy, must be provided by the diet. 
5.1.1.1. Adults 
From the available data on iron losses (Section 2.3.7), the Panel decided that, instead of combining all 
of the losses from the different routes (and hence magnifying the uncertainty of the estimate), it would 
be more accurate to estimate physiological iron requirement using whole-body iron loss data derived 
from the isotope studies undertaken by Hunt et al. (2009). These authors measured basal losses of iron 
in 29 men, 19 menstruating women and 5 postmenopausal women. 
The Panel used individual data on iron turnover and daily losses of iron from the study of Hunt et al. 
(2009)
10
 as a basis of assessing obligatory losses of iron. It was thought that these data provided an 
aggregate of overall losses, which was relatively free of the uncertainties inherent in summating basal 
losses of endogenous iron using, for example, the data of Green et al. (1968). Although these data 
were collected from a North American population group that is not necessarily representative of the 
EU healthy adult population, the Panel agreed that it was possible to use these data as a basis for the 
estimation and probability modelling of the mean and approximate variability of distribution 
percentiles for the iron losses of adult men and premenopausal women in the EU population. Data on 
iron losses of the few postmenopausal women included in this study were not further analysed, as the 
Panel considered this group too small for separate analyses and because the data were different from 
those of men or premenopausal women (see Appendix H). 
Details of the statistical analysis of the data are given in Appendix H. First, summary statistics were 
estimated for the main variables related to iron losses for adult men and premenopausal women and 
for associations among the variables which were considered to be potentially explicative for iron 
losses. From these, a regression model equation for iron losses (as mg/day) was fitted to the data using 
a set of potentially relevant variables. This stage included an assessment of outliers and goodness of 
fit. The regression model was then used to derive a distribution for iron losses combining the model 
equation with parametric distributions fitted to the sampling observations of each of the explanatory 
variables. The Panel considers that the probabilistic approach is a useful method with which to fill in 
data gaps as far as major sources of variability are concerned. The Panel also considers that it provides 
a distribution of iron losses from which percentiles can be estimated as a basis for determining AR and 
PRI values. 
For men, the 50
th
 percentile of the model-based distribution of iron losses is equal to around 
0.95 mg/day. The 90
th
, 95
th
 and 97.5
th
 percentiles are, respectively, equal to iron losses of around 1.48, 
1.61 and 1.72 mg/day. For premenopausal women, the 50
th
 percentile of the model-based distribution 
of iron losses is equal to around 1.34 mg/day. The 90
th
, 95
th
 and 97.5
th
 percentiles are, respectively, 
equal to iron losses of around 2.44, 2.80 and 3.13 mg/day. 
5.1.1.2. Infants 
Newborns have approximately 75 mg iron/kg body weight, corresponding to 260 mg of total iron 
(Widdowson and Spray, 1951; Oski, 1993), of which approximately 70 % is in haemoglobin, 24 % is 
in liver stores as ferritin and the remaining 6 % is in myoglobin and iron-containing enzymes 
(Dallman et al., 1993). A newborn’s iron stores can be increased by about 30–35 mg through delayed 
clamping of the umbilical cord (i.e. two minutes or later after birth) (Hutton and Hassan, 2007), with a 
calculated difference in serum ferritin concentration of 4 µg/L, resulting from the high haemoglobin 
                                                     
10 The very kind provision of the individual data by Gerald Combs and LuAnn Johnson from the USDA Human Nutrition 
Research Center, Grand Forks, North Dakota, USA, is acknowledged. 
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content of fetal blood and from placental sources. Owing to redistribution of iron from haemoglobin to 
iron stores, in healthy, term, normal-birth weight infants, there is sufficient iron for the formation of 
haemoglobin and myoglobin concomitant with growth until about six months of age in fully breast-fed 
infants (Chaparro, 2008). Extra iron requirements during this period can be provided by human milk 
alone (even if its iron concentration is low). Therefore, an additional appreciable requirement for 
dietary iron does not exist before the sixth month of life (Domellof, 2011). With regard to the dietary 
iron requirement of infants aged 7–11 months, there is no need to differentiate between their feeding 
modes, i.e. whether they are breast-fed or formula-fed in addition to complementary feeding. 
The main requirements for iron in older infants (7–11 months) are for the replacement of obligatory 
faecal, urinary and dermal losses (basal losses); the increase in haemoglobin mass (both blood volume 
and haemoglobin concentration); the increase in tissue (non-storage) iron; and the increase in storage 
iron to build a reserve. Fomon et al. (2005) used 
58
Fe as a tracer in 35 normal-weight infants aged 4–
168 days, and performed a follow-up study until 26 months of age. They observed endogenous 
gastrointestinal iron losses of 22 µg/kg body weight per day, i.e. higher than those reported in adult 
men (12 µg/kg body weight per day). This value is close to that proposed by Oski (1993) (20 µg/kg 
body weight per day). Based on a loss of 20 µg/kg body weight per day, Oski (1993) estimated a daily 
requirement of 0.78 mg of absorbed iron for a 10-kg, 12-month-old infant, comprising 0.2 mg to 
replace losses (0.020 mg/kg body weight × 10 kg) and 0.58 mg required for blood volume increase 
and tissue growth. 
Domellof and Hernell (2002) assumed a requirement of absorbed iron of 0.6 mg/day by the end of the 
sixth month, made up of 0.5 mg/day for iron in haemoglobin and 0.1 mg/day for iron in muscle and 
other tissues. The relative proportions of these amounts are similar to those indicated by Oski (1993) 
for iron in haemoglobin and tissue. Domellof and Hernell (2002) then calculated that there is a need of 
0.15 mg for daily obligatory losses according to estimated losses of 20 µg/kg body weight per day 
(Oski, 1993), resulting in a total requirement of absorbed iron of 0.75 mg for an infant weighing 
7.5 kg. Assuming iron losses of 22 µg/kg body weight per day (Fomon et al. (2005), derived from 
direct isotopic observations) and an average body weight of 8.6 kg for boys and girls aged nine months 
(WHO Multicentre Growth Reference Study Group, 2006), i.e. the midpoint of the age class 7–11 
months, daily losses are 0.19 mg/day. Using the figure derived by Domellof and Hernell (2002) of 
0.6 mg/day for iron requirement for growth of infants aged six months leads to a daily requirement of 
absorbed iron of 0.79 mg/day (Table 5). 
Table 5:  Calculation of physiological iron requirement of infants aged 7–11 months 
 Girls and boys 
Median weight of girls and boys (kg) 
(a)
  8.6 
Physiological requirement: total losses plus needs for growth (mg/day) 
(b)
  0.79 
(a): Average of median weight-for-age of male and female infants aged 9 months according to the WHO Growth Standards 
(WHO Multicentre Growth Reference Study Group, 2006). 
(b): Algebraic sum of total losses of 0.022 mg/kg body weight per day × body weight (kg) plus growth needs of 0.6 mg/day. 
5.1.1.3. Children 
The iron requirements of children reflect the synthesis of new tissues involved in their growth rate and 
losses of body iron per kilogram of body weight. Endogenous losses decrease after the third year of 
life from 22 to 12 µg/kg body weight per day, as is observed in adult men (Section 2.3.7). From 1 to 7 
years of age, dietary iron requirements increase only slightly owing to the small rates of increase in 
weight. With puberty, higher intakes are needed to compensate for increased requirements for growth 
and, in girls, for menstrual losses. The mean age of menarche in the EU (with 91.8 % coverage of the 
EU population) has been estimated to be 12.7 years (van Buuren et al., 2012). However, the age at 
menarche varies widely and menarche is considered to be normal if occurring between 11 and 15 years 
of age, and early if occurring at ≤ 10 years (Glueck et al., 2013). 
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The main compartments containing iron are blood haemoglobin, the liver, the macrophage–monocyte 
system (i.e. the RES) and myoglobin of muscles (Wang and Pantopoulos, 2011). Using isotopic 
studies, Fomon et al. (2005) determined that tissue iron contents in 15 boys and 16 girls were 
37.6 mg/kg at 6 months, 35.2 mg/kg at 13 months and 34.9 mg/kg at 26 months. Dewey and Chaparro 
(2007) estimated a body iron content of 420 mg, which is equivalent to a tissue iron content of 
42 mg/kg body weight in a 10-kg infant. In adult men and women, tissue iron contents, estimated from 
isotope dilution, were 48 mg/kg body weight and 38 mg/kg body weight, respectively (Hunt et al., 
2009). The iron content per kilogram of body weight is consistent with the value of 45 mg/kg body 
weight estimated by Oski (1993), i.e. a total amount of body iron of 450 mg in a 10-kg infant 
subdivided into haemoglobin, tissue iron and iron stores. Considering the possible age-related changes 
of the average iron content in body compartments and the changes in the distribution of fat mass 
taking place with puberty, the Panel considers a tissue iron content of 40 mg/kg body weight as a 
reasonable value for children of both sexes from 1 to 11 years of age, i.e. pre puberty. With early 
puberty, there is an increase in accretion of fat mass in girls (Laurson et al., 2011) which continues 
throughout (young) adulthood (Vink et al., 2010). Therefore, from age 12 years onwards, the Panel 
considers it appropriate to use the tissue iron content estimated in adults (Hunt et al., 2009), i.e. 48 mg 
iron/kg body weight for boys and 38 mg/kg body weight for girls, for factorial calculations, taking into 
account the differences in accretion of fat mass taking place in puberty. 
Estimated average daily iron requirements for growth between 12 months and 18 years have been 
derived according to body weights at the 50
th
 percentile for various age classes (1–3, 4–6, 7–11 and 
12–17 years), for both sexes combined until 11 years of age and for girls and boys separately from 
12 years onwards, as reported in Table 6. 
Table 6:  Requirements for absorbed iron for growth in boys and girls aged 1 to 17 years 
Age group 1–3 years 4–6 years 7–11 years 12–17 years 
Boys Girls 
Age boundary (year) 1 4 4 7 7 12 12 18 12 18 
Median weight (kg) of 
boys and girls at age 
boundary 
9.3 
(a)
 16.2 
(b)
 16.7 
(c)
 24.1 
(d)
 24.1 
(d)
 42.1 
(e)
 41.5 
(f)
 69.3 
(g)
 42.6 
(h)
 57.4 
(i)
 
Weight gain (kg)  6.9 
(j)
 7.4 
(k)
 18.0 
(l)
 27.8 
(m)
 14.8 
(m)
 
Body iron (mg/kg) 40 40 40 48 38 
Iron in total weight 
gained (mg) 
276 296 720 1 334 562 
Requirement for 
absorbed iron for 
growth per year (mg) 
92 99 144 222 94 
Requirement for 
absorbed iron for 
growth per day (mg) 
0.25 0.27 0.39 0.61 0.26 
To cover the whole age range, it was considered that a child is 3 years of age until his or her 4th birthday, 6 years of age until 
his or her 7th birthday, 11 years of age until his or her 12th birthday and 17 years of age until his or her 18th birthday. As 
weight data for the day before the 4th, 7th, 12th and 18th birthdays were not available, median weights for boys and girls aged 
4, 7, 12 and 18 years, respectively, were used instead. 
(a): Average of median weight-for-age of boys and girls aged 12 months according to the WHO Growth Standards (WHO 
Multicentre Growth Reference Study Group, 2006). 
(b): Average of median weight-for-age of boys and girls aged 48 months according to the WHO Growth Standards (WHO 
Multicentre Growth Reference Study Group, 2006). 
(c): Average of median body weight of boys and girls aged 4 years (van Buuren et al., 2012). 
(d): Average of median body weight of boys and girls aged 7 years (van Buuren et al., 2012). 
(e): Average of median body weight of boys and girls aged 12 years (van Buuren et al., 2012). 
(f): Median body weight of boys aged 12 years (van Buuren et al., 2012). 
(g): Median body weight of boys aged 18 years (van Buuren et al., 2012). 
(h): Median body weight of girls aged 12 years (van Buuren et al., 2012). 
(i): Median body weight of girls aged 18 years (van Buuren et al., 2012). 
(j): Net weight gain in kilograms between 1 and 4 years. 
(k): Net weight gain in kilograms between 4 and 7 years. 
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(l): Net weight gain in kilograms between 7 and 12 years. 
(m): Net weight gain in kilograms from 12 years. 
 
Up to the fourth year of life, losses of iron (resulting from intestinal, renal and dermal losses) have 
been estimated as 0.022 mg/kg body weight per day (Fomon et al., 2005). Iron requirements for 
growth are 0.25 mg/day (Table 6) and the requirement for absorbed iron is 0.51 mg/day (Table 7). For 
children aged 4 years and over, basal iron losses decrease to 0.012 mg/kg body weight per day. For 
children aged 4–6 years, requirements for growth are stable, in line with the constant yearly gain in 
body weight, while there is an increase in the daily requirement for absorbed iron for growth of 
0.39 mg/day in children aged 7–11 years (see Table 6). The requirements for absorbed iron are 
0.50 mg/day for ages 4–6 years and 0.76 mg/day for ages 7–11 years (Table 7). 
In adolescence, the need for iron increases in both boys and girls, as it is a period of rapid growth in 
both sexes and, in females, periodic menstrual blood losses take place after menarche. As the mean 
age of menarche in the EU is 12.7 years (van Buuren et al., 2012), menstrual blood losses should be 
considered from 12 years with a geometric mean iron loss of 0.25 mg/day (Harvey et al., 2005).
11
 
Considering the increased requirement for growth, obligatory losses and menstrual losses in girls after 
menarche, the requirement for absorbed iron is 1.27 mg/day in boys and 1.13 mg/day in girls 
(Table 7). 
Table 7:  Calculation of physiological iron requirement for children aged 1–17 years 
Age group 1–3 years 4–6 years 7–11 years 12–17 years 
Boys Girls 
Median weight (kg) of girls and boys 11.8 
(a)
 19.0 
(b)
 30.3 
(c)
 52.7 
(d) 51.6 (d) 
Physiological requirement: total losses 
plus needs for growth (mg/day)  
0.51 
(e)
 0.50 
(f)
 0.76 
(g)
 1.27 
(h)
 1.13 
(i)
 
To cover the whole age class, it was considered that a child is 3 years of age until his or her 4th birthday, 6 years of age until 
his or her 7th birthday, 11 years until his or her 12th birthday and 17 years until his or her 18th birthday. As weight data for the 
day before the 4th, 7th, 12th and 18th birthdays were not available, median weights for boys and girls aged 4, 7, 12 and 18 
years, respectively, were used instead. 
(a): Average of median weight-for-age of male and female children aged 24 months according to the WHO Growth 
Standards (WHO Multicentre Growth Reference Study Group, 2006). 
(b): Average of median body weight of boys and girls aged 5 years (van Buuren et al., 2012). 
(c): Average of median body weight of boys and girls aged 9 years (van Buuren et al., 2012). 
(d): Median body weight of boys or girls aged 14.5 years (van Buuren et al., 2012). 
(e): Algebraic sum of total losses of 0.022 mg/kg body weight per day × body weight (kg) plus growth needs of 0.25 mg/day 
(see Table 6). 
(f): Algebraic sum of total losses of 0.012 mg/kg body weight per day × body weight (kg) plus growth needs of 0.27 mg/day 
(see Table 6). 
(g): Algebraic sum of total losses of 0.012 mg/kg body weight per day × body weight (kg) plus growth needs of 0.39 mg/day 
(see Table 6). In the case of early–normal menarche, menstrual iron losses need to be replaced and the physiological 
iron requirement increases by 0.25 mg/day. 
(h): Algebraic sum of total losses of 0.012 mg/kg body weight per day × body weight (kg) plus growth needs of 0.61 mg/day 
(see Table 6). 
(i): Algebraic sum of total losses of 0.012 mg/kg body weight per day × body weight (kg) plus growth needs of 0.26 mg/day, 
plus geometric mean menstrual losses of 0.25 mg/day. In the case of late–normal menarche, menstrual iron losses do not 
need to be replaced and the physiological iron requirement decreases by 0.25 mg/day. 
5.1.1.4. Pregnancy 
The total quantity of iron required to support a singleton pregnancy of an average adult woman is 
835 mg. This is calculated factorially as follows: total obligatory losses (faecal, urinary and dermal) of 
                                                     
11 Linda Harvey from the Institute of Food Research, Norwich Research Park, UK, kindly provided individual data on 
menstrual blood losses. Based on these data, the geometric mean iron loss and percentiles as presented in Appendix A were 
calculated. 
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300 mg,
12
 270 mg for the neonate (Bothwell, 2000; Milman, 2006), 90 mg for the placenta and 
umbilical cord (Bothwell, 2000; Milman, 2006), and 175 mg for blood loss at delivery (mean of values 
given by Bothwell (2000) and Milman (2006)). Some of this iron can be supplied from maternal liver 
stores, and the remainder has to be provided by the diet. 
Although the need for iron changes throughout the course of pregnancy, in line with the exponential 
growth of the fetus, it is not possible when setting DRVs to provide values for each stage of gestation; 
therefore, average daily values are calculated over the 280 days of gestation. Adaptive physiological 
changes take place to meet the demands of the growing fetus and the other products of conception. 
Such changes are anticipatory in that they happen before the period of exponential growth of the fetus. 
They include expansion of the plasma and blood volumes, and of red blood cell mass starting at 6–8 
weeks and peaking at 28–34 weeks of gestation. The dilutional effect of this expansion induces a fall 
in serum ferritin concentration, but its relationship with systemic iron stores is not lost and 
concentrations approximating 15 µg/L are indicative of depleted liver iron stores (Blackburn, 2012). 
The increased need for iron is also met by increases in the efficiency of iron absorption (Bothwell et 
al., 1979; Hallberg and Hultén, 1996). Barrett et al. (1994) determined absorption rates of dietary iron 
during pregnancy using isotope labels in a group of 12 women consuming a diet supplying daily 9 mg 
of non-haem iron (see Section 2.3.2). A progressive increase in iron absorption was found in the three 
trimesters of pregnancy. In parallel, serum ferritin concentrations decreased, reflecting expansion of 
the plasma volume and the use of maternal iron depots for fetal growth. Accordingly, these increases 
in iron absorption in healthy women eating a mixed diet may balance the increased requirements in 
later pregnancy, as indicated in other isotopic studies in pregnant women (Whittaker et al., 1991; 
Whittaker et al., 2001). 
There is a great deal of uncertainty in the estimation of total quantity of iron absorbed during 
pregnancy. However, the amount of iron absorbed may be predicted using data from an isotopic study 
(Barrett et al., 1994), and assuming, in a conservative way, that the same percentage iron absorption 
observed at week 12 of gestation is valid for the period 0–23 weeks of gestation; that the percentage 
iron absorption observed at week 24 of gestation is valid for the period 24–35 weeks of gestation; and 
that the percentage iron absorption observed at week 36 of gestation is valid for the period 36–40 
weeks of gestation. Percentage iron absorption figures reported in Table 8 are geometric means. The 
quantity of non-haem iron absorbed (mg/day) has been calculated assuming a dietary non-haem iron 
intake of 9 mg/day and 4 mg haem iron/day from meat (as given to the women for three days before 
the absorption study) throughout the entire pregnancy. As there is no evidence for an increase in haem 
iron absorption during pregnancy (Young et al., 2010), it is assumed to be 25 % at all stages of 
pregnancy (Section 2.3.2). However, the Panel considers that this may be an underestimate, as 
insufficient data are available on the efficiency of haem iron absorption throughout pregnancy. 
Table 8:  Iron absorption during pregnancy calculated based on data from Barrett et al. (1994) on 
iron absorption from a test meal 
 Time of gestation 
12 weeks 
(weeks 0–23, days  
1–161 = 161 days in 
total) 
24 weeks 
(weeks 24–35, gestational 
days 162–245 = 84 days  
in total) 
36 weeks 
(weeks 36–40, gestational 
days 246–280 = 35 days  
in total) 
Geometric mean percentage 
non-haem iron absorption  
7.2 36.3 66.1 
Non-haem iron absorbed 
(mg/day) from a diet 
supplying 9 mg/day of non-
haem iron 
0.65 3.27 5.95 
                                                     
12 1.08 mg/day × 280 days. The value of 1.08 mg/day is reported in Hunt et al. (2009) as the mean basal losses in five 
postmenopausal women. The Panel considers that basal iron losses during pregnancy are the same as those of non-
menstruating women. 
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 Time of gestation 
12 weeks 
(weeks 0–23, days  
1–161 = 161 days in 
total) 
24 weeks 
(weeks 24–35, gestational 
days 162–245 = 84 days  
in total) 
36 weeks 
(weeks 36–40, gestational 
days 246–280 = 35 days  
in total) 
Haem iron absorbed 
(mg/day) from a diet 
supplying 4 mg/day of haem 
iron 
1.0 1.0 1.0 
Total amount of iron 
absorbed (mg) in each 
gestational period  
265 358 243 
Total iron absorbed (mg) 
throughout gestation 
866 
According to the study by Barrett et al. (1994), in which the percentage absorption of non-haem iron 
was measured from a meal containing 3.2 mg of non-haem iron extrinsically labelled with a stable 
isotope of iron, the total estimated quantity of iron absorbed from a diet providing 13 mg iron/day 
(9 mg non-haem iron and 4 mg iron from meat daily) would be 866 mg over the entire pregnancy 
(Table 8). As the quantity of iron required for pregnancy is around 835 mg (see above), if this 
theoretical calculation is correct, no additional dietary iron will be required. The Panel notes that the 
percentage absorption measured from the test meal of a white roll, bacon and orange juice may be an 
overestimate of overall dietary iron absorption. This is supported by the fact that the women in this 
study had a mean serum ferritin concentration of 43.8 µg/L at week 12 of gestation, which is 
equivalent to liver iron stores of 350 mg, and a mean serum ferritin concentration of 5.4 µg/L at week 
36, indicating that they had mobilised around 300 mg of iron from liver stores. The Panel notes that 
the quantity cannot be estimated accurately, as the relationship between serum ferritin concentration 
and liver iron may be confounded by haemodilution (Faupel-Badger et al., 2007). 
The calculation above is conservative, as it does not take into account the utilisation of iron stores. The 
Panel selected a target value of 30 µg/L for serum ferritin in women of child-bearing age, as this 
reflects an adequate level of iron stores to support a pregnancy. This is also proposed in the UK 
guidelines of the British Committee for Standards in Haematology, which state that pregnant women 
with a serum ferritin concentration < 30 µg/L should be offered oral iron supplements (Pavord et al., 
2012). The Panel assumed that, at this concentration, in the absence of any other adaptation, a 15 µg/L 
drop in serum ferritin concentration signifies the release of 120 mg of iron (1 µg/L of serum ferritin 
equals 8 mg of storage iron in an adult, see Section 2.4) from the liver. Stores would fall to virtually 
zero by delivery (with a serum ferritin concentration of 15 µg/L, i.e. the level associated with 
depletion of iron stores). The net cost of pregnancy is therefore 715 mg iron (total cost, 835 mg minus 
mobilised stores, 120 mg). 
The calculations based on the data from the isotope studies can be compared with a different approach 
using the Dainty et al. (2014) model. Assuming serum ferritin concentrations of 30 µg/L (early 
pregnancy, up to week 23), which is associated with an efficiency of iron absorption of 18 %, and 
15 µg/L (late pregnancy, from week 24 until term), which is associated with an efficiency of iron 
absorption of 31 % (see Section 5.1.2), the quantity of absorbed iron from a mixed diet can be 
calculated. With a serum ferritin concentration of 30 µg/L, in order to supply 835 mg of absorbed iron 
(i.e. the total quantity of iron required for a pregnancy), the total dietary intake needs to be 4 639 mg 
(835 mg / 0.18), which equates to 16.6 mg/day over 280 days of gestation. With a serum ferritin 
concentration of 15 µg/L, absorption is 31 % and the total dietary intake needs to be 2 694 mg 
(835 mg / 0.31), which equates to 9.6 mg/day. In practice, serum ferritin concentration will fall 
gradually as the pregnancy progresses, and taking the mean value of these two estimates, the average 
dietary intake to provide the required quantity of iron would be 13.1 mg/day. Assuming a CV of 20 %, 
to take into account the wide inter-individual variation in iron requirements in pregnant women, this 
would equate to a theoretical PRI of 18.3 mg/day. If the theoretical calculations are repeated using the 
net cost of pregnancy of 715 mg iron, the average iron intake required to support a pregnancy would 
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be 11.2 mg/day. Assuming a CV of 20 %, this would equate to a theoretical PRI of 15.7 mg/day. This 
theoretical calculation is an alternative approach to using percentage iron absorption values derived 
from the isotope studies and is based solely on the relationship between serum ferritin concentration 
and efficiency of iron absorption. 
The Panel notes that the conclusion from these different approaches is similar in that there is no need 
for additional dietary iron during pregnancy, provided that there are adequate iron stores at conception. 
This is a result of the increasing efficiency of iron absorption during pregnancy. However, the Panel 
notes that the Dainty et al. (2014) model has not been validated for pregnant women. Furthermore, it 
does not make any allowance for adaptive changes in efficiency of absorption that occur in pregnancy, 
and hence is likely to be a conservative estimate. 
5.1.1.5. Lactation 
Based on an iron concentration of mature human milk in European women of around 0.3 mg/L 
(Section 2.3.7.4) and assuming an average milk volume of 0.8 L/day (Butte et al., 2002; 
FAO/WHO/UNU, 2004; EFSA NDA Panel, 2009), the Panel estimates that the amount of iron 
secreted in breast milk during the first six months of lactation is 0.24 mg/day. Together with basal iron 
losses of about 1 mg/day (Hunt et al., 2009) in a non-menstruating woman of normal body weight, the 
total requirement for absorbed iron during the lactation period amounts to about 1.2–1.3 mg/day. As 
breastfeeding and its duration may delay the return of menses (lactational amenorrhoea) (Kramer and 
Kakuma, 2004), the requirement for absorbed iron in most lactating women may be less than in non-
lactating premenopausal women. However, taking into account that lactating women might resume 
menstruation while they are still lactating, the Panel considers that the requirement for absorbed iron 
in lactating women is similar to that of non-lactating premenopausal women. 
5.1.2. Algorithms and models used to estimate iron absorption 
Several algorithms have been developed that can be used to predict iron absorption from whole diets 
in order to derive iron requirements. The first one (Hallberg and Hulthén, 2000) used iron absorption 
data from single meals labelled with radioiron, adjusted to a reference dose absorption of 40 %. The 
absorption value was then multiplied by the expected effect of different amounts of dietary factors 
known to influence iron absorption including phytate, polyphenols, ascorbic acid, meat, fish and 
seafood, and calcium. For each factor, an equation describing the dose–effect relationship was 
developed and allowance was made for interactions between individual factors. Estimated absorption, 
calculated as the sum of iron absorbed from all meals using the algorithm, was not significantly 
different from measured absorption from radioisotopically labelled meals (four per day for five days) 
in the haem and non-haem iron extrinsically labelled with radioisotopes. Other algorithms have been 
developed using absorption data from single meals (Reddy et al., 2000; Rickard et al., 2009). 
More recently, there have been attempts to develop complete diet-based algorithms because the single-
meal studies overestimate the effect of enhancers and inhibitors. Armah et al. (2013) used data from 
complete diet studies undertaken in the USA, which were either high or low in meat, tea, calcium or 
ascorbic acid. They combined 159 observations and used multiple linear regression to quantify the 
effect of different factors on non-haem iron absorption: 
Ln absorption (%) = 6.294 – 0.709 ln (SF) + 0.119 ln (C) + 0.006 ln (MFP + 0.1) – 0.055 ln 
(T + 0.01) – 0.247 ln (P) – 0.137 ln (Ca) – 0.083 ln (NH) 
where SF is serum ferritin (μg/L), C is ascorbic acid (mg), MFP is meat, fish and poultry (g), T is tea 
(number of cups), P is phytate (mg), Ca is calcium (mg) and NH is non-haem iron (mg). 
Predicted non-haem iron absorption values from the algorithm were compared with measured single-
meal and complete diet non-haem iron absorption data, and the R
2
 values were 0.57 (P < 0.001) and 
0.84 (P < 0.0001), respectively. The more accurate prediction for whole diets is not surprising, as the 
algorithm was developed from complete diet datasets. Serum ferritin concentration was the most 
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important explanatory factor with respect to non-haem iron absorption. Dietary factors were relatively 
unimportant, with phytate being the only significant factor in the model; total phytate was used 
because data for the hexa- and penta-inositol phosphates (which bind strongly with iron, unlike the 
lower inositol phosphates) are not generally available, but a better model might have been generated 
with the use of individual inositol phosphate data. 
The systematic review of iron absorption studies from whole diets by Collings et al. (2013) included a 
detailed analysis of data from studies where there were individual data on iron absorption, iron status 
and dietary enhancers and inhibitors. Such data were reported in five studies carried out in the USA. 
Pooled data from 40 individuals undertaking studies of identical design gave a mean percentage 
absorption from a self-selected diet, a low bioavailability diet (high calcium, low vitamin C, no meat) 
and a high bioavailability diet (low calcium, high vitamin C, high meat) of 7.09 (SD 6.75) %, 7.17 (SD 
5.80) % and 9.92 (SD 8.78) %, respectively. When the Cook et al. (1991) equation was applied to 
normalise the data to a serum ferritin concentration of 15 μg/L, these values increased to 16.90 (SD 
17.3) %, 16.72 (13.37) % and 22.60 (SD 21.76) %, respectively. 
Because dietary factors appear to have little effect on absorption in healthy iron-replete individuals 
consuming Western-style whole diets, a simplified scoring system was used to classify diets and 
derive a regression equation using data from 58 individuals in order to be able to predict iron 
absorption from individuals with differing iron status: 
Log non-haem iron absorption (%) = –0.73 log(ferritin μg/L) + 0.11 (modifier) + 1.82 
where the modifier is 0 (standard diet), –1 (diets that include at least one inhibitor) or 1 (diets that 
include at least one enhancer). 
Using this equation, non-haem iron absorption from diets with and without enhancers/inhibitors was 
calculated for different serum ferritin concentrations. With depleted iron stores (serum ferritin 
concentration ≤ 15 μg/L), non-haem iron absorption from a standard Western diet is 9.2 %; this falls to 
7.1 % with a diet containing inhibitors and increases to 11.8 % with a diet containing enhancers. 
Armah et al. (2015) applied the complete-diet algorithm developed from absorption studies (Armah et 
al., 2013) to estimate total iron absorption from the US diet in all population groups participating in 
NHANES 2001–2002 (≥ 1 year, both sexes), but with the exclusion of pregnant and lactating women 
and individuals with raised C-reactive protein. Non-haem iron absorption was estimated at the 
individual level (n = 6 631) using intake data for enhancers and inhibitors of iron absorption (phytate 
intakes were estimated based on the phytate content of different foods according to Brown et al. 
(2004) and polyphenol intakes were estimated as black tea equivalents from the intake of tea, coffee 
and other polyphenol-containing beverages). It was assumed that 90 % of total iron intake was non-
haem iron, and that the absorption of the remaining 10 % (haem iron) was 25 %. After correcting 
individual non-haem iron absorption values to a serum ferritin concentration of 15 µg/L, and adding 
absorption from haem iron, the percentage total dietary iron absorption was calculated to be 15.5 %. 
Most studies on bioavailability have been undertaken in adults, and it is possible that the whole diet 
absorption figures derived from pooled data and/or algorithms, as described above, may not be 
appropriate for all population groups. Furthermore, the algorithms predict only non-haem iron 
absorption and, in order to calculate total iron absorption from the whole diet, an estimate of the 
quantity of absorbed haem iron has to be added to the value for predicted non-haem iron absorption. 
An alternative method to calculate bioavailability factors to be used for deriving DRVs using factorial 
estimates was developed by Dainty et al. (2014). Data collected for the NDNS, a nationally 
representative sample of adults living in the UK and consuming a mixed Western-style diet, were used 
to develop a predictive model. These include serum ferritin concentration and total (haem and non-
haem) iron intake determined from a 7-day dietary diary. The acute phase reactant α-1-
antichymotrypsin was measured to ensure that the data used were derived from individuals who were 
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free of inflammation. The NDNS sample comprised 495 men and 378 premenopausal women and was 
an iron-sufficient population. Physiological requirements were calculated from body weight and, in 
women, menstrual blood loss, following the IOM (2001) procedure for deriving Dietary Reference 
Intakes. The data were entered into a model to generate values for dietary iron absorption. In the men 
(mean iron intake 13.5 ± 5.1 mg/day; mean serum ferritin concentration 121.6 ± 112.1 µg/L), the mean 
calculated (haem and non-haem) iron absorption (50
th
 percentile requirement for 1.08 mg absorbed 
iron/day) was 8 %. In the women (mean iron intake 9.8 ± 3.8 mg/day; mean serum ferritin 
concentration 45.5 ± 38.4 µg/L), the mean calculated (haem and non-haem) iron absorption (50
th
 
percentile requirement for 1.56 mg absorbed iron/day) was 17 %. The model can be used to predict 
iron absorption at any level of serum ferritin concentration. For example, at a serum ferritin 
concentration of 60 µg/L, iron absorption would be 11 % in both men and premenopausal women, 
whereas, at a serum ferritin concentration of 30 µg/L, iron absorption would be 18 % in women and 
16 % in men. Using the well-established ratio method (reference serum ferritin divided by measured 
serum ferritin concentration) to normalise iron absorption to account for the effect of iron stores (Cook 
et al., 1991), at serum ferritin concentrations of 60, 45, 30 and 15 µg/L, iron absorption would be 10, 
13, 20 and 30 %, respectively. 
Although serum ferritin concentrations vary widely in all population groups, the Panel considers that a 
serum ferritin concentration of 30 μg/L is an appropriate target concentration for premenopausal 
women, as this reflects iron stores of approximately 120 mg (see Section 2.4). A target serum ferritin 
concentration of 30 µg/L is supported by observed serum ferritin concentrations in premenopausal 
women in the EU. Median serum ferritin concentration of premenopausal women in the UK NDNS 
was 38 µg/L (Dainty et al., 2014), and it was 40 µg/L (2.5
th
 and 97.5
th
 percentile: 4 and 229 µg/L, 
respectively) in 1 144 women aged 18 to > 65 years in Germany (Kohlmeier, 1995). Geometric mean 
serum ferritin concentration was 37 µg/L (SD 2.5)
13
 in 2 079 women aged 18–65 years in the German 
Health Interview and Examination Survey (Baune et al., 2010). In Denmark, median serum ferritin 
concentration in 818 premenopausal women (aged 30–50 years) was 37 µg/L (5th and 95th percentile: 6 
and 134 µg/L, respectively) (Milman et al., 1998), and it ranged from 28 to 39 µg/L in 322 Danish 
females aged 14–23 years, depending on age (Milman et al., 1997). 
5.1.2.1. Iron absorption in infants and children 
Although there are no data on iron absorption from whole diets in older infants (7–11 months), there is 
one paper describing two studies in infants aged nine months in which iron absorption was measured 
from multiple meals labelled with two different forms of stable isotopically enriched iron (Fox et al., 
1998). In the first study, 22 infants were fed meals of a vegetable purée weaning food, to which 
ferrous sulphate or iron glycine was added. Each meal contained 1.6 mg iron in total and they were fed 
on eight consecutive days. Haemoglobin incorporation of the labelled iron (mean ± SE) was 
9.9 ± 0.8 % for ferrous sulphate and 9.0 ± 0.7 % for iron glycine labelled meals. These values were not 
significantly different. In the second study, 24 infants were fed a high-phytate cereal weaning food 
(with milk) and iron bioavailability was compared with the same vegetable purée weaning food as in 
the first study. In the groups fed vegetable purée, haemoglobin incorporation was 9.1 ± 1.3 % from the 
meal containing added ferrous sulphate and 9.8 ± 1.5 % from the meal containing iron glycine. Iron 
bioavailability was significantly lower from the high-phytate cereal meals than the vegetable purée 
weaning food meals (P < 0.001), namely 3.8 ± 0.9 % from the high-phytate cereal meal containing 
ferrous sulphate and 5.2 ± 0.5 % from the meal containing iron glycine. The Panel notes that it is very 
likely that not all of the absorbed iron is incorporated into haemoglobin, and proposed a value for 
overall dietary iron absorption of 10 %. 
Lynch et al. (2007) measured iron absorption in 28 children aged 1–4 years. After a 7-day home 
adaptation to a diet representative of their usual daily mineral intake (6.9 mg iron/day), they were 
given their usual breakfast and lunch, with each meal containing around one-third of the daily iron 
intake and labelled with a stable isotope of iron as ferrous sulphate. The Panel calculated a mean 
                                                     
13 A geometric mean (SD) of 3.6 (0.9) is given in the paper; these figures were back-transformed assuming that they were 
loge-transformed data.  
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absorption of 11.4 % from the reported values for milligrams of iron absorbed (measured from 
isotopic enrichment of haemoglobin, with the assumption that 90 % of absorbed iron was incorporated 
into haemoglobin) and iron intake. However, there were nine children with iron deficiency (low serum 
ferritin concentration) and when these were removed from the calculation the mean absorption of the 
remaining 19 iron-sufficient children was 9.7 %. 
A number of single-meal studies in children have been undertaken using stable isotopes of iron to 
label iron in a test meal. Absorption has been estimated from isotopic enrichment of haemoglobin, and 
assuming 90 % of absorbed iron is utilised for haemoglobin synthesis. The Panel notes that absorption 
values reflect the bioavailability of iron in different foods, but not necessarily the whole diet. Chang et 
al. (2012) measured iron absorption from traditional Chinese home-made complementary food (millet 
porridge with wheat flour dumplings filled with cabbage, tofu and pork, containing 0.8 mg iron and 
fortified with 2 or 4 mg iron) in 29 children aged 24–31 months. Absorption from meals containing 
2 mg iron as ferrous sulphate was 8.0 %, and with NaFeEDTA it was 9.2 %. In 21 children aged 3–6 
years given a meal of toast, jelly or butter, a portion of non-citrus fruit, and either orange or apple juice 
(containing 1.2 mg iron) to which 5 mg isotopically enriched iron was added, absorption was 7.8 % 
from the meal ingested with orange juice and 7.2 % from the meal ingested with apple juice (Shah et 
al., 2003). Etcheverry et al. (2006) reported 7.6 % absorption of non-haem iron from a beef chilli meal 
(n = 12) and 3.5 % from a soy chilli meal (n = 14) in children aged 4–8 years. Both meals contained 
3.3 mg non-haem iron. Avalos Mishaan et al. (2004) examined the effect of consuming a typical 
Peruvian breakfast meal (white bread and butter, plus reconstituted evaporated milk with sugar, 
containing 1.3 mg iron) on iron bioavailability of a micronutrient-fortified beverage (containing 7 mg 
iron) in 40 children aged 6–9 years. Mean iron absorption was 9.6 % from the meal plus beverage and 
11.6 % from the beverage alone. 
Fomon et al. (2005) administered a stable isotope of iron to 30 infants aged five months in order to 
label body pools and thereby measure endogenous iron losses between 13 and 26 months. There was a 
close relationship between losses and absorption (measured as total iron absorbed over approximately 
one year), but with very high inter-individual variation. They suggested that greater losses stimulate 
higher absorption, which would be consistent with the well-established inverse relationship between 
plasma/serum ferritin concentration and iron absorption, as also observed in their study (data not 
reported). The Panel assumes that this relationship also applies to older children. 
Data from intervention (Appendix I) and observational (Appendix J) studies show that infants with an 
iron intake ranging from 3.1 to 4.8 mg/day have sufficient iron. Infants consuming an average of 
8 mg/day of iron during the second half of infancy (partly through iron-fortified phytate-rich cereals) 
do not develop iron deficiency (Niinikoski et al., 1997; Lind et al., 2003; Gunnarsson et al., 2004). 
Diets at this age are rich in cereals and vegetables containing substances that possibly inhibit the 
absorption of iron (Fomon et al., 2005), but, despite the composition of the diet, it appears to supply 
sufficient bioavailable iron to infants still consuming breast milk (Domellof et al., 2002a). 
5.2. Iron intake and health consequences 
For the Nordic Nutrition Recommendations (NNR) 2012, a systematic literature review on health 
effects of different intakes of iron at different life stages was undertaken to estimate the requirement 
for adequate growth, development and maintenance of health (Domellof et al., 2013). Two specific 
research questions were addressed: (1) What is the minimal dose of dietary iron intake that will 
prevent poor functional or health outcomes in different age groups within the general population 
including the risk groups for iron deficiency? (2) What is the highest dose of dietary iron intake that is 
not associated with poor functional or health outcomes in different age groups within the general 
population including some risk groups for iron overload? A total of 55 articles were identified as 
relevant and the evidence was graded. Most studies were focused on vulnerable groups, namely young 
children and women of child-bearing age. There was some evidence that prevention of iron deficiency 
or iron deficiency anaemia improves cognitive/motor/behavioural development in young children, and 
treatment of iron deficiency anaemia improves attention and concentration in school children and adult 
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women. There was insufficient evidence to show negative health effects of iron intakes at levels 
suggested by NNR 2004 (Nordic Council of Ministers, 2004). 
A series of systematic reviews were conducted by EURRECA, an EU-funded Network of Excellence 
(Harvey et al., 2013). The EURRECA standardised systematic review methodology included 
randomised controlled trials with an adequate control group, as these provide the highest level of 
evidence. The selected health outcomes included tiredness, physical performance, immune function, 
impaired thermoregulation, restless leg syndrome and cognitive function. The studies suggested a 
modest positive effect of iron supplementation on cognition and psychomotor outcomes in anaemic 
infants and children after supplementation periods of at least two months’ duration (Hermoso et al., 
2011), but there was no effect on fetal growth (Vucic et al., 2013). A large degree of heterogeneity 
between study populations, iron doses and outcome measures prevented meta-analyses for most health 
outcomes, so it was not possible to draw conclusions about the relationships between iron intake and 
tiredness, physical performance, immune function, thermoregulation and restless leg syndrome. The 
EURRECA reviews highlight the dearth of health outcome data for setting DRVs for iron. 
SACN (2010) undertook a comprehensive literature review of the role of iron in human nutrition, 
including the potential adverse effects of both iron deficiency and iron excess, in order to inform 
public health policy makers responsible for developing dietary recommendations for iron. The 
findings of SACN are summarised as follows. They concluded that, although low haemoglobin 
concentrations have been associated with impaired physical work capacity, reproductive efficiency 
and cognitive and psychomotor development, many of the studies had poorly reported outcomes and 
inadequate characterisation of iron deficiency, making interpretation of the data difficult. Iron 
supplementation studies indicated that iron deficiency anaemia is a cause of poor motor development 
in children in the first three years of life and on cognitive development in older children, but there was 
insufficient evidence to specify thresholds of anaemia or iron deficiency at which these health 
outcomes might occur. There was some evidence from randomised controlled trials that suggests that 
iron supplementation may impair physical growth of iron-replete infants and children, but further 
studies are required to characterise this effect. Intervention studies of iron supplementation during 
pregnancy have not shown beneficial or adverse effects on pregnancy outcomes. There were 
insufficient data to demonstrate an association between intakes of total dietary iron or body iron 
content and colorectal cancer. Observational studies of iron intake and cardiovascular disease did not 
suggest an association, although high intake of haem iron was associated with increased risk, possibly 
due to other components of meat or lifestyle factors. There was no evidence that dietary iron is 
associated with arthritis, diabetes mellitus or neurodegenerative disease. 
SACN (2010) also pointed out that a risk assessment of iron and health is complicated by a number of 
uncertainties. The Panel considers that the following are relevant when attempting to establish DRVs 
for iron using data on health consequences: inaccurate estimates of iron intake and quantities of haem 
and non-haem iron in the diet; poor correlation between iron intake and status; difficulties in 
measuring adaptive and functional responses to variations in iron intake (bioavailability); lack of 
sensitive and specific markers to assess iron status and confounding by other dietary and lifestyle 
factors and by responses to infection and inflammation; inadequate characterisation of iron deficiency 
anaemia and the relative role of iron deficiency and other causes of anaemia in studies investigating 
the health consequences of iron deficiency. The Panel notes that these uncertainties make it difficult to 
determine dose–response relationships or to confidently predict the risks associated with iron 
deficiency or excess. 
The Panel concludes that health outcomes cannot be used for the setting of DRVs for iron. 
6. Data on which to base Dietary Reference Values 
The Panel considers that setting DRVs for iron for adult men and women using modelled obligatory 
iron losses is appropriate (Section 5.1.1.1 and Appendix H). The 50
th
 and 97.5
th
 percentile losses were 
used as a basis for calculating an AR and a PRI for men (Section 6.1.1), and these data were also used 
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for postmenopausal women (Section 6.1.3). The skewed distribution of basal losses of iron probably 
arising from menstrual losses necessitated some careful evaluation of the upper cut-off level for losses 
and requirements, and of the derivation of a PRI for premenopausal women in general (Section 6.1.2) 
and during pregnancy (Section 6.3) and lactation (Section 6.4). A factorial approach combined with 
data on iron turnover, body iron content and the rate of tissue synthesis were used to estimate 
requirements in infants aged 7–11 months and children up to 17 completed years (Section 6.2). 
6.1. Adults 
The Panel notes that iron requirements are very different before and after menopause owing to the 
presence or absence of menstrual iron losses and considers that the occurrence of menopause, rather 
than age, should define DRVs for women. The Panel also considers that DRVs do not need to be 
derived for vegetarians as a separate population group, because the bioavailability of iron from 
European vegetarian diets is not substantially different from diets containing meat (see Section 2.3.2). 
6.1.1. Men 
The 50
th
 percentile of the model-based distribution of obligatory losses is 0.95 mg/day and the 97.5
th
 
percentile is 1.72 mg/day (Section 5.1.1.1 and Appendix H). A representative serum ferritin 
concentration at the lower end of observed distributions and reference ranges was taken as a serum 
ferritin concentration of 30 µg/L for men. This is associated with a percentage dietary iron absorption 
of 16 % (Dainty et al., 2014). Using this figure to convert the physiological requirement into the 
dietary requirement results in calculated dietary requirements at the 50
th
 percentile of 5.9 mg/day and 
at the 97.5
th
 percentile of 10.8 mg/day. After rounding, the Panel derives an AR of 6 mg/day and a PRI 
of 11 mg/day for men. 
6.1.2. Premenopausal women 
The 50
th
 percentile of the model-based distribution of iron losses for these women who are in their 
reproductive years (Section 5.1.1.1 and Appendix H) is approximately 1.34 mg/day. The 90
th
, 95
th
 and 
97.5
th
 percentiles are, respectively, 2.44, 2.80 and 3.13 mg/day and reflect the skew resulting from the 
large menstrual losses of some women (see Section 2.3.7.2). The Panel assumes that this group has a 
serum ferritin concentration of 30 µg/L, which corresponds to a percentage absorption of 18 % 
(Dainty et al., 2014). From these data, a dietary requirement at the 50
th
 percentile of 7.4 mg/day can be 
derived. Intakes meeting the dietary iron requirement of approximately 90, 95 and 97.5 % of the 
premenopausal women are calculated as 13.6, 15.6 and 17.4 mg/day, respectively. After rounding, the 
Panel derives an AR of 7 mg/day and a PRI of 16 mg/day for premenopausal women. The Panel 
considers that the PRI meets the dietary requirement of 95 % of women in their reproductive years and 
is derived from a group of premenopausal women, some of whom use oral contraceptives, as is the 
case in the EU (see Section 2.3.7.2). For the remaining 5 % of the women with very high losses, iron 
absorption is probably up-regulated in accordance with lower serum ferritin concentrations in order to 
compensate for these losses. However, it is uncertain at which level of absorptive efficiency this up-
regulation occurs, and the Panel cannot presume that this does occur. Therefore, it is not possible to 
derive a dietary requirement for this subgroup of women with very high iron losses. The Panel 
assumes that these high iron losses are due to high menstrual blood losses. This is supported by the 
observation in Hunt et al. (2009) that menstrual iron losses accounted for 90 % of the variation in total 
iron losses for the subset of women who provided complete menstrual collections (n = 13) and 
accounted for the skewed distribution of iron losses in these women. 
6.1.3. Postmenopausal women 
In the absence of reliable data on endogenous losses of iron in postmenopausal women, the Panel 
decided to set the same DRVs for postmenopausal women as those set for adult men, i.e. an AR of 
6 mg/day and a PRI of 11 mg/day. The Panel notes that this may be a conservative estimate, as their 
lower body weight is probably associated with lower endogenous losses of iron. 
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6.2. Infants aged 7–11 months and children 
The dietary iron requirement is estimated from the physiological iron requirement (Sections 5.1.1.2 
and 5.1.1.3) considering percentage iron absorption from the diet. For infants aged 7–11 months, the 
Panel used a value of 10 % absorption based on the results of the two studies in 9-month-old infants 
carried out by (Fox et al., 1998), described in Section 5.1.2.1. In children aged 1–11 years, there is 
very limited information on iron absorption from whole diets. Non-haem iron absorption in children 
aged 1–4 years from a combination of breakfast and lunch, labelled with 58Fe stable isotope, was 
reported to be 9.7 % in iron-sufficient children (Lynch et al., 2007). Iron absorption from single meals 
varies according to the type of meal and the form and quantity of added iron, and ranges from 3.5 % 
(in a soy meal containing inhibitory factors) to 9.6 % (in a simple breakfast meal; Section 5.1.2.1). The 
Panel considered that 10 % is the best estimate of dietary iron absorption in children up to the age of 
11 years. In the absence of any data for dietary iron absorption in children aged 12–17 years, the 16 % 
absorption value derived from studies in adult men (Section 5.1.2) was used to convert physiological 
requirements into dietary intakes for this age group. The Panel acknowledges that an assumption has 
to be made that the relationship between serum ferritin concentration and efficiency of absorption 
holds for all age groups. There are no data to support this assumption but, from a physiological 
perspective, there are no indications that age will affect the relationship. 
To calculate the PRI, in the absence of knowledge about the variation in requirement, a CV of 20 % is 
used for infants and children of all ages. The justification for this is the wide variation in rates of 
growth in children. In addition, a very high inter-individual variation (eight-fold) has been reported in 
iron losses and iron absorption (three-fold) in children aged 1–2 years (Fomon et al., 2005). The Panel 
recognises that differences in dietary patterns including the consumption of diets of low iron 
bioavailability (e.g. little or no meat, high intake of whole-grain cereals, and high intakes of milk), 
may also contribute to the high variation in requirements. 
In infants aged 7–11 months, the requirement for absorbed iron is 0.79 mg/day. Considering that iron 
absorption is 10 %, the dietary requirement is calculated as 7.9 mg/day, and an AR of 8 mg/day is 
derived. Based on a CV of 20 %, the PRI is 11 mg/day. 
In children aged 1–3 years, the requirement for absorbed iron is 0.51 mg/day (Table 7). Assuming 
10 % absorption, the dietary requirement is calculated as 5.1 mg/day, and an AR of 5 mg/day is 
derived. Based on this and using a CV of 20 %, the PRI is 7 mg/day. 
For children aged 4–6 years, the physiological requirement is estimated as 0.50 mg/day (Table 7). 
Assuming 10 % absorption, the dietary requirement is calculated as 5.0 mg/day, and an AR of 
5 mg/day is derived. Based on this and using a CV of 20 %, the PRI is 7 mg/day. 
In children aged 7–11 years, the requirement for absorbed iron is 0.76 mg (Table 7). Assuming 10 % 
absorption, the dietary requirement is calculated as 7.6 mg/day. After rounding, an AR of 8 mg/day is 
derived. Based on this and using a CV of 20 % and rounding, the PRI is 11 mg/day. 
In children aged 12–17 years, the requirement for absorbed iron is 1.27 mg/day in boys and 
1.13 mg/day in girls (Table 7). Assuming 16 % absorption, the dietary requirement is calculated as 
7.9 mg/day for boys and 7.1 mg/day for girls. After rounding, an AR of 8 mg/day for boys and of 
7 mg/day for girls aged 12–17 years is derived. In the absence of knowledge about the variation in 
requirement, the PRI for boys aged 12–17 years is estimated based on a CV of 20 % and, after 
rounding, is set at 11 mg/day. 
In setting a PRI for girls aged 12–17 years, the Panel considers that there are uncertainties related to 
the great variability in the rate and timing of physiological development and maturation, the onset of 
menarche, and the extent of and the skewed distribution of menstrual iron losses. The factorially 
calculated AR for girls aged 12–17 years is slightly lower than that derived for premenopausal women 
based on probabilistic modelling. It is probable that the 16 % absorption used to calculate the dietary 
requirement of approximately half of adolescent girls underestimates that of adolescents in general, 
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and there is evidence to support this possibility, but it is not enough to inform the setting of a PRI. 
Using a CV of 20 % to set a PRI would result in a value of 9.9 mg/day for the dietary requirement of 
about 97–98 % of adolescent girls. However, once growth has ceased in adolescent girls, their 
physiological and dietary requirements for iron can be expected to match those of premenopausal 
women. Thus, to take into account the uncertainties described above, in the transition to adulthood, the 
Panel has elected to set the PRI for adolescent girls as the mean of the calculated dietary requirement 
of 97–98 % of adolescent girls (9.9 mg/day) and the PRI for premenopausal women (16 mg/day). 
After rounding, a PRI of 13 mg/day is derived for girls aged 12–17 years. 
6.3. Pregnancy 
In the first trimester of pregnancy, iron intake should cover basal losses of about 1.08 mg/day. The 
requirements for absorbed iron then increase exponentially, up to about 10 mg/day during the last six 
weeks of pregnancy, but at the same time there is a progressive increase in the efficiency of iron 
absorption (Section 5.1.1.4). This can compensate for the higher needs, provided adequate iron stores 
are present at conception. The Panel therefore considers that ARs and PRIs for pregnant women are 
the same as for non-pregnant women of childbearing age (Section 6.1.2), with the important caveat 
that women enter pregnancy with an adequate iron status (serum ferritin concentration ≥ 30 μg/L). 
6.4. Lactation 
The Panel notes that the amount of iron secreted in breast milk during the first six months of lactation 
is 0.24 mg/day. Together with basal losses of 1.08 mg/day, the total requirement for absorbed iron 
during the first months of lactation is calculated to be 1.3 mg/day, assuming that menstruation has not 
yet resumed. The requirement for absorbed iron is slightly less than in non-pregnant, non-lactating 
women, but, for depleted iron stores to be replenished, the Panel considers that the AR and PRI for 
lactating women are the same as for non-pregnant women of childbearing age (Section 6.1.2). 
CONCLUSIONS 
The Panel concludes that ARs and PRIs for iron can be derived factorially. ARs for men and 
premenopausal women were estimated based on modelled whole-body iron losses using data from 
North American adults and a percentage dietary iron absorption that relates to a serum ferritin 
concentration of 30 µg/L. In men, obligatory losses at the 50
th
 percentile are 0.95 mg/day and the AR 
was calculated taking into account 16 % absorption. The PRI was calculated as the requirement at the 
97.5
th
 percentile of whole-body iron losses and was rounded. For postmenopausal women, the same 
DRVs as for men are set. In premenopausal women, the 50
th
 percentile of the model-based distribution 
of iron losses is equal to 1.34 mg/day, and the AR was calculated, taking into account 18 % 
absorption. The Panel decided to set a PRI covering the needs of 95 % of premenopausal women, and 
this is based on the 95
th
 percentile of whole-body iron losses in this population group. For the 
remaining 5 % of the women with very high losses, iron requirements are higher, but there may be a 
compensatory up-regulation in the efficiency of absorption. However, it is uncertain to which level of 
absorptive efficiency this up-regulation occurs, so it is not possible to derive a dietary requirement for 
this subgroup of women with very high losses. In infants aged 7–11 months and children, 
requirements were calculated factorially, considering needs for growth and replacement of iron losses, 
and assuming 10 % dietary iron absorption for ages 7 months to 11 years and 16 % dietary iron 
absorption thereafter. In the absence of knowledge about the variation in requirement, PRIs for infants 
and children were estimated using a CV of 20 %. In girls aged 12–17 years, the PRI was set at the 
midpoint of the calculated dietary requirement of 97–98 % of adolescent girls and the PRI for 
premenopausal women. For pregnant and lactating women, for whom it was assumed that iron stores 
and enhanced absorption provide sufficient additional iron, DRVs are the same as for premenopausal 
women. 
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Table 9:  Summary of Dietary Reference Values for iron 
Age Average Requirement 
(mg/day) 
Population Reference Intake 
(mg/day) 
7–11 months 8 11 
1–6 years 5 7 
7–11 years 8 11 
12–17 years (M) 8 11 
12–17 years (F) 7 13 
≥ 18 years (M) 6 11 
≥ 18 years (F) 
Premenopausal 7 16 
(a)
 
Postmenopausal 6 11 
Pregnancy As for non-pregnant premenopausal women As for non-pregnant premenopausal women 
Lactation As for non-lactating premenopausal women As for non-lactating premenopausal women 
F, females; M, males. 
(a): The PRI covers the requirement of approximately 95 % of premenopausal women. 
 
RECOMMENDATIONS FOR RESEARCH 
The Panel recommends that: 
 Iron homeostasis be better characterised to enable the development and validation of markers 
indicating adaptation to insufficient iron supply. 
 Dose–response data be generated for iron intake/status and functional outcomes/health 
endpoints, e.g. growth and development in children, pregnancy outcome, dementia. 
 Iron absorption and metabolism in pregnancy be investigated, including causes of iron 
deficiency and its effect on fetal development and consequences for later life. The Panel also 
recommends that longitudinal data on serum ferritin concentration and other appropriate 
markers of iron status in pregnancy be generated in order to predict the risk of developing iron 
deficiency anaemia. 
 Effects of different physiological states on iron requirements be investigated, e.g. overweight, 
obesity, low-grade inflammation, pregnancy, ageing. 
 Iron absorption from whole diets in all age groups, effects of different dietary patterns on 
bioavailability, and haem iron content of cooked and processed meat, meat products and other 
flesh foods be investigated. 
 Data on whole-body iron losses in all population groups be generated, especially in 
menstruating women. The Panel also recommends that the relationship between iron losses 
and absorption efficiency be investigated, especially in women with high menstrual losses. 
 The bioavailability of iron fortificants be investigated, as well as their contribution to total 
dietary iron intake. 
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APPENDICES 
Appendix A. Percentiles of daily iron loss with menstruation based on individual data from 
Harvey et al. (2005) 
Percentile  Menstrual iron loss (mg/day) 
5 0.03 
10 0.07 
15 0.09 
20 0.11 
25 0.13 
30 0.17 
35 0.19 
40 0.21 
45 0.23 
50 0.26 
55 0.29 
60 0.36 
65 0.41 
70 0.48 
75 0.59 
80 0.69 
85 0.82 
90 0.91 
95 1.32 
97 1.51 
98 1.92 
Menstrual iron losses were quantified by the direct measurement of menstrual blood loss per menstrual cycle. Menstrual iron 
loss was subsequently calculated by Harvey et al. (2005) from the total menstrual blood loss of each participant based on the 
following equation: 
MIL (mg/day) = MBL (mL) × Hb (mg/mL) × 0.00334 
     cycle length 
Where MIL is menstrual iron loss, MBL is menstrual blood loss and 0.00334 is equivalent to the fraction of iron in 
haemoglobin (Hb) at a concentration of 1 mg/mL.  
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Appendix B. Cut-off values for biochemical indicators of iron deficiency proposed in the 
literature 
Table 10:  Cut-off values for haemoglobin concentration (UNICEF/UNU/WHO, 2001) and other 
biomarkers of iron status that indicate the presence of anaemia (at altitudes < 1 000 m) (Zimmermann, 
2008)  
Population group Hb 
(g/L) 
Haematocrit 
(%) 
ZPP 
(µmol/mol 
haem)
 
MCV 
(fL) 
Serum iron 
(µg/L) 
TSAT 
(%)
 
6–59 months < 110 0.33   < 40–50  
5–11 years < 115 0.34 > 40  < 40–50  
12–14 years < 120 0.36 > 40 < 82 < 40–50 < 15 % 
Women < 120 0.36 > 40 < 82 < 40–50 < 15 % 
Pregnant women < 110 0.33     
Men > 15 years < 130 0.39 > 40 < 82 < 40–50 < 15 % 
Hb, haemoglobin; MCV, mean corpuscular volume; TSAT, transferrin saturation; ZPP, erythrocyte zinc protoporphyrin. 
Table 11:  Definition of anaemia according to the UK guidelines on the management of iron 
deficiency in pregnancy (Pavord et al., 2012) 
Timepoint Haemoglobin (g/L) 
1
st
 trimester < 110 
2
nd
 trimester < 105 
3
rd
 trimester < 105 
Post-partum < 100 
The guidelines also state that non-anaemic women identified to be at increased risk of iron deficiency should have their 
serum ferritin concentration checked early in pregnancy and be offered oral iron supplements if serum ferritin is < 30 µg/L. 
Table 12:  Cut-off values for serum ferritin concentration (UNICEF/UNU/WHO, 2001)  
 Serum ferritin (µg/L) 
 < 5 years of age  ≥ 5 years of age 
Severe risk of iron overload No cut-off > 200 (adult male) 
> 150 (adult female) 
Depleted iron stores in the presence of infection < 30 No cut-off 
Depleted iron stores < 12 
(a)
 < 15 
(a): < 9 µg/L at 6 months and < 5 µg/L at 9 months (Domellof et al., 2002b). 
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Appendix C. Dietary surveys in the EFSA Comprehensive European Food Consumption Database included in the nutrient intake calculation and 
number of subjects in the different age classes 
Country Dietary survey Year Method Days Age 
(years) 
Number of subjects 
Infants 
< 1 year 
Children 
1–< 3 
years 
Children 
3–< 10 
years 
Children 
10–< 18 
years 
Adults 
18–< 65 
years 
Adults 
65–< 75 
years 
Adults 
≥ 75 years 
Finland/1 DIPP 2000–2010 Dietary record 3 0.5–6 499 500 750     
Finland/2 NWSSP 2007–2008 48-hour dietary 
recall (a) 
2 × 2 (a) 13–15    306    
Finland/3 FINDIET2012 2012 48-hour dietary 
recall (a) 
2 (a) 25–74     1 295 413  
France INCA2 2006–2007 Dietary record 7 3–79   482 973 2 276 264 84 
Germany/1 EsKiMo 2006 Dietary record 3 6–11   835 393    
Germany/2 VELS 2001–2002 Dietary record 6 < 1–4 158 347 299     
Ireland NANS 2008–2010 Dietary record 4 18–90     1 274 149 77 
Italy INRAN-SCAI 2005–2006 Dietary record 3 < 1–98 16 (b) 36 (b) 193 247 2 313 290 228 
Latvia FC_PREGNANTWOMEN 2011 24-hour dietary recall 2 15–45    12 (b) 991 (c)   
Netherlands DNFCS 2007–2010 24-hour dietary recall 2 7–69   447 1 142 2 057 173  
Sweden Riksmaten 2010–2011 Dietary record 
(web) (d) 
4 18–80     1 430 295 72 
United 
Kingdom/1 
DNSIYC 2011 Dietary record 4 0.3–1.5 1 369 1 314      
United 
Kingdom/2 
NDNS Rolling Programme 
(Years 1–3) 
2008–2011 Dietary record 4 1–94  185 651 666 1 266 166 139 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; DNSIYC, Diet and Nutrition Survey of Infants and Young Children; EsKiMo, 
Ernährungsstudie als KIGGS-Modul; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; FINDIET, the national dietary survey of Finland; INCA, étude Individuelle 
Nationale des Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione – Studio sui Consumi Alimentari in Italia; NANS, National Adult 
Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme 
von Säuglingen und Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): A 48-hour dietary recall comprises two consecutive days. 
(b): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation, as the results may not be statistically robust (EFSA, 2011a) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
(c): One subject with only one 24-hour dietary recall day was excluded from the dataset, i.e. final n = 990. 
(d): The Swedish dietary records were introduced through the internet. 
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Appendix D. Iron intake in males in different surveys according to age classes and country 
Age class Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n Average Median P5 P95 
Infants (b) Germany VELS 84 6.0 5.9 3.2 9.4 84 1.9 1.9 1.0 3.0 
Finland DIPP_2001_2009  247 3.0 3.2 0.4 5.7 245 1.5 1.5 0.8 2.2 
United Kingdom DNSIYC_2011 699 5.9 5.8 2.7 9.5 699 1.7 1.7 0.9 2.5 
Italy INRAN_SCAI_2005_06 9 2.6 1.9 
(c) (c) 9 0.9 0.5 
(c) (c) 
1 to < 3 Germany VELS 174 7.0 6.5 3.6 11.4 174 1.5 1.4 1.0 2.2 
Finland DIPP_2001_2009 245 5.4 5.2 2.8 7.9 245 1.5 1.5 1.0 2.1 
United Kingdom NDNS Rolling Programme Years 1–3  107 6.3 6.0 4.2 10.0 107 1.3 1.3 0.9 1.9 
United Kingdom DNSIYC_2011 663 5.9 5.7 3.1 9.2 663 1.4 1.4 0.8 2.2 
Italy INRAN_SCAI_2005_06 20 6.0 6.2 
(c) (c) 20 1.2 1.1 
(c) (c) 
3 to < 10 Germany EsKiMo 426 11.5 11.2 7.2 17.0 426 1.5 1.5 1.1 2.1 
Germany VELS 146 8.7 7.7 5.3 14.0 146 1.5 1.4 1.1 2.4 
Finland DIPP_2001_2009 381 8.3 8.0 5.5 12.3 381 1.4 1.4 1.0 1.9 
France INCA2 239 10.7 10.2 5.7 17.3 239 1.7 1.6 1.1 2.4 
United Kingdom NDNS Rolling Programme Years 1–3 326 8.6 8.3 5.1 12.6 326 1.4 1.3 1.0 1.9 
Italy INRAN_SCAI_2005_06 94 9.9 9.6 5.6 16.3 94 1.3 1.3 1.0 2.1 
Netherlands DNFCS 2007–2010 231 9.2 9.0 5.6 13.3 231 1.1 1.0 0.8 1.5 
10 to < 18 Germany EsKiMo 197 11.8 11.3 7.2 18.7 197 1.5 1.4 1.0 2.1 
Finland NWSSP07_08 136 11.6 11.2 6.9 18.1 136 1.4 1.4 1.0 2.1 
France INCA2 449 13.6 12.8 7.5 22.2 449 1.7 1.7 1.2 2.6 
United Kingdom NDNS Rolling Programme Years 1–3  340 11.2 10.8 6.7 17.8 340 1.4 1.3 1.0 2.0 
Italy INRAN_SCAI_2005_06 108 12.3 11.8 7.4 18.2 108 1.3 1.2 1.0 1.9 
Netherlands DNFCS 2007–2010 566 11.2 10.9 6.7 17.6 566 1.1 1.0 0.7 1.5 
18 to < 65 Finland FINDIET2012 585 13.2 12.5 7.4 21.2 585 1.4 1.4 1.0 2.1 
France INCA2 936 14.4 13.7 7.5 23.1 936 1.7 1.6 1.1 2.6 
United Kingdom NDNS Rolling Programme Years 1–3 560 12.8 12.3 6.6 20.1 560 1.5 1.4 0.9 2.1 
Ireland NANS_2012 634 14.7 14.3 8.3 22.2 634 1.5 1.5 1.0 2.1 
Italy INRAN_SCAI_2005_06  1 068 12.6 12.2 7.1 19.8 1 068 1.4 1.4 1.0 1.9 
Netherlands DNFCS 2007–2010 1 023 13.1 12.7 7.7 19.4 1 023 1.2 1.1 0.8 1.7 
Sweden Riksmaten 2010 623 14.1 13.4 7.8 22.3 623 1.4 1.4 1.0 2.0 
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Age class Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n Average Median P5 P95 
65 to < 75 Finland FINDIET2012 210 11.9 11.4 6.6 18.8 210 1.5 1.4 0.9 2.1 
France INCA2 111 15.0 14.3 7.6 24.5 111 1.8 1.6 1.2 2.7 
United Kingdom NDNS Rolling Programme Years 1–3  75 12.9 12.2 6.2 19.8 75 1.5 1.5 0.9 2.2 
Ireland NANS_2012 72 13.3 13.4 6.9 19.0 72 1.5 1.5 1.1 2.1 
Italy INRAN_SCAI_2005_06 133 13.3 12.8 7.0 19.4 133 1.5 1.5 1.1 2.1 
Netherlands DNFCS 2007–2010 91 12.1 11.8 6.2 18.3 91 1.3 1.3 1.0 1.7 
Sweden Riksmaten 2010 127 13.0 12.9 7.5 19.8 127 1.5 1.5 1.1 2.0 
≥ 75 France INCA2 40 12.6 11.4 
(c) (c) 40 1.6 1.5 
(c) (c) 
United Kingdom NDNS Rolling Programme Years 1–3 56 10.8 9.7 
(c) (c) 56 1.5 1.5 
(c) (c) 
Ireland NANS_2012 34 11.4 10.1 
(c) (c) 34 1.5 1.5 
(c) (c) 
Italy INRAN_SCAI_2005_06 69 12.6 12.0 7.8 18.6 69 1.4 1.4 1.0 2.0 
Sweden Riksmaten 2010 42 12.1 12.1 
(c) (c) 42 1.4 1.4 
(c) (c) 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; DNSIYC, Diet and Nutrition Survey of Infants and Young Children; EsKiMo, 
Ernährungsstudie als KIGGS-Modul; FINDIET, the national dietary survey of Finland; INCA, étude Individuelle Nationale des Consommations Alimentaires; FC_PREGNANTWOMEN, food 
consumption of pregnant women in Latvia; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione – Studio sui Consumi Alimentari in Italia; NANS, National Adult 
Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; P5, 5th percentile; P95, 95th percentile; VELS, Verzehrsstudie zur 
Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): Number of individuals in the population group. 
(b): The proportions of breast-fed infants were 58 % in the Finnish survey, 40 % in the German survey, 44 % in the Italian survey and 21 % in the UK survey. Most infants were partly breast-
fed. For the Italian and German surveys, breast milk intake estimates were derived from the number of breastfeeding events recorded per day multiplied by standard breast milk amounts 
consumed on an eating occasion at different ages. For the UK survey, the amount of breast milk consumed was either directly quantified by the mother (expressed breast milk) or 
extrapolated from the duration of each breastfeeding event. As no information on the breastfeeding events were reported in the Finnish survey, breast milk intake was not taken into 
consideration in the intake estimates of Finnish infants. 
(c): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation, as the results may not be statistically robust (EFSA, 2011a) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
Dietary Reference Values for iron 
 
EFSA Journal 2015;13(10):4254 73 
Appendix E. Iron intake in females in different surveys according to age classes and country 
Age class Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n Average Median P5 P95 
Infants (b) Germany VELS 75 5.5 5.7 2.0 9.0 75 1.9 1.9 0.9 3.1 
Finland  DIPP_2001_2009 252 2.8 2.5 0.4 5.7 251 1.6 1.5 0.9 2.6 
United Kingdom  DNSIYC_2011  670 5.2 5.0 2.0 8.3 670 1.7 1.7 0.8 2.5 
Italy  INRAN_SCAI_2005_06 7 3.5 4.1 
(c) (c) 7 1.2 1.1 
(c) (c) 
1 to < 3 Germany VELS 174 6.6 6.4 3.8 10.6 174 1.6 1.5 1.1 2.4 
Finland  DIPP_2001_2009 255 5.0 5.0 2.8 7.6 255 1.5 1.4 0.9 2.0 
United Kingdom  NDNS Rolling Programme Years 1–3  78 6.1 5.8 2.9 10.0 78 1.3 1.3 0.7 1.8 
United Kingdom DNSIYC_2011 651 5.7 5.4 2.8 9.6 651 1.4 1.4 0.9 2.2 
Italy INRAN_SCAI_2005_06 16 6.0 5.4 
(c) (c) 16 1.3 1.2 
(c) (c) 
3 to < 10 Germany  EsKiMo  409 10.6 10.3 6.5 16.3 409 1.6 1.5 1.1 2.1 
Germany  VELS  147 7.8 7.4 4.7 12.9 147 1.5 1.4 1.0 2.5 
Finland  DIPP_2001_2009 369 7.5 7.3 4.7 11.0 369 1.4 1.4 1.0 2.0 
France  INCA2 243 9.5 8.9 5.7 15.1 243 1.7 1.6 1.2 2.4 
United Kingdom NDNS Rolling Programme Years 1–3 325 8.5 7.9 4.7 13.7 325 1.4 1.3 0.9 2.1 
Italy INRAN_SCAI_2005_06 99 9.1 9.2 5.1 13.4 99 1.2 1.2 0.9 1.7 
Netherlands DNFCS 2007–2010 216 8.8 8.4 5.5 13.1 216 1.1 1.1 0.8 1.4 
10 to < 18 Germany EsKiMo 196 11.6 11.2 7.5 17.3 196 1.6 1.5 1.1 2.1 
Finland NWSSP07_08 170 9.9 9.4 5.7 16.1 170 1.5 1.5 1.1 2.1 
France  INCA2 524 10.9 10.3 5.8 17.2 524 1.7 1.7 1.2 2.6 
United Kingdom  NDNS Rolling Programme Years 1–3  326 9.2 8.9 5.0 13.6 326 1.4 1.3 0.9 2.0 
Italy INRAN_SCAI_2005_06  139 10.5 10.2 6.2 16.9 139 1.3 1.2 0.9 2.1 
Latvia (d)  FC_PREGNANTWOMEN_2011 12 14.7 15.3 
(c) (c) 12 1.5 1.5 
(c) (c) 
Netherlands DNFCS 2007–2010 576 9.6 9.2 6.0 14.6 576 1.1 1.1 0.7 1.6 
18 to < 65 Finland FINDIET2012 710 10.5 10.3 6.0 16.0 710 1.5 1.4 1.0 2.1 
France INCA2 1 340 11.1 10.5 5.7 18.3 1 340 1.7 1.6 1.1 2.6 
United Kingdom  NDNS Rolling Programme Years 1–3  706 10.5 10.2 5.4 16.1 706 1.6 1.5 1.0 2.4 
Ireland NANS_2012 640 11.0 10.7 6.1 17.6 640 1.5 1.5 1.0 2.1 
Italy  INRAN_SCAI_2005_06  1 245 10.2 9.9 5.7 15.8 1 245 1.4 1.3 1.0 2.0 
Latvia (d)  FC_PREGNANTWOMEN_2011  990 17.9 15.2 8.8 34.9 990 2.1 1.8 1.1 4.1 
Netherlands DNFCS 2007–2010 1 034 11.0 10.4 6.6 16.7 1 034 1.3 1.3 0.9 2.0 
Sweden Riksmaten 2010 807 11.6 11.1 6.2 18.6 807 1.5 1.5 1.0 2.2 
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Age class Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n Average Median P5 P95 
65 to < 75 Finland FINDIET2012 203 9.4 9.0 5.4 14.7 203 1.5 1.5 1.1 2.3 
France INCA2 153 10.6 10.1 6.2 16.9 153 1.7 1.6 1.2 2.5 
United Kingdom NDNS Rolling Programme Years 1–3 91 10.7 10.7 6.3 17.5 91 1.8 1.6 1.2 2.8 
Ireland NANS_2012 77 11.0 11.2 6.7 16.7 77 1.6 1.6 1.1 2.5 
Italy INRAN_SCAI_2005_06 157 10.1 10.0 5.7 16.7 157 1.5 1.4 1.0 2.1 
Netherlands DNFCS 2007–2010 82 10.7 10.6 6.2 16.2 82 1.5 1.4 1.1 2.0 
Sweden Riksmaten 2010 168 11.1 10.7 6.4 17.6 168 1.6 1.6 1.1 2.3 
≥ 75 France INCA2 44 9.9 9.7 
(c) (c) 44 1.6 1.6 
(c) (c) 
United Kingdom  NDNS Rolling Programme Years 1–3  83 10.5 9.8 6.3 16.0 83 1.7 1.6 1.2 2.4 
Ireland NANS_2012  43 10.5 10.5 
(c) (c) 43 1.7 1.6 
(c) (c) 
Italy  INRAN_SCAI_2005_06  159 9.6 9.3 5.8 14.1 159 1.4 1.4 1.0 2.0 
Sweden  Riksmaten 2010 30 10.3 9.7 
(c) (c) 30 1.5 1.4 
(c) (c) 
DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; DNSIYC, Diet and Nutrition Survey of Infants and Young Children; EsKiMo, 
Ernährungsstudie als KIGGS-Modul; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; FINDIET, the national dietary survey of Finland; INCA, étude Individuelle 
Nationale des Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione – Studio sui Consumi Alimentari in Italia; NANS, National Adult 
Nutrition Survey; NDNS, National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; P5, 5th percentile; P95, 95th percentile; VELS, Verzehrsstudie zur 
Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): Number of individuals in the population group. 
(b): The proportions of breast-fed infants were 58 % in the Finnish survey, 40 % in the German survey, 44 % in the Italian survey and 21 % in the UK survey. Most infants were partially breast-
fed. For the Italian and German surveys, breast milk intake estimates were derived from the number of breastfeeding events recorded per day multiplied by standard breast milk amounts 
consumed on an eating occasion at different ages. For the UK survey, the amount of breast milk consumed was either directly quantified by the mother (expressed breast milk) or 
extrapolated from the duration of each breastfeeding event. As no information on the breastfeeding events were reported in the Finnish survey, breast milk intake was not taken into 
consideration in the intake estimates of Finnish infants. 
(c): 5th or 95th percentile intakes calculated from fewer than 60 subjects require cautious interpretation, as the results may not be statistically robust (EFSA, 2011a) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
(d): Pregnant women only. 
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Appendix F. Minimum and maximum percentage contribution of different food groups (FoodEx2 level 1) to iron intake in males 
Food groups Age 
< 1 year 1 to < 3 years 3 to < 10 years 10 to < 18 years 18 to < 65 years 65 to < 75 years ≥ 75 years 
Additives, flavours, baking and processing aids < 1 < 1 0 < 1–1 < 1 < 1 0 
Alcoholic beverages < 1 < 1 < 1 < 1 2–9 2–13 3–13 
Animal and vegetable fats and oils < 1 < 1–1 < 1–1 < 1–1 < 1–1 < 1–1 < 1–1 
Coffee, cocoa, tea and infusions < 1–1 < 1–8 2–14 3–8 1–9 1–11 1–7 
Composite dishes < 1–3 < 1–11 < 1–11 1–14 1–14 1–12 < 1–14 
Eggs and egg products < 1–1 1–2 1–4 1–4 1–3 1–3 1–3 
Fish, seafood, amphibians, reptiles and invertebrates < 1 < 1–6 < 1–6 1–5 1–6 2–6 2–5 
Food products for young population 44–67 4–22 < 1–1 < 1 < 1 – – 
Fruit and fruit products 3–9 5–9 2–5 1–4 1–5 3–6 2–6 
Fruit and vegetable juices and nectars < 1–2 1–5 1–8 1–6 1–4 < 1–4 < 1–3 
Grains and grain-based products 10–18 32–38 31–42 31–40 25–42 21–43 20–49 
Human milk < 1–15 < 1–1 – – – – – 
Legumes, nuts, oilseeds and spices 1–3 1–7 1–7 1–6 2–7 2–7 2–5 
Meat and meat products < 1–7 5–14 6–19 9–24 11–27 11–27 11–21 
Milk and dairy products 1–4 4–8 3–7 2–6 1–4 1–4 1–3 
Products for non-standard diets, food imitates and food 
supplements or fortifying agents 
0 0 0–1 < 1–1 < 1–1 < 1 0 
Seasoning, sauces and condiments < 1–1 < 1–4 < 1–2 < 1–2 < 1–2 < 1–2 < 1–1 
Starchy roots or tubers and products thereof, sugar plants < 1–10 2–10 3–8 4–10 3–8 3–10 4–9 
Sugar, confectionery and water-based sweet desserts < 1 1–6 2–8 2–9 1–4 1–3 < 1–3 
Vegetables and vegetable products 1–7 4–7 4–9 4–12 3–14 3–15 4–13 
Water and water-based beverages < 1–1 < 1–9 < 1–10 < 1–9 < 1–4 < 1–2 < 1–2 
“–” means that there was no consumption event of the food group for the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix G. Minimum and maximum percentage contribution of different food groups (FoodEx2 level 1) to iron intake in females 
Food groups Age 
< 1 year 1 to < 3 years 3 to < 10 years 10 to < 18 years 18 to < 65 years 65 to < 75 years ≥ 75 years 
Additives, flavours, baking and processing aids < 1 0 0 < 1–1 < 1 0 0 
Alcoholic beverages < 1 < 1 < 1 < 1 < 1–6 1–6 2–5 
Animal and vegetable fats and oils < 1 < 1–1 < 1–1 < 1–1 < 1–1 < 1–1 < 1–1 
Coffee, cocoa, tea and infusions < 1–1 < 1–10 1–13 2–11 2–10 1–11 2–11 
Composite dishes < 1–2 < 1–11 < 1–11 < 1–15 1–14 1–12 1–13 
Eggs and egg products < 1–1 1–2 1–4 1–3 1–3 1–3 1–3 
Fish, seafood, amphibians, reptiles and invertebrates < 1–1 < 1–5 < 1–4 < 1–8 1–6 2–5 1–4 
Food products for young population 45–72 4–22 < 1–1 < 1 < 1 – < 1 
Fruit and fruit products 3–8 5–6 2–5 2–6 2–6 4–8 3–8 
Fruit and vegetable juices and nectars < 1–2 1–4 2–7 2–6 1–4 1–3 1–3 
Grains and grain-based products 9–19 31–42 31–39 31–42 26–48 20–43 19–47 
Human milk < 1–5 < 1 – – – – – 
Legumes, nuts, oilseeds and spices < 1–7 1–7 1–6 1–5 3–7 3–6 2–4 
Meat and meat products 1–7 5–14 6–19 8–20 9–24 10–26 8–23 
Milk and dairy products 1–5 4–8 2–8 1–6 1–5 2–4 2–4 
Products for non-standard diets, food imitates and food 
supplements or fortifying agents 
0 0 0–1 0–1 < 1–2 < 1–1 0–2 
Seasoning, sauces and condiments < 1–1 < 1–1 1 < 1–2 < 1–2 < 1–1 1 
Starchy roots or tubers and products thereof, sugar plants 2–9 4–9 3–8 3–10 3–7 3–7 3–8 
Sugar, confectionery and water-based sweet desserts < 1–2 < 1–5 2–8 2–12 1–13 < 1–3 1–2 
Vegetables and vegetable products 4–8 4–6 4–9 4–11 4–16 4–17 5–16 
Water and water-based beverages < 1–1 < 1–7 < 1–11 < 1–8 < 1–5 < 1–4 < 1–3 
“–” means that there was no consumption event of the food group for the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix H. Re-analysis of data on endogenous iron losses from Hunt et al. (2009) 
SOURCE OF INFORMATION 
H1. Data sources 
The current analysis is based on individual data provided by the US Department of Agriculture, 
Agricultural Research Service, Grand Forks Human Nutrition Research Center and the University of 
North Dakota, Grand Forks, USA. The individual data are the property of these institutions and, 
therefore, they cannot be disclosed by EFSA. The study and the corresponding set of data were 
identified in the literature and selected by the NDA Panel. 
The original research was aimed at measuring total endogenous iron losses in men and women. The 
study recruited men and women who had participated at least one year earlier in studies of healthy 
subjects who were administered iron radioisotope (
55
Fe). All subjects meeting this criterion were 
enrolled in a 3-year study that involved semi-annual blood sampling. Subjects completed a 
questionnaire on general health and factors that might affect body iron excretion at the beginning and 
at the end of the study. The list of questions and the outcomes of the questionnaire were not made 
available to EFSA. Throughout the study the subjects had to update information about health, iron 
supplement use or blood losses due to medical conditions or care, pregnancy, use of chemical forms of 
birth control or hormone replacements and dates of menstruation. 
Subjects were considered eligible for the final analysis according to the following criteria: 
 provision of semi-annual blood samples for at least one year; 
 no use of iron supplements; 
 no surgery; 
 no blood donation; 
 if women, no occurrence of pregnancy or menopause during the study. 
Based on the weak X-rays emitted by the radioisotope, the biological half-life of iron was determined 
for each subject from blood samples collected semi-annually. Body iron was determined as the sum of 
circulating haemoglobin iron plus body iron stores, based on measurements from samples collected on 
two separate days at the beginning and again at the end of each subject’s participation. 
The metabolic body weight (body weight to the power of 0.75) (EFSA NDA Panel, 2010), not 
available from the original dataset, was computed for the current analysis in order to better investigate 
the potential effect of body weight on iron losses. Since fat mass does not contribute significantly to 
iron losses, the transformation of body weight into metabolic body weight was assumed to be able to 
better highlight the association between iron losses and lean body mass. 
The variable named “turnover rate” in the dataset, expressing the percentage of iron losses per year, 
was transformed into a rate, dividing it by 100, in order to get values between 0 and 1. However, the 
same name was maintained for the variable. The transformation was carried out because, for variables 
bounded by values 0 and 1, it may be easier to find a parametric distribution to represent variability 
(typically a beta distribution). 
While 53 subjects entered the analysis performed by Hunt et al. (2009), 55 were included in the 
dataset provided to EFSA; the difference being the inclusion of two women for whom the 
menstruating status was not specified. 
It is not clear from the paper by Hunt et al. (2009) how repeated measurements on blood samples 
collected twice per year for 1–3 years have been summarised in the dataset provided to EFSA. The 
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latter includes only one value per subject. Therefore, it was not possible to estimate intra-subject 
variability and increase precision of the estimate. 
The composition of the sample in terms of sex/menstruating status subgroup is reported in Table 13. 
Table 13:  Frequency of the four subgroups 
Group Number Frequency (%) 
Men 29 52.7 
Women—menstruating 19 34.6 
Women—postmenopausal 5 9.1 
Women—unknown menstruating status 2 3.6 
All subgroups 55 100 
H2. Eligibility criteria for subject selection and data preprocessing 
The same eligibility criteria established by Hunt et al. (2009) were maintained in the analysis, except 
for exclusion of postmenopausal women. The summary statistics of age at the beginning of the study, 
body weight, BMI, metabolic body weight, serum ferritin concentration, iron losses, biological half-
life and turnover rate are reported in Table 14 (by sex) and Table 15 (by subgroups). 
Table 14:  Summary statistics by sex 
 Mean Standard deviation Median Minimum Maximum 
Age at start (years) 
Female 42.07 7.09 41.79 30.19 57.62 
Male 42.96 8.03 42.54 30.42 58.30 
Body weight (kg) 
Female 71.87 11.58 72.95 52.00 89.20 
Male 91.65 14.89 90.40 61.80 130.90 
BMI (kg/m
2
) 
Female 27.11 4.49 27.39 18.65 36.14 
Male 28.78 3.69 28.27 21.77 35.32 
Metabolic body weight (actual body weight to the power of 0.75, kg) 
Female 24.62 3.00 24.96 19.36 29.03 
Male 29.55 3.59 29.32 22.04 38.70 
Iron losses (mg/day) 
Female 1.73 1.12 1.53 0.57 4.88 
Male 1.07 0.47 1.18 0.11 2.07 
Iron biological half-life (years) 
Female 3.83 1.72 3.92 0.72 7.46 
Male 8.99 6.20 7.24 4.30 31.61 
Iron turnover rate (rate/year) 
(a)
 
Female 0.25 0.20 0.18 0.09 0.96 
Male 0.10 0.04 0.10 0.02 0.16 
Serum ferritin (µg/L) 
Female 58.65 60.33 36.61 6.58 284.75 
Male 164.19 87.41 138.50 50.70 356.75 
(a): Percentage of iron losses per year, transformed into a rate, i.e. dividing by 100, in order to get values between 0 and 1. 
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Table 15:  Summary statistics by subgroups by sex/menstruating status 
 Mean Standard deviation Median Minimum Maximum 
Age at start (years) 
Women—menstruating 39.86 4.72 38.72 31.60 46.63 
Women—postmenopausal 49.92 4.92 48.40 45.53 57.62 
Women—unknown menstruating status 43.49 18.82 43.49 30.19 56.80 
Men 42.96 8.03 42.54 30.42 58.30 
Body weight (kg) 
Women—menstruating 73.48 10.21 73.60 56.00 87.60 
Women—postmenopausal 67.56 14.36 64.80 53.00 89.20 
Women—unknown menstruating status 67.25 21.57 67.25 52.00 82.50 
Men 91.65 14.89 90.40 61.80 130.90 
BMI (kg/m
2
) 
Women—menstruating 27.89 2.63 25.13 20.47 36.14 
Women—postmenopausal 25.49 3.72 22.84 19.64 30.68 
Women—unknown menstruating status 23.77 5.66 23.37 19.36 28.89 
Men 28.78 3.59 29.32 22.04 35.32 
Metabolic body weight (body weight to the power of 0.75, kg) 
Women—menstruating 25.05 4.33 28.04 19.38 28.63 
Women—postmenopausal 23.49 4.08 23.80 20.70 29.03 
Women—unknown menstruating status 23.37 7.24 23.77 18.65 27.37 
Men 29.55 3.69 28.27 21.77 38.70 
Iron losses (mg/day) 
Women—menstruating 1.97 1.22 1.58 0.65 4.88 
Women—postmenopausal 1.08 0.28 0.99 0.86 1.57 
Women—unknown menstruating status 1.11 0.77 1.11 0.57 1.66 
Men 1.07 0.47 1.18 0.11 2.07 
Iron biological half-life (years) 
Women—menstruating 3.46 1.78 3.67 0.72 7.46 
Women—postmenopausal 4.69 1.01 4.24 3.78 5.92 
Women—unknown menstruating status 5.16 1.69 5.16 3.96 6.36 
Men 8.99 6.20 7.24 4.30 31.61 
Iron turnover rate (rate/year) 
(a)
 
Women—menstruating 0.29 0.22 0.19 0.09 0.96 
Women—postmenopausal 0.15 0.03 0.16 0.12 0.18 
Women—unknown menstruating status 0.14 0.05 0.14 0.11 0.17 
Men 0.10 0.04 0.10 0.02 0.16 
Serum ferritin (µg/L) 
Women—menstruating 47.82 41.40 32.48 6.575 148.75 
Women—postmenopausal 96.88 111.55 39.42 21.93 284.75 
Women—unknown menstruating status 65.96 27.03 65.96 46.85 85.075 
Men 164.19 87.41 138.50 50.70 356.75 
(a): Percentage of iron losses per year, transformed into a rate, i.e. dividing by 100, in order to get values between 0 and 1. 
For the two women with unknown menstruating status the Panel considered it reasonable to allocate 
them into one of the two groups: menstruating women or postmenopausal women based on the 
assessment of age and the use of birth control measures (if any). Owing to the limited size of the 
group, the postmenopausal women could not be analysed independently. Therefore, it was decided to 
test whether these women could be merged with either the men or menstruating women groups. 
H2.1. Allocation of women with unknown menstruating status 
The dataset included two females for which menstruating status was unknown. In order to avoid their 
exclusion from the dataset, the size of which was already limited, the two individuals were included in 
one of the two female subgroups on the basis of age and use of birth control measures. 
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According to this criterion the following attribution was performed: 
Subject code Age Birth control measure Subgroup 
25 30 Yes Menstruating women 
26 57 Unknown Postmenopausal women 
H2.2. Allocation of the subgroup of postmenopausal women 
The limited number of observations available for postmenopausal women did not allow any analysis 
on this group independently. The option of merging these women with either the men or menstruating 
women groups was investigated. The criterion of the similarity with respect to the variables iron 
losses, iron turnover rate, iron half-life and metabolic body weight was considered appropriate for this 
purpose. The boxplot of iron losses in the four subgroups is presented in Figure 2. The t-test with 
unequal variance (Ramsey, 1980) was used for this scope. 
 
Figure 2:  Boxplot of iron losses by group 
The results of the comparison between postmenopausal women and men are presented in Table 16. 
Table 16:  Comparison of postmenopausal women and men  
 Mean difference Lower CI Upper CI P-value 
Iron losses –0.1075 –0.4806 0.2657 0.5321 
Iron turnover rate –0.0593 –0.0904 –0.0281 0.0021 
Iron biological half-life 4.4219 1.9481 6.8957 0.0009 
Metabolic body weight 5.4162 1.5365 9.2959 0.0130 
CI, confidence interval. 
A significant difference in the iron turnover rate, iron half-life and metabolic body weight is observed 
between the two groups. The distribution of the variables in the two groups is presented in Figures 3–
6. In the figures, number 1 is the group of men and number 3 is the group of postmenopausal women. 
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Figure 3:  Distribution of iron losses in men (top) and postmenopausal women (bottom) 
 
Figure 4:  Distribution of turnover rate in men (top) and postmenopausal women (bottom) 
 
Figure 5:  Distribution of biological half-life in men (top) and postmenopausal women (bottom) 
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Figure 6:  Distribution of metabolic body weight in men (top) and postmenopausal women (bottom) 
The results of the comparison of postmenopausal and menstruating women are reported in Table 17. 
Table 17:  Comparison of postmenopausal and menstruating women  
 Mean difference Lower CI Upper CI P-value 
Iron losses 0.7181 0.0824 1.3538 0.0285 
Iron turnover rate 0.1201 0.0170 0.2232 0.0246 
Iron biological half-life –0.9589 –2.1539 0.2360 0.1087 
Metabolic body weight 0.6346 –3.2414 4.5106 0.7096 
CI, confidence interval. 
A significant difference in iron losses and turnover rate is observed between the two groups, which is 
also evident from the comparison of the distribution of variables given in Figures 7–10. In the figures, 
number 2 is the group of menstruating women and number 3 is the group of postmenopausal women. 
 
Figure 7:  Distribution of iron losses in postmenopausal (bottom) and menstruating women (top) 
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Figure 8:  Distribution of turnover rate in postmenopausal (bottom) and menstruating women (top) 
 
Figure 9:  Distribution of biological half-life in postmenopausal (bottom) and menstruating women 
(top) 
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Figure 10:  Distribution of metabolic body weight in postmenopausal (bottom) and menstruating 
women (top) 
Owing to the significant difference observed in the means of several variables when comparing 
postmenopausal women to either men or menstruating women, it was decided to exclude 
postmenopausal women from the analysis. 
DATA QUALITY 
Information about the setting of the studies and the methodology used to collect the data (including 
laboratory techniques) can be found in the references provided by Hunt et al. (2009). 
One of the major strengths of the data is represented by the effort carried out by the researchers to 
control for potential confounding deriving from blood loss that could have occurred for reasons other 
than elimination via usual routes. Strict eligibility criteria were set up in this respect. Some variables 
related to dietary consumption habits and lifestyle were measured in the study using a questionnaire. 
Such data were not made available to EFSA. These aspects could represent potential confounding 
factors that influence iron losses and that cannot be accounted for in the current analysis because of 
lack of data. It is assumed that the dietary consumption habits and lifestyle of subjects in the sample 
are representative of those of the North American healthy adult population. Blood samples were 
collected every six months. The processing of these data in order to provide a summary measure per 
subject, as in the dataset provided to EFSA, was performed by Hunt et al. (2009) and could not be 
investigated further in the present analysis because of lack of information. 
The subjects in the sample received a different dose of iron supplements from their participation in a 
previous study, and from which they were recruited. Eleven subjects received a single intravenous 
dose of 5 µCi Fe mixed with each subject’s own plasma. One to two years before the present study, 42 
subjects had received two oral doses separated by several weeks, with a total dose of 1–2 µCi Fe as 
haemoglobin iron. For the two subjects with unknown menstruating status, the dose of iron 
administered in the previous study is not reported since they were not included in the final analysis. In 
principle, differences in the dose of iron administered in the previous study could represent a 
confounding factor in the assessment of iron losses, but the Panel considers that sufficient time had 
elapsed to enable the physical decay of this isotope with a half-life of 44.5 days. 
METHODS OF ANALYSIS 
In order to provide a basis for the estimate of various percentiles of iron losses for the healthy EU 
adult population, a model was developed according to the following steps: 
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 summary statistics were estimated for the main variables related to iron losses for the two 
subgroups as resulting from preprocessing (men and menstruating women); 
 possible association among variables indicated by the Panel as potentially explanatory 
variables for iron losses was investigated in order to reduce the risk of introducing 
autocorrelated variables into the regression model; 
 a regression model for iron losses (in mg/day) was fitted to the data provided by Hunt et al. 
(2009) selecting among the set of potentially exploratory variables those with limited 
correlation. This step also included analysis of outliers and assessment of goodness of fit; 
 the equation estimated via the regression model was used to derive a distribution for iron 
losses combining the latter equation with parametric distributions fitted on sample data for 
each of the input factors. 
Owing to the significant differences in the distribution of iron losses between men and menstruating 
women, the Panel decided to perform separate analyses for the two subgroups. Postmenopausal 
women were excluded from the analysis since their numbers were too limited and the similarity with 
one of the other two groups did not appear sufficient to merge them. 
H3. Statistical analysis—men 
H3.1. Summary statistics 
A description of the main characteristics of the sample of male subjects is provided in Table 18. 
Table 18:  Summary statistics for men 
Variable Number Mean Standard 
deviation 
Median Minimum Maximum 
Initial age (years) 29 42.96 8.03 42.54 30.42 58.30 
Body weight (kg) 29 91.65 14.89 90.4 61.8 130.9 
BMI (kg/m
2
) 29 28.78 3.59 29.32 22.04 35.32 
Metabolic body weight (kg) 29 29.55 3.59 29.32 22.04 38.70 
Iron losses (mg/day) 29 1.07 0.47 1.18 0.11 2.07 
Iron losses (µg/kg actual body 
weight per day) 
29 11.63 4.80 11.82 1.38 20.84 
Biological half-life of iron (years) 29 8.99 6.20 7.24 4.30 31.61 
Iron turnover rate (rate/year) 29 0.10 0.04 0.10 0.02 0.16 
Serum ferritin (µg/L) 29 164.19 87.41 138.50 50.70 356.75 
The median body weight, about 90 kg, and the median BMI, about 29 kg/m
2
, of this sample of North 
American healthy adult men are larger than the corresponding values in the EU adult male population 
(measured median body weight in 16 580 men aged 18–79 years is 80.8 kg; median BMI is 
26.1 kg/m
2
) (EFSA NDA Panel, 2013). This difference could introduce a bias in estimating the 
population mean of iron losses with a regression model. As a mitigation action it was decided to use 
the metabolic body weight instead. In addition, it was considered appropriate to perform a sensitivity 
analysis at the end of the process in order to assess the influence of this input variable on the estimate 
of iron losses. 
The values of 31.6 for biological half-life of iron (subject 49) and 0.16 for iron turnover rate (subject 
46) appear extreme with respect to the mean of the sample (8.99 and 0.10, respectively). An 
investigation of the possibility that these subjects represent outliers was performed (see Section H3.4). 
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H3.2. Assessing association among variables 
A Pearson correlation coefficient was estimated in order to assess the linear correlation among iron 
losses (mg/day) and potential explanatory factors; metabolic body weight, iron biological half-life, 
iron turnover rate, serum ferritin concentration. The variables with the highest level of association are 
the iron turnover rate and biological half-life, which are also highly correlated (–0.84). The iron 
turnover rate was retained because it had the highest level of correlation. Metabolic body weight was 
also significantly correlated with iron losses and was retained for setting up the regression model. 
Table 19:  Pearson correlation coefficients (Prob > |r| under H0: Rho = 0) 
  Body weight 
(kg) 
Metabolic 
body weight 
(kg) 
Iron losses 
(mg/day) 
Biological 
half-life of 
iron (years) 
Iron 
turnover 
rate 
(rate/year) 
Serum 
ferritin 
(µg/L) 
Body weight (kg) 1 0.99954 
(< 0.0001) 
0.40809 
(0.0280) 
–0.16678 
(0.3872) 
0.04941 
(0.7991) 
0.41500 
(0.0252) 
Metabolic body 
weight (kg) 
0.99954 
(< 0.0001) 
1 0.41197 
(0.0264) 
–0.16739 
(0.3854) 
0.05343 
(0.7831) 
0.40939 
(0.0274) 
Iron losses 
(mg/day) 
0.40809 
(0.0280) 
0.41197 
(0.0264) 
1 –0.79348 
(< 0.0001) 
0.91898 
(< 0.0001) 
0.17266 
(0.3704) 
Biological half-
life of iron 
(years) 
–0.16678 
(0.3872) 
–0.16739 
(0.3854) 
–0.79348 
(< 0.0001) 
1 –0.83988 
(< 0.0001) 
0.1833 
(0.3412) 
Iron turnover rate 
(rate/year) 
0.04941 
(0.7991) 
0.05343 
(0.7831) 
0.91898 
(< 0.0001) 
–0.83988 
(< 0.0001) 
1 –0.0664 
(0.7322) 
Serum ferritin 
(µg/L) 
0.41500 
(0.0252) 
0.40939 
(0.0274) 
0.17266 
(0.3704) 
0.1833 
(0.3412) 
–0.0664 
(0.7322) 
1 
 
 
Figure 11:  Scatter plot and frequency distribution 
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Table 19 shows that iron turnover rate and biological half-life are highly correlated. Iron turnover rate 
has a stronger linear association with iron losses. In addition, its relationship with iron losses is linear 
while that with half-life is not. Therefore, in order to use a simpler and more parsimonious structure 
for the model, iron turnover rate was kept in the analysis. Metabolic body weight is preferred over 
body weight based on the reasoning above. 
H3.3. Setting up a regression model 
A linear regression model was used to explain iron losses. Based on previous correlation analysis, 
metabolic body weight and iron turnover rate were considered as potential covariates that might have 
an effect on the output and have limited autocorrelation. 
The form of the model is given in equation [1]: 
 [1] 
where: 
is iron losses (in mg/day) 
are regression coefficients for the explanatory factors 
X1 is metabolic body weight 
X2 is iron turnover rate 
is the random error term on individual i-th with . 
The goodness of fit of the model was assessed using as indicators the adjusted R squared and the 
Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Normality of the 
residuals was assessed graphically. 
The output of model fitting is reported in Tables 20–22. 
Table 20:  Analysis of variance 
Source Degrees of freedom Sum of squares Mean square F value Pr > F 
Model 2 5.93161 2.96581 541.79 < 0.0001 
Error 26 0.14233 0.00547   
Corrected total 28 6.07394    
Table 21:  Indicators for goodness of fit 
Root mean-square error 0.07399 R squared 0.9766 
Dependent mean 1.07059 Adjusted R squared 0.9748 
Coefficient of variation 6.91085 Akaike (AIC) –148.2 
  Bayesian (BIC) –144.1 
Table 22:  Parameter estimates 
Variable Parameter 
estimate 
Standard 
error 
Lower 
95 % CI 
Upper 
95 % CI 
Pr > |t| 
Intercept –1.44460 0.12000 –1.69126 –1.19794 < 0.0001 
Metabolic body weight (kg) 0.04718 0.00390 0.03917 0.05520 < 0.0001 
Iron turnover rate (rate/year) 11.504 0.384 10.713 12.294 < 0.0001 
CI, confidence interval. 
ii XXY   22110
Yi
j
i  2,0  N
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Both variables are able to explain a significant component of the variability of iron losses in men and 
are retained in the model. 
H3.4. Outlier analysis 
Graphical diagnostics for detection of outliers are reported in Figure 12. No individual had externally 
studentised residuals outside the range (–3; +3). However, subject 46 was borderline (iron turnover 
rate 0.16, iron losses 2.07 mg/day – Cook’s D influence statistic = 0.4, externally studentised 
residual = 2.99). The Panel considered it appropriate to exclude the subject from the analysis. 
 
Figure 12:  Diagnostics for detection of outliers 
Summary statistics of the main factors in men after removal of outliers are reported in Table 23. 
Table 23:  Summary statistics for men after removal of outliers 
Variable Number Mean Standard 
deviation 
Median Minimum Maximum 
Initial age (years) 28 42.90 8.18 41.61 30.42 58.30 
Body weight (kg) 28 91.37 15.09 89.40 61.80 130.90 
BMI (kg/m
2
) 28 28.65 3.69 28.05 21.77 35.32 
Metabolic body weight (kg) 28 29.48 3.64 29.07 22.04 38.70 
Iron losses (mg/day) 28 1.03 0.43 1.10 0.11 1.63 
Iron losses (µg/kg actual body 
weight per day) 
28 11.30 4.54 11.40 1.38 19.08 
Biological half-life of iron (years) 28 9.16 6.25 7.31 4.41 31.61 
Iron turnover rate (rate/year) 28 0.10 0.03 0.09 0.02 0.16 
Serum ferritin (µg/L) 28 159.39 85.02 136.92 50.70 356.75 
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After exclusion of the outlier, the change in indicators for goodness of fit was negligible. The revised 
parameter estimates are reported in Table 24. 
Table 24:  Parameter estimates after exclusion of one outlier 
Variable Parameter estimate Standard 
error 
Lower 
95 % CI 
Upper 
95 % CI 
Pr > |t| 
Intercept –1.38942 0.10668 –1.60912 –1.16971 < 0.0001 
Metabolic body weight (kg) 0.04624 0.00343 0.03918 0.05330 < 0.0001 
Iron turnover rate (rate/year) 11.14889 0.35698 10.41367 11.88410 < 0.0001 
CI, confidence interval. 
H3.5. Estimate the distribution of endogenous iron losses via a probabilistic model 
The knowledge of the probability distribution of iron losses representing its variation in the target 
population is an information of paramount importance when setting DRVs. Data collected on a 
reduced sample are unlikely to represent the overall distribution of the EU healthy adults, especially 
for the tails of the distribution. 
The probabilistic approach provides a useful methodological support to fill in gaps in the data as far as 
major sources of variability and uncertainty are concerned. Variation in iron losses can be modelled by 
fitting a parametrical distribution to the observed measurements of the input factors and using them to 
derive a probability distribution for the mineral losses with the aid of the model estimated via the 
regression analysis. The same approach can be used to account for important sources of uncertainty in 
the model inputs. 
In real life, the explanatory factors of the regression model (metabolic body weight and iron turnover 
rate) represent quantities whose value varies across the target population. Parametric modelling uses 
parametric distributions that are based on the observed data but generate additional values below, 
between and above the observed values. This has the advantage of being able to represent the full 
range of potential values for the factors of interest, but requires assumptions to be made about the 
shape of the distribution. If unbounded distributions are used, they will certainly generate a small 
proportion of unrealistically high values, even if they fit the data well. Truncations have been used in 
this analysis to avoid this issue. The model fitting accounts for the inter-individual variability of the 
factors in the population. In practice, the distribution of these factors is also somehow uncertain 
because of the limited size of the datasets (sampling uncertainty) and the potential limitation in the 
representativeness of the sample towards the target population. These considerations could affect the 
choice of the shape of the distribution, especially in the lower and upper tails. In this analysis the 
potential sources of uncertainty are not assessed quantitatively. Their impact on the distribution of iron 
losses and final conclusions are described in Sections H3.1 and H7.2. 
A different approach was taken for the regression coefficient parametric modelling. These inputs are 
assumed to be deterministic (not variable in the population) but uncertain because estimated on a 
sample. The uncertainty for these parameters was addressed modelling the 95 % interval estimates 
with appropriate distributions. 
Monte Carlo simulation techniques were used to generate the parametric distributions and combine 
them into the equation model estimated by the regression analysis. Monte Carlo simulations are 
numerical sampling techniques that are the most robust and least restrictive with respect to model 
design and model input specification (Frey and Rhodes, 1999). One advantage of using Monte Carlo 
sampling is that, with a sufficient sample size, it provides an excellent approximation of the output 
distribution. Also, since it is a random sampling technique, the resulting distribution of values can be 
analysed using standard statistical methods (Burmaster and Anderson, 1994). In a Monte Carlo 
simulation the model combining the input distributions is recalculated many times with random 
samples of each distribution to produce numerous scenarios or iterations. Each set of model results or 
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outputs represents a scenario that could occur and the joint distribution of output parameters is a 
representation of the variability and/or uncertainty in the outputs. 
In this analysis, Monte Carlo sampling techniques have been used to propagate probabilistic factor 
inputs through the equation estimated via the regression analysis to generate a probability distribution 
for iron losses. The issue of correlation among variables whose distributions are combined is not 
addressed in the following since explanatory variables with limited association were selected for the 
regression analysis. 
This approach foresees the performance of the following steps: 
 a parametric probability distribution is fitted to the observed data for each input factor 
included in the regression model. Since regression parameters are affected by sampling 
uncertainty, a distribution is used to account for it; 
 the fitted distributions are combined in the equation model estimated via the regression 
analysis using Monte Carlo sampling techniques; 
 a distribution for iron losses is estimated; 
 estimates of the percentiles of the distribution are provided as a basis for computing the AR 
and PRI. 
H3.6. Probability distribution for the explanatory variables 
The probabilistic distributions for the explanatory variables metabolic body weight and iron turnover 
rate have been fitted on the data from Hunt et al. (2009). 
A normal distribution was used for modelling variability in metabolic body weight. Visual analysis of 
the data confirmed that this is a reasonable choice. The median and standard deviation of the observed 
data after removal of the outlier were taken as mean and standard deviation of the normal distribution. 
The median was preferred over the mean since it is more robust with respect to extreme values of the 
distribution. Truncation was applied (22, 39) in order to avoid unrealistic values. 
The beta distribution is used for fitting iron turnover rate. In fact, the beta distribution, bounded by the 
interval between 0 and 1, is useful for representing variability in a fraction that cannot exceed 1. 
Because the beta distribution can take on a wide variety of shapes, such as negatively skewed, 
symmetric and positively skewed, it can represent a large range of empirical data. The sampling 
median and standard deviation obtained after removal of the outlier were assumed to be the true mean 
and standard deviation of the distribution. The shape parameters of the beta distribution were derived 
from them using the method of matching moments (Frey and Rhodes, 1999): 
 
 
where: 
and are the sampling mean and variance, respectively; and 
and are the estimates of the parameters of the beta distribution. 
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It was assumed that the uncertainty in the regression coefficients β0, β1, β2 could be well represented 
using a Pert distribution assigning the largest probability to the central value of the estimated CIs and 
decreasing probabilities to the other values included between the lower and upper bound of the CI. 
A description of the distributions used for the input factors and the specification of whether they 
model variability or uncertainty is provided in Table 25. 
Table 25:  Fitted distributions for the explanatory variables and regression coefficients  
Input factor V/U 
(a)
 Distribution Unit 
Distribution of metabolic body weight (X1) V ~normal(29, 3.6) truncated (22, 39) kg 
Distribution of iron turnover rate (X2) V ~beta(6.661, 63.642) truncated (0.02, 0.16)  
Intercept (β0) U ~Pert(–1.61, –1.39, –1.17) mg/day 
Metabolic body weight regression 
coefficient (β1) 
U ~Pert(0.039, 0.046, 0.053) mg/day 
per kg 
Iron turnover rate regression coefficient 
(β2) 
U ~Pert(10.41, 11.15, 11.88) mg/day 
per rate 
(a): V, variability; U, uncertainty. 
The distributions of metabolic body weight and iron turnover rate are provided in Figures 13–16 (in 
couples, frequency distribution based on data and fitted distribution obtained via simulation). Fitted 
distributions for the regression coefficients are shown in Figures 17–19. 
 
Figure 13:  Frequency distribution of metabolic body weight in the sample of men 
 
Figure 14:  Probability distribution of metabolic body weight 
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Figure 15:  Frequency distribution of iron turnover rate in the sample of men 
 
Figure 16:  Probability distribution of iron turnover rate 
 
Figure 17:  Probability distribution of intercept 
 
Figure 18:  Probability distribution of regression coefficient for metabolic body weight 
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Figure 19:  Probability distribution of regression coefficient for iron turnover rate 
H4. Results—men 
A distribution of daily iron losses is obtained by combining the probability distributions for the 
explanatory variables and regression coefficients into equation [1]. From the distribution it is possible 
to derive percentiles of interest. 
 
Figure 20:  Distribution of iron losses—90th percentile 
 
Figure 21:  Distribution of iron losses—95th percentile 
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Figure 22:  Distribution of iron losses—97.5th percentile 
 
Figure 23:  Distribution of iron losses—50th percentile 
The 90
th
, 95
th
 and 97.5
th
 percentiles of iron losses (Figure 20–22) are, respectively, equal to around 
1.48, 1.61 and 1.72 mg/day. The 50
th
 percentile of the distribution is equal to around 0.95 mg/day 
(Figure 23). 
H5. Statistical analysis—menstruating women 
H5.1. Summary statistics 
Summary statistics for the group of menstruating women are provided in Table 26. 
Table 26:  Summary statistics for menstruating women 
Variable Number Mean Standard 
deviation 
Median Minimum Maximum 
Initial age (years) 20 39.37 5.08 38.55 30.19 46.63 
Body weight (kg) 20 72.41 11.04 73.05 52.00 87.60 
BMI (kg/m
2
) 20 27.43 4.70 27.39 18.65 36.16 
Metabolic body weight (kg) 20 24.77 2.86 24.99 19.36 28.63 
Iron losses (mg/day) 20 1.90 1.22 1.55 0.57 4.88 
Iron losses (µg/kg actual body 
weight per day) 
20 26.36 17.54 20.58 9.03 75.17 
Biological half-life of iron 
(years) 
20 3.61 1.85 3.76 0.72 7.46 
Iron turnover rate (rate/year) 20 0.28 0.22 0.18 0.09 0.96 
Serum ferritin (µg/L) 20 47.77 40.30 33.38 6.58 148.75 
 
The median body weight, about 72 kg, and the median BMI, about 27 kg/m
2
, of this sample of North 
American healthy adult menstruating women are larger than the corresponding values in the EU adult 
female population (measured median body weight in 19 998 women aged 18–79 years is 65.1 kg; 
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median BMI is 24.5 kg/m
2
) (EFSA NDA Panel, 2013). This difference could introduce a bias in 
estimating the population mean of iron losses with a regression model. As a mitigation action it was 
decided to use the metabolic body weight instead. In addition, it was considered appropriate to 
perform a sensitivity analysis at the end of the process in order to assess the influence of this input 
variable on the estimate of iron losses. 
The values of 0.7 years for iron biological half-life (subject 14) and 0.96 for iron turnover rate (same 
subject) appear extreme with respect to the mean of the sample (3.6 and 0.28, respectively). An 
investigation of the possibility that this subject represents an outlier was performed (Section H5.4). 
The same summary statistics have also been computed for the group of menstruating women taking 
hormonal birth control measures to investigate whether they differ in some respect from the rest of the 
group, and are reported in Table 27. 
Table 27:  Summary statistics for menstruating women taking hormonal birth control measures 
Variable Number Mean Standard 
deviation 
Median Minimum Maximum 
Age (years at start) 5 35.25 3.23 36.42 30.19 38.72 
Body weight (kg) 5 71.88 15.03 77.30 52.00 87.60 
Metabolic body weight (kg) 5 24.60 3.92 26.07 19.36 28.63 
Iron losses (mg/day) 5 1.01 0.25 1.09 0.57 1.15 
Iron losses (µg/kg actual body 
weight per day) 
5 14.06 3.03 13.30 10.89 18.81 
Biological half-life of iron 
(year) 
5 5.16 1.12 5.72 3.96 6.36 
Iron turnover rate (rate/year) 5 0.14 0.03 0.12 0.11 0.18 
Serum ferritin (µg/L) 5 66.60 56.26 46.85 10.90 148.75 
H5.2. Assessing association among variables 
A Pearson correlation coefficient was estimated in order to assess the linear correlation among iron 
losses (mg/day) and potential explanatory factors; metabolic body weight, iron biological half-life, 
iron turnover rate, serum ferritin concentration. As for men, the variables with the highest level of 
association are iron turnover rate and biological half-life, which are also highly correlated (–0.81). The 
iron turnover rate was retained because it had the highest level of linear correlation. Metabolic body 
weight was not significantly correlated with iron losses but was retained for setting up the model in 
order to more thoroughly investigate any potential influence on the variability of iron losses. Serum 
ferritin was significantly correlated with iron losses but also with iron turnover rate (–0.52). It was also 
retained for further analysis. 
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Table 28:  Pearson correlation coefficients (Prob > |r| under H0: Rho = 0) 
  Body 
weight 
(kg) 
Metabolic 
body weight 
(kg) 
Iron losses 
(mg/day) 
Biological 
half-life of 
iron (years) 
Iron 
turnover 
rate 
(rate/year) 
Serum 
ferritin (µg/L) 
Body weight (kg) 1 0.99986 
(< 0.0001) 
0.13992 
(0.5563) 
–0.07419 
(0.7559) 
–0.03843 
(0.8722) 
0.08033 
(0.7364) 
Metabolic body 
weight (kg) 
0.99986 
(< 0.0001) 
1 0.14358 
(0.5459) 
–0.07777 
(0.7445) 
–0.03518 
(0.8829) 
0.07979 
(0.7381) 
Iron losses 
(mg/day) 
0.13992 
(0.5563) 
0.14358 
(0.5459) 
1 –0.85037 
(< 0.0001) 
0.94545 
(< 0.0001) 
–0.48441 
(0.0304) 
Biological half-
life of iron 
(years) 
–0.07419 
(0.7559) 
–0.07777 
(0.7445) 
–0.85037 
(< 0.0001) 
1 –0.80864 
(< 0.0001) 
0.60698 
(0.0045) 
Iron turnover rate 
(rate/year) 
–0.03843 
(0.8722) 
–0.03518 
(0.8829) 
0.94545 
(< 0.0001) 
–0.80864 
(< 0.0001) 
1 –0.52045 
(0.0186) 
Serum ferritin 
(µg/L) 
0.08033 
(0.7364) 
0.07979 
(0.7381) 
–0.48441 
(0.0304) 
0.60698 
(0.0045) 
–0.52045 
(0.0186) 
1 
 
With respect to the preference of iron turnover rate over biological half-life, similar considerations as 
for men apply (see Section H3.2). 
No significant correlation between metabolic body weight and iron losses was observed, but it was 
decided to nevertheless keep metabolic body weight in the model. This was carried out as metabolic 
body weight may still explain a small part of the variability, since it is not correlated with any other 
variable. 
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Figure 24:  Scatter plot and frequency distribution 
H5.3. Setting up a regression model 
As for men, a linear regression model was used in order to explain iron losses in menstruating women. 
Based on previous correlation analysis, metabolic body weight, iron turnover rate and serum ferritin 
concentration were considered as potential covariates that might have an effect on the output and have 
limited autocorrelation among them. 
The form of the model is given in equation [2]: 
 [2] 
where:  
is iron losses (in mg/day) 
are regression coefficients for the explanatory factors 
X1 is metabolic body weight 
X2 is iron turnover rate 
X3 is serum ferritin concentration 
is the random error term on individual i-th with . 
ii XXXY   3322110
Yi
j
i  2,0  N
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The goodness of fit of the model was assessed using as indicators the adjusted R squared and AIC and 
BIC. Normality of the residuals was assessed graphically. 
The output of model fitting is reported in Tables 29–31. 
Table 29:  Analysis of variance 
Source Degree of freedom Sum of squares Mean square F value Pr > F 
Model 3 26.34716 8.78239 65.97 < 0.0001 
Error 16 2.12998 0.13312   
Corrected total 19 28.47713 19   
Table 30:  Indicators for goodness of fit 
Root mean-square error 0.36486 R squared 0.9252 
Dependent mean 1.89619 Adjusted R squared 0.9112 
Coefficient of variation 19.24176 Akaike (AIC) –38.79 
  Bayesian (BIC) –35.8 
Table 31:  Parameter estimates 
Variable Parameter 
estimate 
Standard 
error 
Lower 
95 % CI 
Upper 
95 % CI 
Pr > |t| 
Intercept –1.47222 0.75311 –3.06874 0.12431 0.0683 
Metabolic body weight (kg) 0.07594 0.02937 0.01367 0.13821 0.0199 
Iron turnover rate (rate/year) 5.39667 0.45518 4.43173 6.36160 < 0.0001 
Serum ferritin (µg/L) –0.00013562 0.00244 –0.00531 0.00503 0.9563 
CI, confidence interval. 
Metabolic body weight and iron turnover rate significantly explained the variance of iron losses, the 
intercept was marginally insignificant and was kept in the model. Serum ferritin concentration is not 
significant when the other variables are in the model. 
H5.4. Outlier analysis 
Graphical diagnostics for detection of outliers are reported in Figure 25. Two individuals had 
externally studentised residuals well outside the range (–3; +3). These are subjects 14 and 16. 
Table 32:  Outlier analysis for menstruating women 
Subject Iron losses Iron 
turnover 
rate 
Biological 
half-life 
Metabolic 
body weight 
Serum 
ferritin 
Cook’s D Externally 
studentised 
residuals 
14 4.64 0.96 0.72 22 8.30 5 –5.7 
16 4.88 0.63 1.10 25 26.7 0.65 5.4 
Cook’s D, Cook’s distance. 
The Panel considered it appropriate to exclude the subjects from the analysis. 
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Figure 25:  Diagnostics for detection of outliers 
Summary statistics of the main factors in menstruating women after removal of outliers are reported in 
Table 33. 
Table 33:  Summary statistics after removal of outliers—menstruating women 
Variable Number Mean Standard 
deviation 
Median Minimum Maximum 
Initial age (years) 18 38.67 4.85 37.72 30.19 46.63 
Body weight (kg) 18 72.94 11.36 74.90 52.00 87.60 
BMI (kg/m
2
) 18 27.57 4.90 27.79 18.65 36.14 
Metabolic body weight (kg) 18 24.90 2.94 25.46 19.36 28.63 
Iron losses (mg/day) 18 1.58 0.78 1.53 0.57 3.67 
Iron losses (µg/kg actual body 
weight per day) 
18 21.43 9.20 19.61 9.03 44.16 
Biological half-life of iron 
(years) 
18 3.91 1.69 3.90 1.32 7.46 
Iron turnover rate (rate/year) 18 0.22 0.12 0.18 0.09 0.52 
Serum ferritin (µg/L) 18 51.13 41.05 36.61 6.58 148.75 
H5.5. Model estimates without outliers 
After exclusion of the outliers, the change in goodness of fit indicators was negligible. The revised 
parameter estimates are reported in Table 34. 
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Table 34:  Parameter estimates after exclusion of two outliers 
Variable Parameter 
estimate 
Standard 
error 
Lower 
95 % CI 
Upper 
95 % CI 
Pr > |t| 
Intercept –1.08987 0.33011 –1.79349 –0.38624 0.0048 
Metabolic body weight (kg) 0.05460 0.01359 0.02564 0.08356 0.0011 
Iron turnover rate (rate/year) 5.95745 0.33714 5.23885 6.67605 < 0.0001 
 
The revised model [2a] includes only two explanatory variables significantly explaining the variability 
of iron losses: 
  [2a] 
The other assumptions remain fixed. 
H5.6. Estimate the distribution of iron losses via a probabilistic model 
Following the same approach as for men, the following steps have been performed: 
 a parametric probability distribution is fitted to the observed data for each input factor 
included in the regression model. Since regression parameters are affected by sampling 
uncertainty, a distribution is used to account for it; 
 the fitted distributions are combined in the equation model estimated via the regression 
analysis using Monte Carlo sampling techniques; 
 a distribution for iron losses is estimated; 
 estimates of the percentiles of the distribution are provided as a basis for computing the AR 
and PRI. 
H5.7. Probability distribution for the explanatory variables 
The probabilistic distributions for the explanatory variables metabolic body weight and iron turnover 
rate have been fitted on the data from Hunt et al. (2009). 
In the group of menstruating women the distribution of metabolic body weight is bimodal. This is 
probably because a large proportion of women in the sample had a high body weight, which could 
raise doubts on the representativeness of the sample with respect to the target population. A mixture of 
two normal distributions with means of 22, 28 and both with a standard deviation of 2 was used in 
order to fit the observed data after exclusion of outliers. The sampling median and standard deviation 
were taken as mean and standard deviation of the combined normal distribution. Truncation was 
applied in order to avoid unrealistic values (20,26) and (24,29). 
The beta distribution was used to fit the iron turnover rate. The same reason as for men applies here. 
Sampling median and standard deviation obtained after removal of the outliers were assumed to be 
mean and standard deviation of the population distribution. 
It was assumed that the uncertainty in the regression coefficients β0, β1, β2 could be well represented 
using a Pert distribution assigning the largest probability to the central value of the estimated CIs and 
decreasing probabilities to the other values included in the lower and upper bound of the CI. 
A description of the distributions used for the input factors and the specification of whether they 
model variability or uncertainty is provided in Table 35. 
  
ii XXY   22110
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Table 35:  Fitted distributions for the explanatory variables and regression coefficients  
Input Factor V/U 
(a)
 Distribution Unit 
Distribution of metabolic body weight (X1) V ~bimodal(0.5*Normal(22,2) truncated 
(20,26), 0.5*Normal(28,2) truncated (24,29)) 
kg 
Distribution of iron turnover rate (X2) V ~beta(1.845,8.540) truncated (0.04,0.6)  
Equation intercept (β0) U ~Pert(–1.79, –1.090, –0.386) mg/day 
Metabolic body weight regression 
coefficient (β1) 
U ~Pert(0.026, 0.055, 0.084) mg/day 
per kg 
Iron turnover rate regression coefficient 
(β2) 
U ~Pert(5.239, 5.957, 6.676) mg/day 
per rate 
(a): V, variability; U, uncertainty. 
The same methodology as for men was applied to generate the distributions for metabolic body 
weight, iron turnover rate and regression coefficients. 
The distributions of metabolic body weight and iron turnover rate are provided in Figures 26–29 (in 
couples, frequency distribution based on data and fitted distribution obtained via simulation). Fitted 
distributions for the regression coefficients are shown in Figures 30–32. 
 
Figure 26:  Frequency distribution of metabolic body weight in the sample of menstruating women 
 
Figure 27:  Probability distribution of metabolic body weight 
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Figure 28:  Frequency distribution of iron turnover rate in the sample of menstruating women 
 
Figure 29:  Probability distribution of iron turnover rate 
 
Figure 30:  Probability distribution of intercept 
 
Figure 31:  Probability distribution of regression coefficient for metabolic body weight 
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Figure 32:  Probability distribution of regression coefficient for iron turnover rate 
H6. Results—menstruating women 
A distribution of daily iron losses is obtained by combining the probability distributions for the 
explanatory variables and regression coefficients into equation [2a]. From the distribution it is possible 
to derive percentiles of interest. 
 
Figure 33:  Distribution of iron losses—90th percentile 
 
Figure 34:  Distribution of iron losses—95th percentile 
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Figure 35:  Distribution of iron losses—97.5th percentile 
 
Figure 36:  Distribution of iron losses—50th percentile 
The 90
th
, 95
th
 and 97.5
th
 percentiles of iron losses (Figures 33–35) are, respectively, equal to around 
2.44, 2.80 and 3.13 mg/day. The 50
th
 percentile of the distribution is equal to around 1.34 mg/day 
(Figure 36). 
INTERPRETATION OF THE RESULTS 
H7. Sources of uncertainty and their potential impact on the final estimates 
H7.1. Definitions and general concepts 
In the EFSA context the term uncertainty is intended to cover “all types of limitations in the 
knowledge available to assessors at the time an assessment is conducted and within the time and 
resources agreed for the assessment” (EFSA Scientific Committee draft Guidance on Uncertainty in 
Risk Assessment, unpublished). The need to address uncertainty is expressed in the Codex Working 
Principles for Risk Analysis. These state that “constraints, uncertainties and assumptions having an 
impact on the risk assessment should be explicitly considered at each step in the risk assessment and 
documented in a transparent manner” (Codex Alimentarius Commission, 2015). The Scientific 
Committee of EFSA explicitly endorsed this principle in its Guidance on Transparency in Risk 
Assessment (EFSA, 2009). 
In the risk assessment process it is important to characterise, document and explain all types of 
uncertainty arising in the process to allow risk managers to properly interpret the results. 
Ideally, analysis of the uncertainty would require the following steps: 
1. identifying uncertainties; 
2. describing uncertainties; 
3. assessing individual sources of uncertainty; 
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4. assessing the overall impact of all identified uncertainties on the assessment output, taking 
account of dependencies; 
5. assessing the relative contribution of individual uncertainties to overall uncertainty; 
6. documenting and reporting the uncertainty analysis. 
Uncertainty can be expressed adopting six main approaches: descriptive expression, ordinal scales, 
sets, bounds, ranges and distributions. The first and second of these are qualitative, while the other 
four quantify uncertainty to an increasing extent. 
An EFSA Working Group is currently working on the provision of guidelines on how the uncertainty 
analysis should be performed in a harmonised and structured way. Since the activity is ongoing, in the 
current assessment, only the first two steps (i.e. identification and description) will be considered in 
analysing the uncertainty. This will include stating which assumptions have been made in the various 
steps of the assessment, if any. 
The Panel aimed to assess, in a qualitative way, the potential impact of the individual sources of 
uncertainty on the final outcome and, possibly, on the combined impact of the multiple uncertainties. 
H7.2. Identification and description of the sources of uncertainty 
The model used to set up the estimates that served as a basis for the AR and PRI relies on some 
assumptions about the structure of the regression model (i.e. explanatory variables and linearity of the 
relationship). These assumptions have an influence on the final results in the sense that they determine 
the equation used as a basis for further probabilistic modelling. In addition, the structure of the 
regression model determines the size of the CIs for the regression parameters and, consequently, their 
lower and upper bounds that are used as reference for the PERT distributions fitted to them. Different 
choices may lead to different results. The Panel considers that the fitting of the regression model is 
quite good for both groups (men and menstruating women), which is reassuring. 
Some limitations in the data represent a potential source of uncertainty that could introduce a bias in 
the final estimates. Observations were taken on North American healthy adult subjects. The 
assumption of their representativeness for the EU healthy adult population may not be completely met, 
especially as far as the distribution of body weights is concerned. The small size of the sample is an 
additional source of uncertainty that could affect the true shape and variability of the distribution of 
the variables involved in the assessment. Further research is needed to collect more data of this kind. 
Sources of uncertainty and their potential impact are described in Table 36. 
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Table 36:  Sources of uncertainty and their potential impact on the estimates 
Outcome Source of uncertainty Direction of the effect on the 
outcome 
Estimates of the body weight, BMI 
and metabolic body weight, iron 
losses and various serum 
parameters 
Lack of information about: 
 how repeated measures on the 
same individual (2–6 
observations per subject taken 
during the study) have been 
summarised; 
 aspects related to dietary 
consumption and life-style (i.e. 
not measured) 
It is difficult to evaluate the impact 
of this on the estimate of the 
distribution of iron losses 
Representativeness of the healthy 
European adult population  
Individuals were North American 
subjects with body weight, on 
average, larger than that of the EU 
population. 
The representativeness of the 
sample in terms of aspects that 
might impact on iron losses is 
difficult to assess 
The percentiles of the body weight 
distribution for both men and 
menstruating women are larger 
than those of the corresponding EU 
population. Owing to the linear 
positive relationship assumed 
between body weight and iron 
losses, possible direction of the 
impact of this source of uncertainty 
would be to overestimate the 
percentiles of the distribution of 
iron losses. As a mitigation action a 
sensitivity analysis is performed to 
evaluate how much of the 
variability in iron losses is 
attributable to variations in 
metabolic body weight. 
Since information is lacking on 
other aspects characterising the 
sample, it is not possible to predict 
the impact of potential differences 
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Appendix I. Data derived from intervention studies in Europe on iron intake and markers of iron deficiency and/or iron deficiency anaemia in 
children 
Reference  Design Number of 
individuals 
(number of 
males/number of 
females) 
Age 
group 
Iron intake (mg/day) 
Mean or mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), serum transferrin (g/L), 
serum iron (μmol/L), ZPP (μmol/mol haem), 
TSAT (%) 
Mean or mean ± SD 
Discussion 
Dube et al. 
(2010a) 
Healthy term infants at the 
age of 4–10 months were 
studied. Dietary intake was 
recorded with a daily diet 
record. The high meat group 
received commercial baby 
jars with a meat content of 
12 % by weight, and the low 
meat group received 8 % by 
weight. Intervention was 
from 4 to 10 months  
High meat: 48 
(24 M/24 F) 
Infants 
 
5–7 
months: 
3.86 
8–10 months: 
5.84 
7 months 
(baseline): 
Hb: 118 
Ferritin: 33.3 
Serum Fe: 
56.5 
ZPP: 39.9 
10 months (after 
intervention): 
Hb: 121 
Ferritin: 28.8 
Serum Fe: 54.1 
ZPP: 48.7 
 
Low meat: 49 
(25 M/24 F) 
3.72 5.74 Hb: 116 
Ferritin: 35.5 
Serum Fe: 
58.2 
ZPP: 39.2 
Hb: 119 
Ferritin: 25.5 
Serum Fe: 70.2 
ZPP: 45.0 
Dube et al. 
(2010b) 
Retrospective analysis of 
data from a randomised 
controlled trial. Dietary iron 
and indicators of iron status 
were analysed at the age of 4 
(exclusively milk-fed 
period), 7 and 10 months 
(complementary feeding 
period) 
Breast-fed: 53 
(27 M/26 F) 
Infants 
 
3–4 
months: 
0.46 
5–7 
months: 
1.55 
8–10 
months: 
4.81 
4 months: 
Hb: 118 
Ferritin: 75.2 
Serum Fe: 
57.4 
ZPP: 37.1 
7 months: 
Hb: 114 
Ferritin: 
32.5 
Serum Fe: 
53.5 
ZPP:38.8 
10 months: 
Hb: 119 
Ferritin: 23.5 
Serum Fe: 54.7 
ZPP: 48.4 
 
Iron-fortified 
formula: 23 (8 
M/15 F) 
6.14 6.99 6.96 Hb: 120 
Ferritin: 63.4 
Serum Fe: 
69.7 
ZPP: 48.6 
Hb: 121 
Ferritin: 
36.4 
Serum Fe: 
66.1 
ZPP: 40.8 
Hb: 123 
Ferritin: 35.6 
Serum Fe: 76.5 
ZPP: 47.2 
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Reference  Design Number of 
individuals 
(number of 
males/number of 
females) 
Age 
group 
Iron intake (mg/day) 
Mean or mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), serum transferrin (g/L), 
serum iron (μmol/L), ZPP (μmol/mol haem), 
TSAT (%) 
Mean or mean ± SD 
Discussion 
Engelmann 
et al. 
(1998) 
Parallel intervention study 
(blinded). The low meat 
group received a diet with a 
meat content aimed at the 
average found in an 
observational study of 
infants from the same area 
and the high meat group 
received a diet aimed at a 
meat content about three 
times higher than the low 
meat group 
High meat: 21 
(14 M/7 F) 
8 
months 
3.1 Hb: 119.1 
Ferritin: 15.5 (a) 
Transferrin receptor: 8 
The results suggest that an 
increase in meat intake can 
prevent a decrease in Hb in 
late infancy. However, there 
was no effect on iron stores 
or on cellular iron deficiency, 
evaluated by serum ferritin 
and TfR levels, respectively 
Low meat: 20 
(15 M/5 F) 
8 
months 
3.4 Hb: 113.7 
Ferritin: 17.3 (a) 
Transferrin receptor: 7.4 
Haschke et 
al. (1993) 
The Fe-fortified whey 
predominant formula 
contained 3 mg Fe/L, 
whereas infants in the higher 
Fe level group received 
formula containing 6 mg 
Fe/L. Dietary intake was 
assessed at 183 and 274 days 
Breast-fed 
infants until 274 
days: 30 
Infants 183 days: 
Not 
reported 
274 days: 
Not reported 
90 days: 
Hb: 118 
Ferritin: 136 
183 days: 
Hb: 123 
Ferritin:49 
274 days: 
Hb: 121 
Ferritin: 16 
 
Fe-fortified whey 
predominant 
formula: 27 
2.7 2.4 Hb: 121 
Ferritin: 86 
Hb: 124 
Ferritin: 
41 
Hb: 125 
Ferritin: 21 
Higher Fe level: 
24 
4.9 4.3 Hb: 118 
Ferritin: 102 
Hb: 124 
Ferritin: 
42 
Hb: 126 
Ferritin: 29 
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Reference  Design Number of 
individuals 
(number of 
males/number of 
females) 
Age 
group 
Iron intake (mg/day) 
Mean or mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), serum transferrin (g/L), 
serum iron (μmol/L), ZPP (μmol/mol haem), 
TSAT (%) 
Mean or mean ± SD 
Discussion 
Ilich-Ernst 
et al. 
(1998) 
Girls in pubertal stage 2 who 
were premenarcheal at 
baseline. 7-year, 
randomised, double-blind, 
placebo-controlled trial to 
assess the effects of calcium 
supplementation on bone 
mass acquisition. 
Intervention group treated 
with 1 000 mg Ca/day as 
calcium citrate malate. The 
follow-up period was 4 
years and the girls were seen 
every 6 months  
354 girls 
(baseline) 
10.8 
years 
13.2 Ferritin: 29.2  Serum ferritin concentrations 
at 0, 1, 2, 3, and 4 years were 
not significantly different 
between groups. In addition, 
there was no significant 
difference between groups in 
any of the red blood cell 
indices. 
In summary, growth spurt and 
menstrual status had adverse 
effects on iron stores in 
adolescent girls with low iron 
intake (< 9 mg/day), whereas 
long-term supplementation 
with calcium (total intake: 
< 1 500 mg/day) did not 
affect iron status 
354 girls (1 year) 11.8 
years 
12.1 Ferritin: 33.4  
354 girls (2 
years) 
12.9 
years 
12.7 Ferritin: 31  
354 girls (3 
years) 
13.9 
years 
14.3 Ferritin: 30.8  
354 girls (4 
years) 
14.9 
years 
14.0 Ferritin: 29.6 Hb (placebo): 134 
Hb (supplemented): 
132 
Lind et al. 
(2003) 
Double-blind parallel 
intervention trial in infants 
lasting for 2 months  
Commercial 
milk-based cereal 
drink and 
porridge: 94 (50 
M/44 F) 
6–12 
months 
6–8 months: 
7.5 
9–10 
months: 
9.9 
6 months: 
Hb: 116 
Ferritin: 48.5 
12 months: 
Hb: 119 
Ferritin: 25.3 
Extensive production in the 
phytate content of weaning 
cereals had little long-term 
effect on the iron and zinc 
status of Swedish infants  
Phytate-reduced 
commercial 
milk-based cereal 
drink and 
phytate-reduced 
porridge: 90 (44 
M/46 F) 
7.6 10.3 Hb: 115 
Ferritin: 40.9 
Hb: 120 
Ferritin: 21.3 
Milk-based 
infant formula 
and porridge with 
the usual phytate 
content: 83 (39 
M/44 F) 
4.7 6.2 Hb: 115 
Ferritin: 44.1 
Hb: 117 
Ferritin: 25.2 
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Reference  Design Number of 
individuals 
(number of 
males/number of 
females) 
Age 
group 
Iron intake (mg/day) 
Mean or mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), serum transferrin (g/L), 
serum iron (μmol/L), ZPP (μmol/mol haem), 
TSAT (%) 
Mean or mean ± SD 
Discussion 
Makrides et 
al. (1998) 
Dietary intake was assessed 
with a food frequency 
questionnaire  
Control: 26 (12 
M/14 F) 
6 
months, 
breast-
fed 
infants 
6 months: 
1.5 ± 1.7 
12 months: 
5.2 ± 3.4 
6 months: 
Hb: 120 ± 8 
Ferritin: 53 ± 61 
Serum Fe: 7 ± 3 
Serum transferrin: 
2.6 ± 0.4 
TSAT: 12 ± 4 
12 months: 
Hb: 115 ± 9 
Ferritin: 35 ± 37 
Serum Fe: 8 ± 3 
Serum transferrin: 
2.8 ± 0.4 
TSAT: 11 ± 5 
 
High iron 
weaning diet: 36 
(19 M/17 F) 
1.9 ± 1.9 
 
8.2 ± 2.9 Hb: 122 ± 10 
Ferritin: 53 ± 49 
Serum Fe: 8 ± 3 
Serum transferrin: 
2.7 ± 0.3 
TSAT: 13 ± 6 
Hb: 120 ± 7 
Ferritin: 26 ± 18 
Serum Fe: 9 ± 5 
Serum transferrin: 
2.7 ± 0.3 
TSAT: 13 ± 7 
Niinikoski 
et al. 
(1997) 
Dietary intake assessed with 
a 4-day food record  
Control group: 
39 
3–4 
years 
8.6 ± 2.8 Hb: 122 ± 7 
Serum transferrin: 2.85 ± 0.29 
Ferritin: 19.2 ± 12.4 
Iron: 14.8 ± 5.0 
The children in the 
intervention group consumed 
less saturated fat than those in 
the control group and had 
higher ratios of dietary 
polyunsaturated to saturated 
fatty acids. Long-term 
supervised use of a diet low 
in saturated fat and 
cholesterol did not influence 
intake or serum indicators of 
iron in children  
Intervention 
group: 40 
8.8 ± 4.2 Hb: 123 ± 8 
Serum transferrin: 2.90 ± 0.30 
Ferritin: 21.8 ± 11.6 
Iron: 15.2 ± 5.3 
F, females; Fe, iron; Hb, haemoglobin; M, males; TSAT, plasma transferrin saturation (%); ZPP, zinc protoporphyrin. 
(a): Geometric mean. 
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Appendix J. Data reported in observational studies in Europe on iron intake and markers of iron deficiency and/or iron deficiency anaemia in 
children 
Reference  Design Number of 
individuals 
Age 
(years) 
Iron intake (mg/day) 
Mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), transferrin saturation 
(%), ZPP (μmol/mol haem) 
Mean ± SD 
Discussion 
Gibson 
(1999) 
Data of the UK National 
Diet and Nutrition Survey 
(NDNS). Dietary intakes 
assessed with 4-day 
weighed records 
904 1.5–4.5 5.45 ± 0.06 (a) Hb: 122 ± 0 (a) 
Ferritin: 23.4 ± 0.6 (a) 
ZPP: 54 ± 0.7 (a) 
Despite the difference in total 
iron intake between the cereal 
consumption groups, there was 
no significant difference in iron 
status as measured by ferritin, 
Hb or ZPP 
Gunnarsson 
et al. (2004)  
3-day weighed food records  71 2 7.5 ± 4.2 Hb: 121.8 ± 8.5 
Ferritin: 17.6 ± 9.8 
 
Thane et al. 
(2003) 
7-day weighed dietary 
records  
Boys 167 4–6 % RNI 131 (RNI: 6.1 mg/day)   
8 mg/day (b) 
Hb: 125 ± 9 Ferritin (b): 30 TSAT: 
20 ± 10 
Adequacy of dietary iron intake 
(as % RNI) was significantly 
higher in boys than in girls for 
each age group. 
Poor iron status was generally 
more prevalent in adolescent 
girls of non-Caucasian ethnic 
origin or in those who were 
vegetarians 
228 7–10 % RNI 109 (RNI: 8.7 mg/day)  
9.5 mg/day (b) 
130 ± 8 31 23 ± 9 
212 11–14 % RNI 94 (RNI: 11.3 mg/day)  
10.6 mg/day (b) 
134 ± 10 30 22 ± 8 
163 15–18 % RNI 105 (RNI: 11.3 mg/day)  
11.9 mg/day (b) 
149 ± 9 45 26 ± 11 
Girls 151 4–6 % RNI 118 (RNI: 6.1 mg/day)  
7.2 mg/day (b) 
125 ± 9 24 21 ± 8 
207 7–10 % RNI 96 (RNI: 8.7 mg/day)  
8.4 mg/day (b) 
128 ± 9 33 22 ± 8 
209 11–14 % RNI 59 (RNI: 14.8 mg/day)  
8.7 mg/day (b) 
133 ± 9 29 22 ± 8 
183 15–18 % RNI 56 (RNI: 14.8 mg/day)  
8.3 mg/day (b) 
Values after the arrow were 
calculated based on intakes given as 
% RNI and RNIs in the paper 
131 ± 10 25 22 ± 10 
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Reference  Design Number of 
individuals 
Age 
(years) 
Iron intake (mg/day) 
Mean ± SD 
Indices of iron status: Hb (g/L), serum 
ferritin (μg/L), transferrin saturation 
(%), ZPP (μmol/mol haem) 
Mean ± SD 
Discussion 
Thorisdottir 
et al. (2011) 
Iron status, dietary intake 
and anthropometry were 
prospectively assessed in a 
randomly selected infant 
population  
141 (73 
boys) 
Infants At 9 months: 
6.28 ± 3.19 
At 12 months: 
6.82 ± 3.97 
At 12 months: 
Hb: 120.96 ± 8.19 
 
141 (61 
girls) 
6.27 ± 2.73 5.77 (1.97) (c) Hb: 120.28 ± 8.28 
Hb, haemoglobin; RNI, reference nutrient intake; TSAT, plasma transferrin saturation (%); ZPP, zinc protoporphyrin. 
(a): Mean ± SE. 
(b): Geometric mean. 
(c): Median (interquartile range). 
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ABBREVIATIONS 
Afssa Agence française de sécurité sanitaire des aliments 
AR Average Requirement 
CI confidence interval 
COMA Committee on Medical Aspects of Food Policy 
CV coefficient of variation 
D-A-CH Deutschland–Austria–Confoederatio Helvetica 
DH UK Department of Health 
DIPP type 1 Diabetes Prediction and Prevention 
DMT divalent metal transporter 
DNFCS Dutch National Food Consumption Survey 
DNSIYC Diet and Nutrition Survey of Infants and Young Children 
DRV Dietary Reference Value  
EAR Estimated Average Requirement 
EDTA ethylenediaminetetraacetic acid 
EsKiMo Ernährungsstudie als KIGGS-Modul 
FAO Food and Agriculture Organization of the United Nations 
FC_PREGNANTWOMEN food consumption of pregnant women in Latvia 
FFQ food frequency questionnaire 
FINDIET national dietary survey of Finland 
Hb haemoglobin 
HRT hormone replacement therapy 
INCA étude individuelle nationale des consommations alimentaires 
INRAN-SCAI Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione – Studio 
sui Consumi Alimentari in Italia 
IOM US Institute of Medicine of the National Academy of Sciences 
IRE iron-responsive element 
IRP iron-responsive protein 
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LOAEL Lowest Observed Adverse Effect Level 
LRNI Lower Reference Nutrient Intake 
MCH mean cell haemoglobin 
MCV mean corpuscular volume 
mRNA messenger ribonucleic acid 
NANS National Adult Nutrition Survey 
NCM Nordic Council of Ministers 
NDNS National Diet and Nutrition Survey 
NHANES National Health and Nutrition Examination Survey 
NL Netherlands Food and Nutrition Council 
NNR Nordic Nutrition Recommendations 
NOAEL No Observed Adverse Effect Level 
NWSSP Nutrition and Wellbeing of Secondary School Pupils 
PRI Population Reference Intake 
RDA Recommended Dietary Allowance 
RES reticuloendothelial system 
RI Recommended Intake 
RNI Reference Nutrient Intake 
SACN UK Scientific Advisory Committee on Nutrition 
SCF Scientific Committee for Food 
SD standard deviation 
SE standard error 
sTfR soluble serum transferrin receptor 
TfR transferrin receptor 
TIBC total iron-binding capacity 
TSAT transferrin saturation 
UL Tolerable Upper Intake Level 
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VELS Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von 
Säuglingen und Kleinkindern für die Abschätzung eines akuten 
Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln 
WHO World Health Organization 
ZPP erythrocyte zinc protoporphyrin 
 
